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This thesis describes the synthesis of pyrroloquinolines and pyrroloquinoxalinones in order to 
probe a decarboxylation mechanism which takes place in nature. The mechanism is believed to 
occur through an azomethine ylide cycloaddition reaction using ylide A. Simplifying this model, 
cycloadducts with the general structure of C were synthesised from quinolinium salts B. In addition, 
oxidation, reduction and Suzuki-Miyaura coupling reactions were carried out on the cycloadducts 
generated. Cycloadducts with the general structure of E were synthesised via ylides generated 
from the condensation of amine D with aldehydes. For both series of cyclodducts the substrate 
scope was limited, but reactions worked well with N-methylmaleimide. Unfortunately, attempts at 
generating cycloadducts with ylides more closely resembling A were unsuccessful.   
 
 
Using a cascade process, the reaction of ketone F with either glycine or acetyl hydrazine gave 
tricyclic cycloadducts G and H through the corresponding azomethine ylide or imine. Although the 
substrate scope was limited with these reactions the N-N bond in H could be cleaved to give the 






Finally, we envisaged that by applying a similar cascade process to aldehydes with the general 
structure of J then cycloadduct K could be obtained. Subsequent transformations on any of the 
cycloadducts generated would potentially lead to the natural product (±)-kopsinine. Although 



















So, I suppose this is it…  
First I would like to thank Prof Iain Coldham for giving me the opportunity to do my PhD in his group. 
The help and support throughout my time in the group has been much appreciated. 
I would also like to thank everyone in the Coldham group over the past few years. Nick, Ruaa, Tahani, 
Ziad and Rungroj thanks for making my early days in the group more entertaining then what they may 
have been. However, I would like to say a special thanks to certain people. Ashraf I would make the 
joke and say thanks for all the proof reading, repair jobs, and lone master’s students to look after, but 
in hindsight there were some good times. In particular, reminders about the correct pronunciation of the 
number “…eleven…” have provided much humour over the past few years. Jennifer thanks for putting 
up with me on a daily basis in my final year, even when I was in “bitey” mode, for showing me that 
peaches can look like radishes and for expressing your dislike of broccoli (actually most green 
vegetables) and carrots. I would list more things here (e.g. Star Wars, hair stroking, travel earrings, 
airplane mode, Korean love hearts and Chris Hemsworth) but more importantly thanks for being a good 
friend and for the laughs along the way. Beth thank-you as well: your joyful and bubbly personality has 
made my days a lot happier towards the end of my PhD, so keep on going and you’ll be great. To all 
the master’s students I’ve looked after officially (and un-officially, you know who you are) I would like to 
thank you all for making the lab a fun place work in and for the general humour, banter and (on occasion) 
sarcasm that has accompanied you all. Special thanks goes to Rebecca, Jemma, Matt and Robbie who 
have all been brilliant students and have “churned” whilst under my supervision on cycloaddition 
projects. 
I would also like to thank people in other research groups. Haneesh, thanks for the fortnightly trips to 
Jezza’s (John’s) van and for conversations which have provided light relief during harder times. Arthur 
and Sayantan, thanks as well for the fun times in the office and for the many conversations we’ve had. 
I would like to thank everyone in the Partridge group (James, Fran and George), Harrity group, and 
Jones group as well for the general chit-chat and any help given.                    






Chapter 1 – Introduction ............................................................................................................... 1 
1.1 Azomethine ylides .................................................................................................................. 1 
1.2 Formation of azomethine ylides ............................................................................................. 5 
Chapter 2 – Synthesis of Pyrroloquinolines and Pyrroloquinoxalinones Towards 
Developing a Flavin Model .......................................................................................................... 16 
2.1 Introduction to Flavins and Function in Decarboxylases ..................................................... 16 
2.2 Previous work ....................................................................................................................... 21 
2.3 Aims...................................................................................................................................... 24 
2.4 Synthesis of aldehydes 83 and 98 ....................................................................................... 25 
2.5 Attempted cycloaddition reactions with aldehydes 83 and 98 ............................................. 33 
2.6 Alternative routes to pyrroloquinoline cycloadducts ............................................................ 35 
2.7 Synthesis of pyrroloquinoxalinone cycloadducts ................................................................. 46 
2.8 Moving towards the flavin model.......................................................................................... 54 
2.9 Conclusions and Future Work .............................................................................................. 61 
Chapter 3 – Synthesis of Tricyclic Compounds Using Cascade Chemistry ......................... 63 
3.1 Introduction to cascade chemistry ....................................................................................... 63 
3.2 Previous work ....................................................................................................................... 64 
3.3 Aims...................................................................................................................................... 72 
3.4 Synthesis of cycloadduct 232 and optimisation ................................................................... 73 
3.5 Synthesis of salt 240 ............................................................................................................ 75 
3.6 Expanding the substrate scope............................................................................................ 76 
3.7 Activation of alkene in ketone 241 ....................................................................................... 80 
3.8 Tricyclic products from azomethine imines .......................................................................... 82 
3.9 Conclusion and Future Work ............................................................................................... 86 
Chapter 4 – Towards the Synthesis of Kopsinine Using Cascade Chemistry ...................... 88 
4.1 Introduction to indole alkaloids and previous work .............................................................. 88 
4.2 Previous synthetic routes towards Kopsinine ...................................................................... 90 
4.3 Aims.................................................................................................................................... 102 
v 
 
4.4 Synthesis of aldehyde 366 and cycloaddition reactions .................................................... 103 
4.5 Alternative routes towards kopsinine using different aldehydes ....................................... 108 
4.6 Conclusions and Future Work ............................................................................................ 119 
Chapter 5 – Experimental .......................................................................................................... 121 
Appendices ................................................................................................................................. 200 


























TEBAC benzyltriethylammonium chloride 
b.p. boiling point 
BHT butylated hydroxytoluene 
CSA camphorsulfonic acid 
CDI carbonyldiimidazole 
cm centimetre(s)  
c concentrated 
Cy cyclohexyl 
°C degrees Celsius 
DFT density functional theory 
DCB dichlorobenzene 
DIBAL-H diisobutylaluminium hydride 
DME dimethoxyethane 
DMSO dimethyl sulfoxide 
DMF dimethylformamide 
DMPU dimethylpropyleneurea 
EDG electron donating group 
EI electron impact 




ee enantiomeric excess 
eq equivalent(s) 
Fdc or fcd ferulic acid decarboxylase 
FAD flavin adenine dinucleotide 
FMN flavin mononucleotide 
UbiX or ubiX flavin prenyltransferase 
FT fourier transform 





HRMS high resolution mass spectrometry 





LDA lithium diisopropylamide 
LRMS low resolution mass spectrometry 
LUMO lowest unoccupied molecular orbital 
m/z mass to charge ratio 
mCPBA m-chloroperoxybenzoic acid 
MHz megahertz 











MS molecular sieves 
nm nanometre(s) 
n-Bu n-butyl 
NMO N-methylmorpholine N-oxide 
NMR nuclear magnetic resonance 
ppm parts per million 
Ph phenyl 
PPA polyphosphoric acid 
prFMN prenylated flavin mononucleotide 
Pad or pad protein-arginine deiminase 




TBAI tetrabutylammonium iodide 
THF tetrahydrofuran 
TBAF tetra-n-butylammonium fluoride 
TPP tetraphenylporphyrin 
TLC thin layer chromatography 
TOF time of flight 
Ts toluenesulfonyl 
TBA tribromoacetic acid 




v/v volume/volume percentage 




Chapter 1 – Introduction 
1.1 Azomethine ylides  
Azomethine ylides are an example of a nitrogen-based 1,3-dipole. Structurally they are planar 
molecules made up of three sp2 hybridised atoms forming a C–N–C unit. The molecule contains 4 
π-electrons spread over the three atoms and can be represented by 4 different resonance 




In the presence of dipolarophiles, azomethine ylides can undergo 1,3-dipolar cycloaddition 
reactions to generate a variety of heterocycles.2–6 Although they were first discovered in 1963 by 
Huisgen, the use of azomethine ylides in intramolecular cycloaddition reactions was not carried 
out until 1976.1,7 However, since then they have been studied widely for the formation of 5-
membered cyclic amines, such as pyrrolidines, dihydropyrroles and pyrroles. Importantly, 1,3-
dipolar cycloaddition reactions have been used to generate a variety of products via regiocontrolled 
and stereocontrolled pathways.8  
Applying the Woodward−Hoffmann rules to the reaction of a 1,3-dipole with a suitable 
dipolarophile, we can see the reaction involves 6 π-electrons [π4s + π2s].9 The reaction is 
suprafacial on both π-systems and is therefore thermally allowed. It is generally accepted that the 
reaction is a concerted process, where the two carbon-carbon σ-bonds form at the same time and 
on the same face of both the ylide and dipolarophile.10 As a result, the relative stereochemistry of 
the alkene dipolarophile is maintained in the cycloadduct. A general diagram of the concerted 
process is shown in Figure 2. 
 
 
Figure 1 – Resonance forms of an azomethine ylide 
Figure 2 – A 1,3-dipolar cycloaddition reaction 
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The cycloaddition reaction can be explained using frontier molecular orbital (FMO) theory. The 
dominant orbital interaction in the cycloaddition reaction is between the highest occupied molecular 
orbital (HOMO) of the azomethine ylide and the lowest unoccupied molecular orbital (LUMO) of 
the dipolarophile (Figure 3).11 As a result of this, azomethine ylides prefer to react with electron 
poor dipolarophiles in intermolecular cycloadditions, whereas intramolecular cycloaddition 











Stereochemistry is an important factor to consider in cycloaddition reactions, as up to four new 
stereocentres are formed in the cycloadduct. Therefore, this could potentially result in the formation 
of 16 stereoisomers for each regioisomer. The stereochemistry of the C2 and C5 atoms in the 
cycloadduct are determined by the shape of the azomethine ylide. There are four possible 
geometries an azomethine ylide can adopt, which are shown in Figure 4. The W-shaped and U-
shaped ylides lead to the formation of the 2,5-cis-disubstituted pyrrolidine products; whereas the 
two S-shaped ylides lead to the formation of the 2,5-trans-disubstituted pyrrolidine products. 
 
 











In comparison, the stereochemistry of the C3 and C4 atoms is determined by the relative 
orientation of the substituents in the dipolarophile. Due to cycloaddition reactions occurring via a 
concerted mechanism they are usually stereospecific with respect to the alkene. As a result, trans-
disubstituted alkenyl dipolarophiles generally lead to the formation of the 3,4-trans-disubstituted 
pyrrolidine products, while cis-disubstituted alkenyl dipolarophiles lead to the formation of the 3,4-








The orientation of the dipolarophile with respect to the azomethine ylide is another important factor 
as this can lead to the formation of endo and exo diastereoisomers. In general, like Diels−Alder 
reactions, there is a preference for the substituents on the alkene dipolarophile to adopt an endo 
Figure 4 – Different shaped ylides forming cis or trans products 
Figure 5 – Different shaped alkenes forming cis or trans products 
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orientation, rather than the exo, during the cycloaddition reaction. Therefore, in most reactions the 









Most cycloaddition reactions are highly regioselective, however if either the dipole and/or 
dipolarophile are unsymmetrical then regioselectivity is another important factor to consider (Figure 
7).12 This is usually determined by the sizes of the molecular orbitals involved in the reaction, where 
the preferred regioisomer is formed as a result of the maximum overlap between the orbitals in the 
reactants. The relative sizes of the molecular orbitals can be influenced by the presence of electron 
withdrawing groups (EWG) and electron donating groups (EDG) on each reactant. In addition, 
steric and electronic effects may also have an impact on the regioselectivity.   






Figure 6 – Endo and Exo selectivity in cycloaddition reactions 
Figure 7 – Regioselectivity in cycloaddition reactions 
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1.2 Formation of azomethine ylides  
Due to their unstable nature, azomethine ylides are usually synthesised in-situ, and once formed 
can then react with dipolarophiles to generate cycloadducts via an intramolecular or intermolecular 
cycloaddition reaction.1 Although there are many ways to generate azomethine ylides, this brief 
introduction will focus only on a few methods which will be used later in future chapters. 
One of the simplest ways to generate azomethine ylides is by the reaction of an aldehyde or ketone 
with a primary or secondary amine. If the amine contains an electron withdrawing group in the α-
position, such as an ester, then the resulting iminium ion can be deprotonated to give an 
azomethine ylide. Typical examples of amines used to generate azomethine ylides are α-amino 
esters due to their wide availability. One of the first reported examples of this chemistry was in 
1983 by Confalone and co-workers.13 An example is shown in Scheme 1 where aldehyde 1 was 
heated with N-methyl glycine ethyl ester hydrochloride and Na2CO3 in toluene. From this, 
cycloadduct 3 was isolated in 57% yield.  
The range of substrates was then later expanded by using different aldehydes and α-amino 
esters.14,15 This generated a variety of different cycloadducts in good yields. An interesting example 
is shown in Scheme 2 where aldehyde 4 was reacted with pipecoline ethyl ester to give compound 







            
  
Alongside this cyclic esters (lactones) have also been used to generate azomethine ylides, which 
in turn has allowed access to a variety of different polycyclic compounds. As shown in Scheme 3 
Harwood and co-workers reacted lactone 6 with paraformaldehyde and N-phenylmaleimide to give 
cycloadducts 7a and 7b. Development of this chemistry eventually led to the synthesis of 







It should be noted that most examples of this type of chemistry use aromatic aldehydes to generate 
the ylide.17–21 However, aliphatic aldehydes can be used as well. An example of this chemistry has 
been done by Coldham and co-workers and is summarised in Scheme 4.22 Aldehyde 8 was first 
reacted with N-methyl glycine ethyl ester in xylene with a Dean-Stark trap to give the major product 
9a (via the S-shaped ylide) and two other inseparable isomers, which were tentively assigned as 






In addition to using aliphatic aldehydes, additives and metal catalysts can be added to a 
cycloaddition reaction to induce selectivity. A recent example using α-amino esters is shown in 
Scheme 5 where Reisman and co-workers utilised a Cu(I)/brucin-OL catalysed 1,3-dipolar 
cycloaddition reaction between Weinreb amide 10 and imine 11, derived from cinnamaldehyde 
and glycine ethyl ester, to synthesise pyrrolidine 12 in 42% yield and 95% enantiomeric excess 









One of the major drawbacks of using α-amino esters to generate azomethine ylides is that the 
ester group used to stabilise the ylide remains on the cycloadduct formed. While there are methods 
to remove the ester functional group, generating an unstabilised azomethine ylide via 
decarboxylation can be done to overcome this problem.1 This type of chemistry has been widely 
studied by Grigg and co-workers and an example is shown in Scheme 6.24,25 Heating aldehyde 14 
with phenyl glycine in DMF formed product 15, via the W-shaped ylide 17, as a single 
diastereoisomer. It is thought that the reaction proceeds through the oxazolidinone intermediate 











This chemistry has been used to synthesise a number of potential drug molecules and natural 
products.26,27 An example is shown in Scheme 7 where aldehyde 18 was heated separately with 
1,2,3,4-tetrahydro-isoquinoline-2-carboxylic acid 19 and 1,2,3,4-tetrahydro-β-carboline-3-













A more recent example using decarboxylation to form unstabilised ylides is shown in Scheme 8. 
This work was carried out by Trauner and co-workers where they managed to synthesise 5-
deoxymubironine C 24 via a cycloaddition reaction of 23 with sarcosine.28 It was thought that the 
reaction proceeded through azomethine ylide 25. The synthesis of these carbon frameworks was 
particularly interesting as they can be seen in natural products such as (+)-mubironine C 26. 
     
Another useful method that allows the formation of unstabilised ylides involves desilylation. One of 
the first examples of using this method is shown in Scheme 9. The work was carried out by 
Livinghouse and co-workers in 1986 and was towards synthesising the core structure of the 





Using caesium fluoride then allowed the formation of azomethine ylide 29, which underwent a 








In 1997 and then in 2004, Pearson and co-workers reported the formation of azomethine ylides 
via intramolecular N-alkylation of imines and subsequent desilylation.31,32 These azomethine ylides 
were treated with a range of dipolarophiles to produce a series of indolizidine products through an 
intermolecular cycloaddition process. A destannylation method was also developed as well and 
through altering the chain length of the starting imine it was found that different cyclic azomethine 
ylides could be generated, forming products with larger ring sizes (five, six, seven, and eight but 
with a poorer yield). An example is shown in Scheme 10 where imine 31 was heated in toluene to 
give iminium 32. The azomethine ylide 33 was then generated either through desilylation or 
destannylation, and a subsequent cycloaddition reaction with N-phenylmaleimide then gave the 






A more recent application of desilylation to form an azomethine ylide is shown in Scheme 11. In 
2016, Pandey and co-workers managed to synthesise (+)-aspidospermidine 38 where the key step 
involved an intramolecular cycloaddition reaction.33 Mixing precursor 35 with silver fluoride in 
acetonitrile generated azomethine ylide 36 which underwent a cycloaddition reaction to form 
cycloadduct 37 in a very good yield of 92% as a single diastereoisomer. Subsequent Fischer indole 









Unstabilised azomethine ylides can sometimes be generated through deprotonation without the 
need of a carbonyl group in the α-position of the amine or loss of TMS. This chemistry has been 
carried out by Siedel and co-workers and an example is shown in Scheme 12.34 1,2,3,4-
Tetrahydroisoquinoline 39 first undergoes a condensation reaction with benzaldehyde derivative 
40 in the presence of benzoic acid, 3 Å molecular sieves (MS) and toluene. This generates an 
azomethine ylide intermediate, which undergoes an intramolecular cycloaddition reaction to give 
compound 41 in 96% yield. The reaction scope was further expanded to include a variety of other 





An alternative method to synthesise azomethine ylides is through the deprotonation of iminium 
salts, which can be generated through the N-alkylation of aromatic nitrogen containing 
heterocycles, such as pyridine, isoquinoline and other similar structures.35–41 An example reaction 
is shown in Scheme 13 where salt 43 was formed from the reaction of isoquinoline 42 with 2-
bromoacetophenone in tetrahydrofuran (THF). Subsequent deprotonation of 43 then generated 
the azomethine ylide 44.    
 
This method of generating azomethine ylides has been used many times throughout the literature 
to synthesise a variety of cycloadducts. One of the first examples of this work was done by Tsuge 
and co-workers who managed to synthesise a wide range of iminium salts and react them with 
different symmetrical alkenes.42 Some example reactions are shown in Scheme 14 where salts 45 
and 47 were deprotonated using triethylamine and reacted with N-methylmaleimide and N-














Tsuge and co-workers then expanded the range of reactions to include a large number of 
unsymmetrical alkenes.43 Two examples are shown in Scheme 15 where salt 49 was reacted with 
acrylonitrile or with trans-β-nitrostyrene to give products 50 and isomers 51a and 51b respectively. 
Isomers 51a and 51b were isolated in a 1:1 ratio, which implied that the reaction may not have 













Spirocyclic compounds can be synthesised using this chemistry. Some recent work in this area 
has been carried out by Dowden and co-workers and an example is shown in Scheme 16, where 
pyridinium salt 52 was reacted with 3-alkenyl oxindole 53 to give the spirocyclic compound 54 as 
a single diastereoisomer in 88% yield.44 The substrate scope was then expanded using different 
substituted pyridinium salts and 3-alkenyl oxindoles, which gave a range of novel spirocyclic 





This work was then developed further to synthesise a series of highly functionalized 
tetrahydroindolizidines in good yields with generally excellent diastereoselectivity.45 An example is 
shown in Scheme 17 where the corresponding pyridinium ylide was generated from pyridine 
derivative 55 and ethyl diazoacetate in the presence of [Fe(TPP)Cl]. A subsequent in-situ 












It is important to mention that mechanistic studies were carried out which suggested a stepwise 
process was taking place where once the pyridinium ylide formed, via nucleophilic addition to the 
metal carbene or diazonium ylide, it then underwent 1,4-addition to the alkenyloxindole. A 
subsequent cyclisation reaction would then generate the final product. A general mechanism using 










To summarise this chapter, we have demonstrated that azomethine ylides can be generated in a 
number of different ways. Once they have been formed in-situ they can react with dipolarophiles 
via 1,3-dipolar cycloaddition reactions to give products usually in high yields and good selectivities. 
In future chapters we will discuss the application of this chemistry to synthesise novel compounds 








Chapter 2 – Synthesis of Pyrroloquinolines and 
Pyrroloquinoxalinones Towards Developing a Flavin Model 
2.1 Introduction to Flavins and Function in Decarboxylases 
Flavins are a group of organic compounds derived from the tricyclic heterocycle isoalloxazine 62. 
The flavin moiety is utilised in many biochemical pathways where it is often covalently bonded to 
other functional groups to form biological cofactors, such as flavin adenine dinucleotide 63 (FAD) 
and flavin mononucleotide 64 (FMN). These cofactors bind to flavoenzymes not only as cofactors, 
but can also serve as substrates in some flavin-dependent reactions. The natural biochemical 
source of flavin comes from the vitamin riboflavin 65, which is also known as vitamin B2. The 
structures of isoalloxazine, FAD, FMN and riboflavin are shown in Figure 8.46 
 
 
Flavins can undergo redox reactions either as a single two-electron reaction or as two single-
electron reactions, forming an intermediate flavin free radical during the process. Sodium dithionite 
in protic or aqueous media is commonly used in the literature to reduce flavins. This process is 
Figure 8 – Structure of isoalloxazine, FAD, FMN & riboflavin 
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summarised in Scheme 19 where the oxidised flavin 66 (Flox) is converted to the reduced flavin 67 








The ability of flavins to undergo redox reactions is important for the function of flavoenzymes in 
biological pathways. In 2015, while researching the function of decarboxylase enzymes, work 
carried out by Leys and co-workers found a new enzyme cofactor, which was derived from FMN 
64.50 Previous work in the area showed that the bacterial genes ubiX and ubiD (or the homologous 
fungal genes fdc1 and pad1) coded proteins that were responsible for the non-oxidative reversible 
decarboxylation of aromatic substrates.51 Example reactions done are shown in Scheme 20 where 











Continuing on from this work, the Aspergillus niger fdc1 gene was co-expressed with the ubiX gene 
from E. coli. This gave a co-expressed Fdc1 protein called Fdc1UbiX. As expected the Fdc1UbiX 
protein was able to successfully catalyse the reversible decarboxylation of a variety of cinnamic 
acid derivatives as shown by the UV-visible spectra data collected. Further atomic resolution data 
showed that the prenylated FMN 73 (prFMN) cofactor was involved in the reaction. In line with 
previous work it was suggested that prFMN 73 cofactor was formed from the prenylation of FMN 
64 using dimethylallyl-monophosphate and the UbiX protein (or Pad1). This process is summarised 








It was found that activation of prFMN 73 was oxygen dependent. This indicated that prFMN 73 was 
oxidised to form an intermediate. Using data from high resolution mass spectrometry it was 
suggested that prFMN 73 was oxidised to form intermediate 74. This intermediate contains a 1,3-
dipole and is an example of an azomethine ylide. The oxidation process is shown in Scheme 22 


















After further experiments, a mechanism for the decarboxylation of cinnamic acid 69 was proposed. 
50,54 This is shown in Scheme 23 where intermediate 74 undergoes a 1,3-dipolar cycloaddition to 
give the pyrrolidine adduct 75. Fragmentative decarboxylation could take place to give 76, which 
is then protonated using a glutamic acid residue to give another pyrrolidine adduct 77. A retro 1,3-
dipolar cycloaddition then takes place reforming the azomethine ylide 74 and the desired product 
styrene 70. It’s important to mention that this mechanism has some reservations, in particular the 
first step where the 1,3-dipolar cycloaddition reaction occurs. Although 1,3-dipolar cycloaddition 
reactions occur widely in organic chemistry, this was believed to be the first example of an 
enzymatic azomethine ylide cycloaddition. As a result further research has been carried out by 
other research groups into this mechanism as discussed below. In addition to the cycloaddition 
reaction the feasibility of some of the remaining steps is questionable. The fragmentation of adduct 
75 to give 76 is suspicious due to the molecular orbitals in 75 not being aligned, whereas in the 
third step cyclisation of 76 to 77 is potentially problematic as no similar examples of this process 
have been reported in the literature. However, as the whole decarboxylation process take place 





The original mechanism was based on the crystal structures of Fdc1UbiX complexed with a variety 
of substrate analogues.50 However, further research into the area has provided some evidence to 
support this mechanism involving a 1,3-dipolar cycloaddition.50,54 In 2016, Marsh and co-workers 
carried out a range of deuterium isotope studies to investigate the decarboxylation process.55 Their 
results supported the proposed mechanism and also suggested that the rate determining step in 
the catalytic cycle was the final step, where the product-prFMN adduct undergoes a retro 1,3-
dipolar cycloaddition. Furthermore, they postulated that by using a highly electron withdrawn vinyl 
substrate it may have been possible to stabilise the product-prFMN adduct and slow down the rate 
of reaction.   
Continuing with this work, in 2017 Marsh and co-workers attempted to use (Z)-2-fluoro-2-nitro-
vinylbenzene 78 to trap adduct 79 formed after a 1,3-dipolar cycloaddition with prFMN 73 in the 
presence of Fdc1 (Scheme 24).56 Initially they struggled to use 19F NMR and 1H NMR to 
characterise adduct 79 due small amounts being released from the enzyme and its instability once 
it was released. To overcome this problem they used native mass spectrometry, which enables 
the study of intact protein, non-covalent protein-protein and protein-ligand complexes in their 
biological state. Using this technique they were able to dissociate adduct 79 from the enzyme, and 









Finally, density functional theory (DFT) calculations have been done by Chen and co-workers to 
investigate the Fdc1 decarboxylation mechanism with cinnamic acid.57 Their calculations provided 
further support for the proposed mechanism, and like the other studies carried out, concluded that 
the last step where the styrene-prFMN adduct (e.g. 77, Scheme 23) undergoes a retro 1,3-dipolar 
cycloaddition was rate-limiting with an overall barrier of 18.9 kcal mol-1. 
The discovery of this novel decarboxylation mechanism attracted a lot of attention when it was first 
published. If the decarboxylation mechanism is correct, then similar reactions could be done to 
generate a variety of different α-olefins, and once optimised the overall process could provide a 
new efficient route to many industrially important hydrocarbons and chemicals. Therefore, 
investigating the mechanism further is of interest, especially the 1,3-dipolar cycloaddition reaction.  
2.2 Previous work 
Previous research in the Coldham group has been focussed around the use of azomethine ylides 
to synthesise polycyclic molecules. As a result of the work mentioned in the previous section 
related to the decarboxylation of cinnamic acid 69 we wanted to investigate the pathway further by 
trying to provide some further evidence for the 1,3-dipolar cycloaddition step. Due to the complexity 
and large size of prFMN 74, it was first important to simplify the flavin model. Looking at the site 
where the azomethine ylide forms, 74 can be simplified in a number of different ways. This is 
summarised in Figure 9 where removing some of the functional groups off the prenylated flavin 
and N-methylating the N(3) position would give intermediate 80. Making further simplifications by 
removing the dihydrouracil ring would give intermediate 81 and then removing the amide functional 




Ultimately, if cycloaddition products could be successfully isolated from reactions of dipolarophiles 
with intermediate 80 then this could provide some further evidence for the 1,3-dipolar cycloaddition 
step. In addition, synthesis of cycloadducts via intermediates 81 and 82 may be useful as no 
examples were present in the literature.     
To begin work on investigating the cycloaddition reaction we chose to synthesise azomethine ylide 
82. The R2 group was chosen to be a methyl ester due to its electron withdrawing capability, which 
would help stabilise azomethine ylide 86. A potential way to form ylide 86 is shown in Scheme 25 
via a Boc deprotection reaction on 83. Subsequent cyclisation, followed by deprotonation, and 
cycloaddition with an appropriate dipolarophile would hopefully generate the core cycloadduct 87.  
It’s important to mention that similar work has been carried out by Fukuyama and co-workers to 
synthesise ()-daphenylline.58 The most important reaction to synthesise the main core of ()-
daphenylline is shown in Scheme 26, where cleavage of the Boc group from compound 88 by 




heating in toluene at 200 C triggered the formation of a cyclic azomethine ylide. This promoted 





Early work began by attempting to synthesise compound 83 via the synthetic route shown in 
Scheme 27.59 In the first step, aniline (90) was reacted with allyl bromide to give N-allyl aniline 91, 
which was then converted into 2-allyl aniline 92, via a 3,3-sigmatropic rearrangement. Subsequent 
Boc protection and alkylation with methyl bromoacetate using sodium hydride gave compound 94. 
Hydroboration was carried out next to give primary alcohol 95, however this reaction gave a very 
low yield. This may have been due to the hydrolysis of the methyl ester group. Unfortunately, an 







In order to continue with this chemistry, it was decided that the hydroboration reaction to synthesise 
compound 95 would first need to be optimised. If the methyl ester functional group was being 
hydrolysed; therefore reducing the overall yield, then it may be more beneficial to replace the 
methyl ester group in compound 94 with the more robust N,N-dimethyl amide group to give 
compound 96. Hydroboration and Swern oxidation steps would then hopefully give aldehyde 98, 
which could then undergo subsequent Boc deprotection to give 99. By using conditions similar to 
Fukuyama, cyclisation would then take place, forming azomethine ylide 100 which in the presence 
of a suitable dipolarophile would hopefully generate cycloadducts with the general structure of 101. 
These steps are summarised in Scheme 28.   
 
If work on synthesising cycloadducts similar to 101 was successful then further work could lead to 
cycloadducts from intermediates 80 and 81 as well. Therefore, this could provide potential 







2.4 Synthesis of aldehydes 83 and 98 
Before any cycloaddition reactions could be carried out it was important to try and synthesise 
aldehyde 98. To achieve this the synthetic route shown in Scheme 29 was used which was based 
on previously developed chemistry in the group to access compound 93. This could then undergo 
an alkylation reaction with 2-bromo-N,N-dimethylacetamide 102 to give compound 96. Subsequent 
hydroboration and Swern oxidation steps would then hopefully allow aldehyde 98 to be isolated. 
Fortunately, we were provided with a previously synthesised sample of compound 93 to carry out 
the first alkylation reaction. Due to the cost of compound 102 it was decided to synthesise this 
compound first from the more readily available bromoacetyl bromide 103. Using dimethylamine we 
were able to isolate acetamide 102 in 50% yield (Scheme 30). 
 
 
However, when carrying out the alkylation of compound 93 with acetamide 102 in the presence of 
sodium hydride and DMF no desired product was isolated (Scheme 31). This reaction was 
repeated multiple times producing the same result. Furthermore, in each attempt no starting 
material was recovered and an unknown by-product was isolated instead. Initially from 1H NMR 
spectroscopy we thought that the starting material may have cyclised to form 2-methylindoline, but 








A new synthetic route was then devised as shown in Scheme 32 where compound 92 was first 
alkylated with acetamide 102 to give compound 104. This could then undergo a Boc protection 
reaction to give compound 96, which after further reactions would allow aldehyde 98 to be isolated.  
 
As shown in Scheme 33, aniline (90) was first N-alkylated using allyl bromide and potassium 
carbonate in DMF at 85 C to give compound 91 in a low yield of 39%. Initially, we thought that 
this may have been due to the difficult work-up procedure as lots of water was required to remove 
the DMF from the crude product. Furthermore, it was found that compound 91 could be alkylated 




Conversion of compound 91 to compound 92 using a Lewis acid catalysed 3,3-sigmatropic 
rearrangement was achieved using the conditions shown in Scheme 34. The reaction involved 










The next two steps carried out are shown in Scheme 35. Compound 92 was first alkylated with 
acetamide 102 using triethylamine in the presence of DMF at room temperature. The isolated 
compound 104 was then protected using Na2CO3 and Boc2O to obtain compound 96. 
Unfortunately, compound 96 was obtained in a very low yield of 10%. Therefore, it was important 
to try and optimise the Boc protection reaction to obtain a better yield. 
 
It was thought that the choice of base may have played an important part in the synthesis of 
compound 96. As a result, the Boc protection reaction to synthesise 96 was repeated multiple 
times using different bases and conditions. The results obtained are summarised in Table 1 and 













Looking at the data, using a slightly stronger base such as NaOH gave an improved 15% yield. 
The next base used was n-BuLi, which was added to the starting material at 78 C and left to stir 
for 5 minutes before Boc2O was added. The mixture was then warmed to room temperature over 
16 h. This gave a much better yield of 26% and this was increased to 34% when leaving the 
reaction for 10 minutes before quenching with Boc2O. Due to time constraints, no more reaction 
conditions were scoped for the Boc protection reaction and compound 96 was carried forward onto 
the next step.   
Unfortunately, the hydroboration-oxidation reaction of compound 96 was unsuccessful using the 
conditions shown in Scheme 37. Multiple repeats of the reaction were done and different boranes 
such as 9-BBN were also used. In all reactions no starting material was recovered and multiple 





In comparison, it was found when compound 104 was subjected to the same hydroboration-
oxidation conditions shown in Scheme 37, the corresponding primary alcohol 106 was isolated in 
a 40% yield. More importantly, the reaction generated none of the potential secondary alcohol 
product. This is summarised in Scheme 38. 
Table 1 
Base T % Yield of 96 Notes 
NaOH rt 15  
n-BuLi −78 °C to rt 26 
n-BuLi added to starting material 
before Boc2O with 5 min wait 
n-BuLi −78 °C to rt 34 
n-BuLi added to starting material 
before Boc2O with 10 min wait 







It was decided to carry compound 106 forward to see whether the alcohol group could be converted 
into an aldehyde to obtain compound 107. To achieve this, a Swern oxidation reaction was carried 
out as shown in Scheme 39. However, this generated no desired product and no starting material 





The alternative route devised to synthesise aldehyde 98 is shown in Scheme 40. In the first step 
2-aminobenzyl alcohol 108 is O-methylated to give 109. A subsequent reaction with allyl 
magnesium bromide in the second step then gives the 2-substituted aniline 110. Using similar 
alkylation and Boc protection methods as mentioned previously would then hopefully allow 
compound 112 to be isolated. The final step involves a dihydroxylation-diol cleavage reaction to 













Compound 110 was synthesised using a known literature method.60 This is summarised in Scheme 
41 where 2-aminobenzyl alcohol 108 was O-methylated using methanol and concentrated sulfuric 
acid to obtain compound 109 in 76% yield. This was then reacted with allyl magnesium bromide to 
give compound 110 in 50% yield. 
 
Next, compound 110 was alkylated using similar conditions to those mentioned previously 
(Scheme 35). It was found that using an excess of both 2-bromo-N,N-dimethylacetamide 102 and 
triethylamine gave a much better yield of compound 111. However, full conversion of compound 










Moving forward to the Boc-protection step, the optimised conditions used to synthesise compound 
96 were used again to convert compound 111 to compound 112.  These are summarised in 
Scheme 43 where the reaction was carried out using n-BuLi as the base at 78 C. Disappointingly 




This indicated further optimisation needed to be done to try and improve the yield of compound 
112. Applying a similar method to before it was first decided to investigate how changing the base 
would affect the yield. The reaction conditions used are summarised in Scheme 44. Looking at the 
data collected and comparing with the synthesis of compound 112 using the conditions in Scheme 
43, using a weaker base, such as sodium hydroxide, generated a lower yield of the Boc protected 
compound 112. Therefore, although a low yield of compound 112 was obtained using n-BuLi, the 










The next parameter that was investigated was temperature. The reaction in Scheme 43 was 
repeated at 20 C and 40 C (Scheme 45). The reaction at a higher temperature of 20 C 
proved less beneficial as a much lower yield of 16% of compound 112 was obtained. However, a 




Although a slightly higher yield of compound 112 was eventually obtained, this was still a low yield. 
In order to try and obtain a better yield of compound 112, it was decided to swap the alkylation and 
Boc-protection steps around. Boc protection of compound 110 using triethylamine and Boc2O, in 
THF, gave compound 113 in 48% yield. The isolated material was then alkylated with 2-bromo-
N,N-dimethylacetamide 102 and sodium hydride to give compound 112 in a much better yield of 







The final step in the synthesis of aldehyde 98 is shown in Scheme 47 where compound 112 was 
dihydroxylated using osmium tetroxide and N-methylmorpholine N-oxide (NMO). Upon working up 
the reaction the crude product was carried forward onto the next step where the crude diol was 








Before any cycloaddition reactions were attempted, the methyl ester analogue 83 was also 
synthesised using a similar route to compound 98. The overall process is shown in Scheme 48 
where in the first step, compound 113 was alkylated using methyl bromoacetate to give compound 









2.5 Attempted cycloaddition reactions with aldehydes 83 and 98 
Once aldehydes 83 and 98 were isolated the final step in the synthetic route needed to be carried 
out. This involved a Boc-deprotection reaction followed by cyclisation to form an azomethine ylide 
intermediate. This could then react with a dipolarophile, such as N-methylmaleimide. This is 







The initial reaction conditions were the same as those used by the Fukayama group (Scheme 
26).58 These conditions were applied to compounds 83 and 98 and involved heating with NaOAc, 
butylated hydroxytoluene (BHT), and 4 Å molecular sieves in toluene at 200 C under microwave 
conditions. This is summarised in Scheme 50. Unfortunately, after many attempts, no desired 
product was isolated and none of the original starting material was recovered. 
 
Following on from this many other conditions were used to try and isolate the desired products 115 
and 116. These are summarised in Scheme 51 where p-toluenesulfonic acid (TsOH) was first used 
to try and remove the Boc group in compounds 83 and 98. This would have hopefully allowed 
cyclisation to take place and a cycloaddition reaction to occur. Another set of conditions used was 
based around the work done by Sato, Chida and co-workers.61 This involved using trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) and 2,6-lutidine to try and remove the Boc group on 
compound 83. Unfortunately, these methods were unsuccessful and none of the desired products 
were isolated. Due to the disappointing results obtained it was decided to stop work on this 






2.6 Alternative routes to pyrroloquinoline cycloadducts 
From the work done so far it was clear that formation of azomethine ylides similar to 82 was 
problematic. Therefore the next step was to try and apply more conventional methods to form these 
ylides. As mentioned previously one of the simplest ways to form an azomethine ylide is by reacting 
an aldehyde with an amine. Deprotonation of the resulting iminium could then form an azomethine 
ylide. In an attempt to apply this chemistry to synthesise cycloadducts similar to 87 and 101, it was 
decided to react tetrahydroquinoline 117 with benzaldehyde in the presence of benzoic acid and 
N-methylmaleimide. The conditions used were similar to those reported by Seidel and co-workers,  











A potential reason why these reactions didn’t work is due to the -proton in tetrahydroquinoline not 
being acidic enough for deprotonation. Therefore, no azomethine ylide was formed and no 
cycloaddition reaction could take place. An alternative way to generate azomethine ylides is from 
the decarboxylation of amino acids and using this idea we decided to investigate whether similar 
reactions could take place with 1,2,3,4-tetrahydroquinoline-2-carboxylic acid 120. Before any 
reactions could be done compound 120 had to be synthesised. The conditions used are shown in 
Scheme 53 where quinaldic acid 119 was reduced using PtO2 under a hydrogen atmosphere (1 




Compound 120 was then subjected to similar cycloaddition reaction conditions as reported in the 
literature with other amino acids.62–64 This is summarised in Scheme 54 where compound 120 was 
reacted with N-methylisatin 122 and N-methylmaleimide in methanol at 90 C for 1 h. N-
Methylisatin 122 was synthesised from isatin 121 using K2CO3 and methyl iodide. Unfortunately, 













We repeated the reaction with similar amino acids such as L-proline and pipecolinic acid as shown 
in Scheme 55. The reaction with pipecolinic acid 124 was unsuccessful and TLC analysis of the 
crude product indicated that methylisatin 122 had not been consumed in the reaction. This 
suggested that no imine formation had taken place, and as a result none of the desired azomethine 
ylide was formed to generate cycloadduct 125. In comparison, the reaction with L-proline 126 gave 
cycloadduct 127 in 84% yield. X-ray crystallography was done on compound 127 and confirmed 
that only one stereoisomer had been isolated (Figure 10 and Appendix 1). The methyl group 
appears as six protons due to individual molecules in unit cell being disordered, therefore an 

















Figure 10 – X-ray crystal structure of 127 
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The initial results using decarboxylation methods to try and synthesise tetrahydroquinoline 
cycloadducts seemed discouraging. As a result, it was decided to take a different approach to try 
and synthesise these compounds via the deprotonation of iminium salts to generate azomethine 
ylides. Looking further through the literature, quinolinium salts with the general structure 128 had 
been exploited to synthesise a variety of pyrroloquinoline compounds with a structure similar to 
129 (Scheme 56).65–67 Most examples used ketones (R = aryl) as electron withdrawing groups to 
stabilise the intermediate azomethine ylide. Although carboxylic acid derivatives had been used, 
there were few examples of quinolinium salts which contained the ester and amide functional 
groups we were interested in.68–70 Therefore, this provided us with a potentially viable route to the 





The new synthetic approach taken to synthesise compounds 115 and 116 is shown in Scheme 57 
and takes advantage of using quinolinium salts like 128. Using a methyl ester or dimethyl amide 
functional group would give salts 131 and 132, which could be synthesised from quinoline. 
Subsequent deprotonation using an appropriate base would then generate an azomethine ylide 
which could undergo a cycloaddition reaction with N-methylmaleimide to give compounds 133 and 







Synthesis of salts 131 and 132 was achieved using the conditions shown in Scheme 58. Quinoline 
(130) was reacted with the appropriate bromide in toluene. The mixtures were heated at 65 C for 




Once salts 131 and 132 were isolated they were both subjected to the cycloaddition conditions 
shown in Scheme 59 where triethylamine was used to deprotonate the salt forming an azomethine 
ylide intermediate, which then reacted with N-methylmaleimide to generate the cycloadducts 133 
and 134 in good yields of 77% and 87% respectively. X-ray crystallography of compound 133 was 
useful in identifying its relative stereochemistry (Figure 11 and Appendix 2). Using the dihedral 
angles, determined from the X-ray crystallography data, between the C-H bonds on the pyrrolidine 
ring it was possible to assign protons in the 1H NMR spectrum. This was done by applying the 
Karplus relationship to compare the relative sizes of the J-values with the corresponding dihedral 
















Moving forward, the final step in the synthetic route involved the hydrogenation of compounds 133 
and 134 to give compounds 115 and 116. This was achieved by using the conditions shown in 
Scheme 60 where alkenes 133 and 134 were stirred with 10% Pd/C in ethyl acetate, under a 
hydrogen gas atmosphere (1 atm) at room temperature. 1H NMR spectroscopy was used to 
monitor the reaction and showed that the starting materials were fully consumed after 48 h. This 










It was also possible to oxidise compound 134 by heating in the presence of 2,3-dichloro-5,6-






In an attempt to expand the range of cycloadducts further, salt 131 was reacted with a small 
number of other dipolarophiles. Unfortunately with most alkenes and alkynes the reaction was 
unsuccessful generating none of the desired cycloadduct. Dipolarophiles that were unsuccessful 
are shown in Scheme 62. For all the reactions TLC analysis of the crude products indicated that 
the dipolarophile had not been consumed and no new spots were observed after heating the 
reactions for 1 h. Overall, we were unsure about why reactions with these dipolarophiles were 
unsuccessful. This was even more suprising when considering the high reactivity of some of the 













Fortunately, aromatic malononitriles 138a-c gave positive results when they were each reacted 
with salts 131 and 132. The conditions used are summarised in Scheme 63 where compounds 
138a-c were synthesised first by reacting the substituted benzaldehydes 137a-c with malononitrile 
in ethanol at room temperature, in the presence of aqueous NaHCO3. Once the malononitriles 
were isolated, they were then each reacted with salts 131 and 132 to give the products 139–144. 
When carrying out the reactions we found that prolonged heating caused the cycloadducts formed 
to decompose, therefore the reactions were heated for 1 h only. The structures and yields of 
compounds 139–144 are shown in Table 2. The stereochemistry of compound 139 was confirmed 




















































To complete the work on the pyrroloquinolines we attempted to expand the substrate scope further 
by synthesising some compounds starting with 6-chloroquinoline 145. This work was carried out 
alongside a MChem student in the group and the results are summarised in Scheme 64.71 Starting 
with 6-chloroquinoline 145 the corresponding ester and amide quinolinium salts 146 and 147 were 
synthesised using the same conditions used previously. Salts 146 and 147 were isolated in 11% 
yield and 26% yield respectively. In comparison with salts 131 and 132 the 6-chloroquinoline 
derivatives were much more hygroscopic and harder to isolate, hence lower yields were obtained. 
Nonetheless, cycloaddition reactions of salts 146 and 147 with N-methylmaleimide gave the 









We then attempted to do a Suzuki-Miyaura coupling reaction on compound 149. The conditions 
used are shown in Scheme 65 where compound 149 was heated with 
tetrakis(triphenylphosphine)palladium(0), phenyl boronic acid and sodium carbonate. 
Unfortunately, none of the desired product 150 was isolated, however when repeating the reaction 
multiple times we managed to recover the starting material 149. This indicated that oxidative 
addition of the palladium catalyst to compound 149 was not occurring and no coupling reaction 




To overcome this problem it was decided to synthesise the corresponding 6-bromo cycloadduct 
instead and repeat the Suzuki-Miyaura coupling. This is shown in Scheme 66 where starting from 
6-bromoquinoline 151 the amide quinolinium salt 152 was first synthesised in 45% yield. 









We were now in a position to repeat the Suzuki-Miyaura coupling. Applying the same reaction 
conditions as before to cycloadduct 153 we were able to successfully isolate the coupled 






2.7 Synthesis of pyrroloquinoxalinone cycloadducts 
With some successful results obtained with the pyrroloquinolines we decided to move forward onto 
the next flavin model based around synthesising cycloadducts from azomethine ylide 81. To 
access these compounds we devised the synthetic route shown in Scheme 68 where the 
condensation reaction of dihydroquinoxalinone 154 with an aldehyde would generate an iminium 
species that could be deprotonated to give azomethine ylides 81. Different alkenes could then be 
used to trap the azomethine ylides formed allowing cycloadducts with the general structure of 155 





Before any work could be done, dihydroquinoxalinone 154 had to be synthesised. This was done 
using a known literature procedure as shown in Scheme 69.72 Although R2 has the potential to be 
any functional group we chose a methyl group to keep the model simple. The corresponding acid 
chloride of cyanoacetic acid 156 was first reacted with N-methylaniline to give amide 157 in 98% 
yield. This subsequently underwent a tandem nitrosation/cyclisation process with t-butyl nitrite in 
the presence of caesium carbonate, acetic acid and 4 Å MS in acetonitrile to give quinoxalin-2-one 
158 in 74% yield. It’s important to mention that the addition of sodium dithionite was required to 





quinoxalin-2-one 158 was reduced using sodium borohydride to give dihydroquinoxalinone 159 in 











With dihydroquinoxalinone 159 in hand we studied the use of conditions similar to those reported 
by Siedel and co-workers to try and synthesise the desired cycloadduct products.34 As shown in 
Scheme 70, dihydroquinoxalinone 159 was heated with benzaldehyde, 4 Å MS, benzoic acid and 
N-methylmaleimide in toluene, but unfortunately none of the desired cycloaddition product 160 was 
isolated and only starting material was recovered. Changing to a stronger acid from benzoic to 
camphorsulfonic acid gave a similar result, but LCMS analysis of the crude product indicated that 














It was clear that oxidation of the starting material was potentially interfering with the cycloaddition 
reaction. Looking in the literature, similar reactions have been reported where similar 
dihydroquinoxalinones were readily oxidised to form quinoxalin-2-one products. An example is 





To investigate the oxidation reaction, dihydroquinoxalinone 159 was heated under reflux in toluene 
with 10 mol% CSA as shown in Scheme 72. Analysis of the crude reaction mixture by 1H NMR 










When carrying out the same reaction under an inert argon atmosphere, 1H NMR spectroscopy of 
the reaction mixture indicated no oxidised material 159 had been formed. Subsequently, repeating 
the cycloaddition reaction under an inert argon atmosphere as shown in Scheme 73 gave the 
desired cycloadduct 160, as a single diastereoisomer in a moderate yield of 47%. In the reaction 






The stereochemistry of compound 160 was confirmed by using X-ray crystallography (Figure 13 
and Appendix 4), which indicated that compound 160 was presumably formed via the S-shaped 
ylide due to the trans configuration between the protons α to the amine nitrogen atom. Like with 
the pyrroloquinolines correlating the J-values with the dihedral angles, determined from the X-ray 
crystallography data, between the C-H bonds on the pyrrolidine ring allowed assignment of the 











The next step was to optimise the reaction conditions as shown in Scheme 74 and Table 3. Initially 
increasing the amount of CSA caused an increase in the yield of cycloadduct 160, with a maximum 
yield of 57% being obtained when 15 mol% of CSA was added (entry 4). Decreasing the reaction 
temperature caused a decrease in the yield of cycloadduct 160 (entries 7 & 8). Addition of 4 Å 
molecular sieves to act as a drying agent seemed to improve the reaction yield (entry 10). 
Changing the molar ratio of dihydroquinoxalinone 159 and benzaldehyde gave variable yields for 
cycloadduct 160 (entries 11−15) with the best yield being obtained when the molar ratio of 
dihydroquinoxalinone 159:benzaldehyde was 1.5:1 (entry 11). In a final attempt to improve the 
yield, the acid added to the reaction was changed from CSA to benzoic acid; however, this resulted 

















Acid (mol%) Temperature Drying 
Agent 
% Yield 
1 2 1 No Acid 110 °C None 0 
2 2 1 CSA (5 mol%) 110 °C None 14% 
3 2 1 CSA (10 mol%) 110 °C None 47% 
4 2 1 CSA (15 mol%) 110 °C None 57% 
5 2 1 CSA (20 mol%) 110 °C None 49% 
6 2 1 CSA (50 mol%) 110 °C None 47% 
7 2 1 CSA (15 mol%) 90 °C None 40% 
8 2 1 CSA (15 mol%) 70 °C None 31% 
9 2 1 CSA (15 mol%) 110 °C MgSO4 48% 
10 2 1 CSA (15 mol%) 110 °C 4 Å MS 63% 
11 1.5 1 CSA (15 mol%) 110 °C 4 Å MS 69% 
12 1.2 1 CSA (15 mol%) 110 °C 4 Å MS 40% 
13 1 1 CSA (15 mol%) 110 °C 4 Å MS 54% 
14 1.5 1.5 CSA (15 mol%) 110 °C 4 Å MS 38% 
15 1 1.5 CSA (15 mol%) 110 °C 4 Å MS 25% 




Using the optimised conditions (Scheme 75), we then explored the substrate scope of the reaction. 
By varying the aldehyde, we were able to obtain a range of different cycloadducts 164-167 in 
varying yields (Table 4). The reaction was successful with both electron-poor (entry 2) and 
electron-rich (entry 3) benzaldehydes, although the yield of cycloadduct 165 in the latter case was 
low. It was pleasing to find that the reaction was successful with a heteroaryl group (entry 4) and 
with the non-aromatic aldehyde cyclohexanecarbaldehyde, which gave the desired cycloadduct 
167 in 31% yield. In all cases 164-167, we obtained only a single stereoisomer and this was 
assumed to have the same stereochemistry as determined for cycloadduct 160.  
Although the reaction was successful with this range of aldehydes, when the reaction was carried 
out using 2-furaldehyde or 3-methyl-2-butenal no desired product was isolated. With 2-furaldehyde 
the starting material was recovered, whereas with 3-methyl-2-butenal a mixture of products was 






































Continuing with the work we then looked into expanding the alkene scope. Like the 
pyrroloquinolines the cycloaddition reaction was unsuccessful with a variety of dipolarophiles 
including dimethyl furmarate, methyl trans-cinnamate and diethyl acetylenedicarboxylate. This is 
summarised in Scheme 76, where reactions with other failed dipolarophiles are shown. However, 





















Finally, the scope of products was extended by oxidation of cycloadducts 160 and 166 using DDQ. 
Like the pyrroloquinolines, similar reaction conditions were used as shown in Scheme 78. This 








2.8 Moving towards the flavin model 
Having now made progress towards synthesising pyrroloquinolines and pyrroloquinoxalinones we 
wanted to test the flavin model 80. The synthetic route devised to access this model is shown in 
Scheme 79. Starting with flavin derivative 172 a reduction reaction could be done to generate the 
reduced species 173.49 This could then be alkylated with prenyl bromide to give 174, which could 
then undergo a cyclisation reaction to form prenylated flavin 175.74,75 Subsequent oxidation and 
deprotonation would then result in azomethine ylide 80.76,77 Reactions of ylide 80 with alkenes 
would then allow cycloadducts with the general structure 176 to be accessed. This would hopefully 
provide some evidence that a 1,3-dipolar cycloaddition reaction could take place in the biochemical 






Initial work began by attempting to synthesise derivatives of flavin 172. To not overcomplicate the 
flavin structure we initially chose the R1-group to be methyl. Therefore, as shown in Scheme 80, 
nitroaniline 177 was N-methylated using methyl iodide and sodium hydride to give compound 178 
in 78% yield.78 Subsequent reduction of compound 178 using a mixture of sodium borohydride and 







Compound 179 was then reacted with alloxan monohydrate and boric acid in the presence of 
glacial acetic acid.80 This gave the crude flavin 180, which was then methylated using methyl iodide 
and Cs2CO3 in DMF.81 Compound 181 was isolated in a yield of 30% over the two steps (Scheme 
81). Unfortunately, when scaling up the reaction to synthesise larger amounts of compound 181, 
very poor yields were obtained (<10%). This may have been due to the poor solubility of 181 in 
organic solvents. 
 
To try and overcome this problem it was decided to replace the N(10) methyl group with a benzyl 
group to increase its solubility. As a result, a new synthetic route was devised as shown in Scheme 
82. The route used is very similar to the route used to synthesise compound 181. In the first step, 
nitroaniline 177 was N-alkylated using benzyl bromide and sodium hydroxide in acetone.82 Heating 
under reflux for 1 h gave compound 182 in 41% yield. Subsequent reduction of compound 182 
using sodium borohydride and 10% Pd/C gave diamine 183 in 96% yield. Crude flavin 184 was 
then synthesised by reacting 183 with alloxan monohydrate and boric acid in glacial acetic acid. 
The crude flavin 184 was then methylated using potassium carbonate and methyl iodide to give 
the flavin core 185 in a good yield of 74%. This route was more beneficial as the product 185 was 






With flavin core 185 in hand we now wanted to reduce and alkylate at the N(5) position. Looking 
further into the literature, we hoped that once we were able to reduce flavin 185 using a suitable 
reducing agent, such as sodium dithionite, then alkylation would occur readily. However, previous 
studies in the area have shown that the choice of alkylation agent is important as that different 
alkylating agents have the potential to alkylate in different positions on the flavin core (Scheme 
83).83  
The reaction conditions first used in an attempt to reduce compound 185 are shown in Scheme 
84. Sodium dithionite was added to a solution of compound 185 in ethanol and left to stir under an 
argon atmosphere. Prenyl bromide was then added in the hope that alkylation would occur and 
produce compound 189. Unfortunately after multiple attempts and switching to alternative 
alkylating agents including allyl bromide, benzyl bromide and ethyl bromide no desired alkylated 









Looking at the potential issues, we thought there may have been a problem with the reduction 
process. According to the literature, the reduction of vitamin B2 normally results in a colour change 
from yellow to colourless.84 When carrying out the reduction reactions shown in Scheme 84 we 
noticed that none of the reactions produced a similar colour change. As a result we decided to 
investigate other methods to reduce flavins, in particular using zinc and acid. Using the reaction 
conditions shown in Scheme 85 we were able to successfully reduce flavin 185 using activated 
zinc in acetic acid under an argon atmosphere. Upon the addition of activated zinc metal the 
reaction changed colour from yellow/orange to red (Figure 14) which was in agreement with a 
similar example in the literature and indicated that the reduction reaction had occurred.85 Acylation 












Figure 14 – Yellow to red colour change during reduction of 185 using zinc 
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Having now found a method to reduce flavin 185 we then attempted an alkylation reaction using 
ethyl iodide as the alkylating agent (Scheme 86). Unfortunately, upon the addition ethyl iodide the 
reaction mixture began to vigorously bubble eventually causing the reaction vessel to fail and the 
mixture to be exposed to air. Based on the assumption that an organozinc reagent was being 




Moving forward, we then wanted to use a similar acylation reaction to the one shown in Scheme 
85 to get closer to the prenylated flavin intermediate 80. The anhydride 194 was prepared by 
converting 3,3-dimethylacrylic acid 192 into its corresponding acid chloride 193 using oxalyl 
chloride. This was then added to a mixture of 3,3-dimethylacrylic acid 192 and sodium hydride to 
give anhydride 194 in 66% yield. By applying a procedure similar to the reaction in Scheme 85 
using anhydride 194, acylated flavin 195 was isolated in 36% yield (Scheme 87). The structure of 
195 was confirmed using X-ray crystallography which showed that flavin 185 had been acylated in 























We then attempted to cyclise the alkene in acylated flavin 195 onto the aromatic core by heating it 
with AlCl3 as shown in Scheme 88. Our idea was that the AlCl3 may have been able to coordinate 
the two carbonyl groups to allow this process to take place, however after multiple attempts of the 
reaction no desired product was formed. This may have been potentially due to the preference of 
the undesired rotamer of the acyl group. The reaction was repeated at room temperature in CH2Cl2 
but gave the same result.   
Scheme 87 







Unfortunately, due to the difficulties encountered, it was decided to stop work on trying to 
synthesise the final flavin model 80 and move onto a different project.         
2.9 Conclusions and Future Work 
In summary, although we were unsuccessful in providing further evidence for the initial 1,3-dipolar 
cycloaddition reaction in the decarboxylation pathway of cinnamic acid using prFMN 73, we were 
able to synthesise a range of smaller cycloadducts with similar resemblance to the intermediate 
75.  
Using quinolinium salts we successfully managed to perform cycloaddition reactions to isolate 
pyrroloquinolines. We were also able to carry out further reactions on these products, including 
reduction to form the corresponding tetrahydroquinoline and oxidation to form the corresponding 
pyrrole in good yields. Subsequently, we found that if the pyrroloquinoline contained a bromine 
atom in the C(6) position then a Suzuki-Miyaura coupling could be achieved. Shifting the focus 
towards the synthesis of pyrroloquinoxalinones, although the cycloaddition reactions were air 
sensitive, a small number of cyclodducts were synthesised in varying yield. In addition, like the 
pyrroloquinolines some of the molecules were oxidised to obtain the desired pyrrole products. 
Unfortunately, with both the pyrroloquinolines and the pyrroloquinoxalinones the dipolarophile 
scope was very limited, generally only working with a few alkenes such as N-methylmaleimide.    
Efforts to synthesise a prenylated flavin analogue were unsuccessful. Essentially, this was mainly 
due to difficulty in installing the prenyl group onto the flavin core. Taking inspiration from biology, 




Further work could be done on the pyrroloquinoxalinones as the products generated have the 
potential to be biologically active, therefore expanding the substrate scope could prove useful.86–
89 This could be achieved in a number of different ways as shown in Figure 16. Changing the 
aromatic ring, either by adding substituents to the benzene ring or by changing the benzene ring 
to a heteroaryl group is a simple way to expand the scope of products. Furthermore, changing the 
electron withdrawing group from an amide to an ester or thioester could be beneficial as well. 
Alternatively, another electron withdrawing group could be placed in the 2-position as shown. This 
is more likely to have an effect on the cycloaddition reaction and could lead to an expansion in the 












Figure 16 – Potential future work on pyrroloquinoxalinone compounds 
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Chapter 3 – Synthesis of Tricyclic Compounds Using 
Cascade Chemistry  
3.1 Introduction to cascade chemistry  
Within organic synthesis the ability to form complex molecules in an efficient manner is of vital 
importance, particularly when synthesising alkaloid natural products as most synthetic routes are 
generally long and contain multiple chemical reactions. A possible solution to overcome these long 
synthetic routes is to utilise cascade reaction processes. These processes involve using a series 
of chemical reactions which proceed successively due to the presence of highly reactive functional 
groups or reactive intermediates being formed in each step. As a result of this, intermediate 
compounds are usually not isolated or purified; and the addition of extra reagents or changes to 
reaction conditions are not required. Overall, this results in a highly efficient process, which is 
environmentally friendly when compared to using multiple stepwise reactions as less chemical 
waste is generated.90,91       
Within the Coldham group we have successfully managed to utilise dipolar cycloaddition reactions 
in a cascade process, in particular using azomethine ylides. This is summarised in Scheme 89 
where amine 198 first undergoes a condensation reaction with aldehyde 197. This results in the 
formation of imine 199 that can cyclise to give the iminium 200. Subsequent deprotonation or 
decarboxylation can then generate the desired azomethine ylide 201 and intramolecular 
cycloaddition would then result in the tricyclic product 202 being isolated. Formally, this process is 




In this chapter we will discuss the use of this cascade reaction towards the synthesis of small 
tricyclic compounds, which have become a common target in the group. However, it is important 
to mention that this research has also been used to synthesise the main cores of natural products. 
This will be discussed in the next chapter.    
3.2 Previous work  
One of the first synthetic methods used in the group to synthesise tricyclic compounds is shown in 
Scheme 90.92 Using the acyclic aldehyde 203 and heating with a variety of amino acids in toluene 
allowed access to cycloadducts 204a-d in good yields from 77-85% (Table 5). The reactions were 
highly stereoselective as only the all cis diastereoisomer was formed. A contributing factor to the 
high yields was due to the additional ethyl group on aldehyde 203 which prevented enolisation of 













Compound R Group % Yield 
204a H 77 
204b Me 85 
204c CH2Ph 85 





The substrate scope was then expanded by using glycine ethyl ester hydrochloride instead of 
glycine. The reaction conditions used are shown in Scheme 91 and gave product 205 in 81% yield. 
Furthermore, it was found that by altering the chain length of the two alkyl chains attached to the 
aldehyde, cycloadducts could be isolated in good yields that contained different ring sizes (Scheme 
















Compound R Group % Yield 
206a H 82 
206b Me 78 







Continuing with the work, it was found that by replacing the ethyl group on the α-carbon of the 
aldehyde starting material with a tert-butyldimethylsilyl (TBDMS) ether group gave access to a 
small series of novel cycloadducts.93 An example is shown in Scheme 94 where aldehyde 209 was 
reacted with glycine ethyl ester hydrochloride in the presence of Hünig’s base to give cycloadduct 
210. From here the TBDMS group could then be removed to give alcohol 211 and subsequent 
Swern oxidation and decarbonylation reactions gave the tricyclic amine 213.    
Generating different dipoles instead of azomethine ylides also proved to be a successful way of 
expanding the substrate scope. Using hydroxylamine hydrochloride to generate nitrones, and 
applying the reaction conditions shown in Scheme 95 to aldehyde 203 gave the fused tricyclic 
isoxazolidine products 214−216 in good yields as a single diastereoisomer.92 In comparison, using 
substituted hydrazines allowed the formation of tricyclic pyrazolidines such as 217 and 218 in very 
good yields of 91% and 83% respectively (Scheme 96).94 
 
Scheme 95 
 Scheme 94 
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More recently, research in the group has moved on to synthesising similar tricyclic compounds. 
However instead of using aldehydes, acyclic ketones were used. An example reaction is shown in 
Scheme 97 where ketone 219 was heated with hydroxylamine hydrochloride and Hünig’s base in 
toluene.95 This gave cycloadduct 220 in 89% yield as a single diastereoisomer. Furthermore, upon 
reduction of the N-O bond using zinc and acetic acid the spirocyclic compound 221 could be 
isolated.  
 
Like with previous work, varying the alkyl chain length on either side of the ketone allowed access 
to a variety of alternative cycloadducts with different ring structures. It’s important to mention that 
a mixture of inseparable regioisomers was obtained when ketones 222 and 225 were used 
(Scheme 98). However, upon the addition of zinc and acetic acid to the mixture of products gave 
spirocycles which could be separated using column chromatography and were isolated in good 







Using ketone 228, which contained a nitrogen atom between the alkene and ketone functional 
groups, allowed compound 229 to be synthesised in a 94% yield using hydroxylamine 
hydrochloride (Scheme 99). Furthermore, the use of glycine ethyl ester hydrochloride and glycine 
gave access to cycloadducts 230 and 231 respectively via the corresponding azomethine ylide 
when each reacted with ketone 228 (Scheme 100).96 For the cycloaddition reaction using glycine 
it was found that changing the reaction solvent to N,N-dimethylformamide was required to help 









Synthesising compounds 230 and 231 demonstrated the versatility of the cascade cycloaddition 
chemistry with acyclic ketones. As a result of this it was decided to develop the chemistry further 
in an attempt to synthesise more tricyclic compounds via azomethine ylides. This work was 
originally carried out by a MChem student in the group under my supervision in the laboratory.97 
The first reaction attempted is shown in Scheme 101 where ketone 219 was heated with different 
methyl ester derivatives of amino acids in the presence of Hünig’s base and toluene. 





gave cycloadduct 232 in 33% yield. It was thought that the reaction proceeded through azomethine 
ylide 232a. 
Repeating the reactions using amino acids instead of their methyl ester derivative was 
unsuccessful. The reaction conditions used are shown in Scheme 102. In all of the reactions no 
desired products 233 were isolated after column chromatography, but LCMS analysis of the crude 




It was then decided to activate the alkene functional group in ketone 219 by attaching a phenyl 
sulfone group in the terminal position. This was achieved using a Grubbs metathesis reaction as 
shown in Scheme 103 where ketone 219 was reacted with phenyl vinyl sulfone in the presence of 











With compound 235 in hand the cycloaddition reactions using the amino acids shown in Scheme 
104 were carried. The results are summarised in Table 7 where it was pleasing to find that when 
using glycine and phenylalanine the desired cycloadducts 236a and 236c were isolated in 56% 
and 12% yields respectively. Unfortunately, the reaction was unsuccessful when using L-alanine 
and none of the desired product 236b was isolated. It’s important to mention that although the 
addition of the phenyl sulfone group should have improved the rate of cycloaddition, when 










To expand the substrate scope with ketone 235 it was then decided to see whether a cycloaddition 
reaction would take place with glycine methyl ester hydrochloride (Scheme 105). Although TLC 
analysis of the crude product indicated the starting ketone had been consumed none of the desired 
product 237 was isolated. 
      
 
 
Compound R Group % Yield 
236a H 56 
236b Me 0 






Finally, the stereochemistry of cycloadduct 232 was confirmed via X-ray crystallography on 
compound 240 (Figure 17). This was synthesised using a three step process as shown in Scheme 
106 where compound 240 was isolated in 16% yield over the three steps. As only a small sample 
of cycloadduct 232 had been synthesised and due to time constraints intermediates 238 and 239 
were not isolated and characterised. The X-ray crystal structure of compound 240 confirmed that 













Continuing on from previous work done in the group it was important to improve the yields obtained 
when ketone 219 was reacted with glycine methyl ester hydrochloride to give cycloadduct 232. 
Furthermore, although the stereochemistry of 232 was confirmed via X-ray crystallography on 
compound 240, the intermediate compounds 238 and 239 were not characterised. Therefore, it 
was important to synthesise and isolate these compounds as well (Scheme 107). 
   
Following on from this the substrate scope needed to be expanded. This could be achieved using 
a variety of different ketones in place of ketone 219. Some examples of ketones are shown in 
Figure 18 which would result in cycloadducts with different ring structures. 
Scheme 107 




3.4 Synthesis of cycloadduct 232 and optimisation 
Before any cycloaddition reactions could be done ketone 219 needed to be synthesised. The 
reaction conditions used are shown in Scheme 108 where bromopentene 244 was converted into 
its corresponding Grignard reagent using magnesium and THF. This was then cooled to −78 °C 
and copper(I) bromide was added and subsequent addition of acid chloride 245 then formed the 
desired ketone 219, which was isolated in a yield of 79%.95 
 
 
Having obtained ketone 219 the next step was to repeat the initial cycloaddition reaction with 
glycine methyl ester hydrochloride as shown in Scheme 109. Repeating the reaction it was 
pleasing to find that we managed to obtain cycloadduct 232 in 33% yield. Although this was in 
agreement with the previously obtained result TLC analysis of the crude product indicated many 
side products had been formed. 
 
 
We now wanted to optimise these reaction conditions. Repeating the reaction and varying the 
solvent didn’t seem to benefit the reaction as no desired product was isolated when o-xylene or 
DMF were used and in both reactions ketone 219 was recovered. In comparison, the reaction was 









We thought that there may have been a problem with the initial iminium formation. Therefore the 
reaction conditions shown in Scheme 111 were attempted as well. It was thought that by premixing 
the glycine methyl ester hydrochloride and a stoichiometric amount of Hünig’s base would generate 
its free amine form in solution. Subsequently adding ketone 219 and magnesium sulfate would 
then allow the intermediate iminium ion to be formed more readily, which could then be 
deprotonated to form the desired azomethine ylide, and therefore cycloadduct 232 via the addition 
of another equivalent of Hünig’s base. Unfortunately, compound 232 was isolated in a much lower 
yield of 18%. 
In a final attempt to increase the yield of compound 232 we investigated the addition of different 
additives to the initial cycloaddition reaction in Scheme 109. To help with the imine formation we 
first added ZnCl2 to the reaction to act as a Lewis acid, alongside magnesium sulfate which was 
added to remove any water formed. To our disappointment cycloadduct 232 was isolated only in 
10% yield. However, to our surprise when repeating the initial reaction with a large excess of 










Having now obtained the optimised reaction conditions, we then repeated the cycloaddition 
reaction using L-alanine methyl ester hydrochloride (Scheme 113). Although TLC analysis 





3.5 Synthesis of salt 240 
We considered that it was important to re-synthesise compound 240 and in the process 
characterise compounds 238 and 239 as well. Cycloadduct 232 was first reduced using LiAlH4 to 




Next, compound 238 was reacted with 4-bromobenzoyl chloride which was generated from 4-
bromobenzoic acid. Upon the addition of triethylamine, ester 239 was isolated in 59% yield. Finally 
using an ethereal solution of hydrogen chloride, ester 239 was converted into its hydrochloride salt 














3.6 Expanding the substrate scope 
To continue we now wanted to expand the substrate scope by using alternative ketones instead of 
219. Acyclic ketones 222 and 241 were synthesised using similar reaction conditions to those 
shown in Scheme 108. Ketone 222 was synthesised using bromohexene 247 and acid chloride 
245 to give the desired product in 69% yield. In comparison, 241 was synthesised using 





We also decided to prepare aromatic ketones 242 and 243 as well. However to apply the same 
methods used previously we would have to first synthesise the appropriate acid chloride derivative 







Acid chloride 249 was synthesised using a known literature method where phthalide 251 was 
heated with thionyl chloride, benzyltriethylammonium chloride (TEBAC), and boric acid at 130 °C 
for 9 h (Scheme 118).98 Upon working up the reaction the crude acid chloride 249 was isolated in 
89% yield and was carried forward onto the next step without further purification. Using similar 
reaction conditions as mentioned previously ketone 242 was isolated in 27% yield (Scheme 119). 
This yield was low when compared to the aliphatic ketones 222 and 241, which may have been 












In comparison, acid chloride 250 was synthesised using the route shown in Scheme 120. 
Isochroman 252 was first oxidised by using potassium permanganate to give the oxidised product 
253 in 70% yield.99 This was then carried forward onto the next step where phosphorus 
pentachloride was used to convert compound 253 into acid chloride 250 in 92% yield.100 
Using the crude acid chloride 250 and applying the reaction conditions shown in Scheme 121, 
compound 243 was isolated in 9% yield. To our surprise this was much lower yield than expected 
when compared to the other ketones previously synthesised. However, initial TLC analysis of the 





With ketones in hand we reacted them each with glycine methyl ester hydrochloride using the 
same conditions as mentioned before (Scheme 122). Unfortunately in all reactions no desired 
product was isolated, but the starting ketone was recovered. This indicated that there may have 
been problems with the initial imine formation preventing the overall cascade process from 
occurring. Furthermore, the reaction using ketone 241 was repeated with the addition of 0.1 
equivalents of tetrabutylammonium iodide (TBAI) to aid the cyclisation step, and potentially allow 






Due to the success of the previous work done using nitrone cycloaddition chemistry with ketones 
222 and 241, we then decided to investigate whether a similar reaction would take place with 
ketone 242. The reaction conditions used are shown in Scheme 123 where ketone 242 was heated 
with hydroxylamine hydrochloride and Hünig’s base in the presence of magnesium sulfate and 
toluene. Although no desired cycloadduct 259 was isolated some starting material was recovered. 
In addition, an unknown compound was also isolated, and based on the 1H NMR and 13C NMR 
spectroscopic data seemed to suggest that the oxime 260 had been obtained. However, the mass 
spectrum was inconsistent with oxime 260 and did not show the correct molecular ion peak. On 
the assumption we had successfully isolated oxime 260 we then heated it with TBAI in toluene in 










Due to the unsuccessful results obtained so far with expanding the ketone substrate scope it was 
decided to focus on ketone 241 and investigate whether activating the terminal alkene would help 
allow a cycloaddition reaction to take place.  
3.7 Activation of alkene in ketone 241 
As mentioned earlier activation of ketone 219 proved to be beneficial towards allowing 
cycloaddition reactions to take place with amino acids such as glycine and phenylalanine. To 
achieve this a phenyl vinyl sulfone group was introduced in the terminal position of the alkene. As 
a result of this we now wanted to apply similar chemistry to ketone 241 in an attempt to allow a 
successful cycloaddition reaction to take place.    
Starting with ketone 241 a Grubbs metathesis reaction was carried out. The conditions used are 
shown in Scheme 125 where ketone 241 was heated with phenyl vinyl sulfone in dichloromethane, 
in the presence of Grubbs second generation catalyst. In line with previous work done in the group 
on ketone 235, to aid the purification process dimethylsulfoxide (DMSO) was added to the reaction 
mixture after 24 hours to remove any remaining ruthenium impurities in the reaction mixture.101 






With ketone 261 in hand it was subjected to similar cycloaddition reaction conditions as ketone 
235 with glycine in DMF, with the addition of 10 mol% TBAI (Scheme 126). Unfortunately, none of 
the desired product was isolated and although TLC analysis of the reaction mixture indicated that 
the starting material had been consumed many spots could be observed. However, LCMS analysis 
of the crude product gave a peak that corresponded to the mass of the desired product 262. From 
the data collected we thought that the desired cycloadduct 262 was potentially decomposing due 
to the high temperature. Repeating the reaction at 110 °C gave the same results and changing the 




Ketone 261 was then heated with glycine methyl ester hydrochloride, Hünig’s base, magnesium 
sulfate and TBAI in an attempt to form cycloadduct 263 (Scheme 127). Similar to previous 
reactions, TLC analysis showed that the starting material had been consumed, and LCMS analysis 
produced a peak which corresponded to the mass of the desired product 263. Unfortunately, after 
purification of the crude product none of the desired product could be isolated, indicating that it 





Due to the unsuccessful results obtained so far with expanding the ketone substrate scope it was 
decided to stop work here and attempt to synthesise alternative cycloadducts from the ketones 
instead.  
3.8 Tricyclic products from azomethine imines 
Taking inspiration from previous work in the group we then decided to investigate whether 
azomethine imines could be formed from some of the ketones already synthesised. This is outlined 
in Scheme 128 with ketone 219. A reaction with hydrazine 264 would give hydrazone 266, which 
could then cyclise and be deprotonated to give azomethine imine 267. Intramolecular cycloaddition 
would then hopefully allow cycloadducts with the general structure of 265 to be isolated. If this 







It’s important to mention at this point that similar reactions had been done before in the literature, 
albeit the scope was very limited.102 An example is shown in Scheme 129 where ketone 268 was 
reacted with t-butyl carbazate. The resulting hydrazone 269 then underwent an intramolecular 





cycloaddition reaction then gave 271 in a good 75% yield. Furthermore, it was also found that the 









With this in mind we started to do similar reactions with ketone 219. The first reaction attempted 
involved heating ketone 219 with benzylhydrazine dihydrochloride and Hünig’s base in toluene to 
try and obtain cycloadduct 273. However, instead of isolating compound 273 the 6-membered ring 
compound 274 was obtained in 48% yield. The formation of compound 274 was most likely due to 
the nucleophilicity of the NHBn in the intermediate hydrazine, cyclisation would then give 
compound 274 (Scheme 130). 
In an attempt to overcome this problem the reaction was repeated using acetylhydrazine and this 
gave the desired cycloadduct 275 in 61% yield (Scheme 131). Unfortunately repeating the reaction 














Following on from the results obtained and using ketone 241 allowed cycloadduct 277 to be 
isolated in 45% yield. The reaction conditions used are shown in Scheme 133 where TBAI was 
added to aid the cyclisation step. This allowed the desired azomethine imine to be formed and 




When repeating the reaction using ketone 222 we expected to obtain a mixture of regiosiomers 
278 and 279 based on previous results using hydroxylamine to generate nitrones.95 Although TLC 
indicated that the starting material had been consumed in the reaction, no desired products could 






With the limited success of the cycloaddition reactions with azomethine imines our focus then 
shifted towards cleaving the N-N bond in cycloadducts 275 and 277. Although similar reactions 
had been done before in the literature, they generally required Pd/C and hydrogen at high 
pressures.102 In an attempt to use milder reaction conditions to cleave the N-N bond in our 
compounds, we first investigated using samarium diiodide as this had been shown to be a useful 
reagent in the literature.103,104 The reaction conditions used are shown in Scheme 135 where 
samarium diiodide was first prepared using Imamoto’s method by heating samarium metal with 
iodine in THF for 5 h.105 During the reaction the mixture changed colour from orange, to yellow, to 
green, and eventually to the characteristic dark blue colour of samarium diiodide. Once the mixture 
was cooled to room temperature it was added to a solution of cycloadduct 275 in methanol. After 
30 minutes TLC analysis of the reaction mixture indicated starting material was still present and 




Fortunately, we were able to cleave the N-N bond in cycloadduct 275 using borane, however by 
using this reagent the acyl group was reduced as well to give diamine 281 in a moderate yield of 
55%.106 The yield of diamine 281 was lower than expected, which may have been due to problems 
encountered during purification as the diamine was very polar.  Unfortunately, when repeating the 





crude reaction mixture indicated the desired product 282 had formed during the reaction many 









3.9 Conclusion and Future Work 
To conclude this chapter we were able to successfully improve on the initial results obtained in 
synthesising tricyclic amines from ketones using a condensation, cyclisation, cycloaddition 
cascade. In particular it was found that the addition of magnesium sulfate to the original cascade 
reaction helped to improve the yield of the desired cycloadduct. Unfortunately, this success was 
limited as using different ketones, including derivatives which contained aromatic rings did not 
generate any of the desired cycloadducts. In addition, activation of a ketone was achieved using a 
Grubbs metathesis reaction in the hope that the desired cascade process would take place, but 
this was unsuccessful as well. 
Besides generating azomethine ylides, reacting acetyl hydrazine with some of the ketones gave 
access to the corresponding azomethine imines. This allowed the formation of a different set of 
cycloadducts which contained N-N bonds. Like previous reactions, the substrate scope was limited 
as the choice of substituted hydrazine was important. Finally, for one of the cycloadducts 




Although most of our efforts to expand the substrate scope have been unsuccessful future work 
could involve investigating other substituted ketones to see whether the desired cascade 
cycloaddition reaction will take place. Previous work in the group has indicated that activating the 
alkene in ketone 219 proved beneficial in allowing cycloaddition reactions to take place with amino 
acids.97 Therefore, activating the alkene in ketone 222 by introducing an electron withdrawing 
group to give ketone 283 may prove beneficial and allow a cycloaddition reaction to take place via 







Finally, to expand on the results obtained from using azomethine imines investigating other 
methods of cleaving the N-N bond in the cycloadducts generated would be of interest as this could 









Chapter 4 – Towards the Synthesis of Kopsinine Using 
Cascade Chemistry 
4.1 Introduction to indole alkaloids and previous work 
As discussed in the previous chapter the development of the condensation, cyclisation, 
cycloaddition cascade process in the Coldham group has led to the successful synthesis of a range 
of complex polycyclic molecules with various ring structures. It so happens that many of these ring 
structures are present in natural products. Utilising the cascade process in the group has allowed 
efficient access to the main cores of many alkaloid structures, such as the Daphniphyllum, 
Stemona and Yuzurimine alkaloids.107–109 Furthermore, the complete total synthesis of several 
natural products has also been achieved making use of the cascade process.92,110 
Indole alkaloids have been of particular interest in the Coldham group. The monoterpenoid indole 
alkaloids represent one of the largest classes of natural products containing a diverse range of 
complex organic structures. The compounds are widely extracted from the Apocynaceae, 
Loganiaceae, and Rubiaceae plant families and are classified into five main groups according to 
their carbon skeleton. The five main groups are referred to as the Aspidosperma, Ajmalan, 
Corynanthe, Iboga, and Quinoline alkaloids.111 
An example of previous work in the Coldham group using azomethine ylides is shown in Scheme 
138 where three of the Aspidosperma alkaloids were synthesised.112 Cycloadduct 287 was 
generated as a single diastereoisomer from the reaction of aldehyde 286 with glycine in toluene, 
in the presence of camphorsulfonic acid. Subsequent reaction of cycloadduct 286 with aqueous 
HCl and THF at 80 C gave ketone 288, which was then converted to aspidospermidine (38) under 
the Fischer indole synthesis conditions. Subsequent reactions on ketone 288 then allowed 








The ability to synthesise indole alkaloids by applying the cascade process is potentially a useful 
way to access other similar alkaloids. Another example is kopsinine (291) and the structure of both 
isomers is shown in Figure 20.113 Overall, the structure is very similar to aspidospermidine (38) 
however, kopsinine contains an ethyl bridge connecting the C2 and C5 carbon atoms forming a 
bicyclic framework. The natural isomer (−)-kopsinine was first isolated from the Kopsia arborea 
tree, but has been isolated from other plants such as the Vinca erecta.114 Generally, Kopsia is a 
genus of plant belonging to the family Apocynaceae. These plants are commonly found in China, 
Southeast Asia and Australia; and are a rich source of monoterpenoid indole alkaloids. A number 
of compounds have been isolated from these plants and due to their significant biological activity 










The total synthesis of kopsinine has been achieved many times throughout the literature. However, 
before discussing a potential method of synthesising kopsinine using the cascade chemistry 
developed in the group, it’s first important to look at the previous methods used to identify key 
intermediates and useful reactions which may help.   
4.2 Previous synthetic routes towards Kopsinine 
To the best of our knowledge there have only been six reports on the total synthesis of kopsinine. 
Each route varies in length and has its own advantages and disadvantages. In 1985, Magnus and 
Brown reported the first total synthesis of kopsinine consisting of 13 steps as shown in Scheme 
139.115 In the first step, amine 292 undergoes an amide coupling reaction with (R)-(+)-acetic acid 
293 to give a mixture of separable diastereoisomers 294a and 294b. Isomer 294a was then reacted 
with trifluoroacetic anhydride (TFAA) to give 295 and a subsequent alkylation reaction gave 
compound 296. An intramolecular [4+2] cycloaddition reaction then allowed 297 to be isolated. 
Addition of diazene and mCPBA then resulted in the reduction of the alkene and oxidation of the 
sulfide in compound 297. Heating then allowed 298 to be isolated which was then oxidised further 
with TFAA to give 299. Potassium hydroxide was then used to form the carboxylic acid 300 via an 
addition-elimination reaction. The p-methoxysulfonyl group was then removed using Li-NH3 to give 
compound 301, an esterification reaction then gave compound 302. The use of Lawesson’s 
reagent converted the carbonyl in 302 to a thiocarbonyl resulting in compound 303 and in the final 






Soon after this method was published, within the same year Kuehne and Seaton reported a shorter 
synthetic route to synthesise a racemic mixture of kopsinine which consisted of 6 steps (Scheme 
140).116 Indolazepine 304 was first condensed with aldehyde 305 to give the bridged system 306 




as a single diastereoisomer. Oxidation of compound 307 then resulted in 308a and 308b in a 7:3 
ratio and the addition of triethylphosphine then gave 309a and 309b. Heating this mixture with 
phenyl vinyl sulfone then gave 310 via a [4+2] cycloaddition and reduction using Raney nickel then 
gave the final product kopsinine.  
A few years later in 1988, Wenkert and Pestchanker published their route to kopsinine taking 
inspiration from Kuehne and Seaton.117,118 The synthetic route is shown in Scheme 141 where 
pyridine 311 was first hydrogenated to give 312. This was then reacted with indole derivative 313 
to give 314 and treatment with polyphosphoric acid (PPA) then gave the pentacyclic compound 
315. Reduction of this compound using borane and sodium borohydride led to the formation of 
alcohol 317, which was then mesylated to give 318. Using potassium hydride allowed the 
successful β-elimination of 318 to give 319 and a successive oxidation reaction using lead 
tetraacetate then gave 309a. Repeating the same Diels-Alder reaction with phenyl vinyl sulfone 





It would be at least another 20 years until another total synthesis of kopsinine was reported. In 
2011, Macmillan and co-workers reported the synthesis of (−)-kopsinine and a small number of 
other natural products using an organocatalytic addition-cyclisation cascade process.119 Starting 
with compound 320 this was converted into 321, which was then subjected to the cascade process 
using the imidazolidine catalyst 322 and co-catalyst tribromoacetic acid (TBA). This gave 
compound 323 in a very good yield and high enantiomeric excess of 97%. This compound was 
then deprotected using trimethylsilyl iodide which allowed the resultant deprotected species to 
undergo a conjugate addition reaction with triphenylvinylphosphonium bromide. Addition of 




carbomethoxylation using phosgene and methanol, followed by the selective hydrogenation of 324 
resulted in the formation of 325. By applying similar methods used previously compound 325 was 
subjected to a [4+2] cycloaddition reaction with phenyl vinyl sulfone to give 326 and reduction using 
Raney nickel gave (−)-kopsinine (Scheme 142).116  
 
In 2012, Tomioka and co-workers reported the synthesis of (−)-kopsinine utilising a one pot 
[N+2+3] cyclisation reaction to synthesise the main starting material 330.120 This reaction is shown 
in Scheme 143 where the organolithium 328 undergoes a conjugate addition reaction with indole 
327 to give intermediate 331. This is then alkylated with 1-chloro-3-iodopropane to give 332, which 




Hydrogenolysis and N-alkylation of 330 allowed compound 333 to be isolated, which then 
underwent a deprotection reaction to give compound 334. Deprotonation using LiHMDS then gave 
the intermediate dianion 335 which could react via a Claisen condensation reaction to give 
ketoester 336. The mesylation of 336 followed by the addition of potassium tert-butoxide then gave 
(−)-337. Applying similar conditions as proposed by Wenkert and Pestchanker then allowed the 








A year later in 2013, Boger and co-workers proposed a synthetic route to kopsinine using a 
intramolecular [4+2]/[3+2] cycloaddition cascade reaction.121 This reaction is shown in Scheme 




reaction proceeds through an initial [4+2] cycloaddition reaction to give intermediate 340, which 
through the loss of nitrogen then generates intermediate 341. A subsequent [3+2] cycloaddition 
then gives the desired cycloadduct. It’s important to mention compound 338 was not commercially 
available and was synthesised in 4 steps from indole derivative 344 (Scheme 146). In the final step 
















Cycloadduct 339 was then converted to alcohol 351 as a single diastereoisomer using sodium 
cyanoborohydride. Subsequent treatment of alcohol 351 with sodium hydride, carbon disulfide and 
methyl iodide then gave compound 352, which underwent a Chugaev elimination to give 
regioisomers 353a and 353b in a 1:2 ratio. This was unfortunate as only compound 353a was 
useful towards the synthesis of kopsinine. Nonetheless, deprotection of 353a using TBAF gave 
alcohol 354, which was then converted to 355. The ethyl bridge was then installed using a SmI2 




thiolactam 357. Upon treatment of 357 with Raney nickel kopsinine was formed as a racemic 
mixture. These steps are summarised in Scheme 147. 
 
Furthermore, within the same report it was found that by replacing the benzyl group in the indoline 
core of 351 with a Cbz group to give 359 led to an improvement in the regioselectivity of the 
Chugaev elimination step, still producing the mixture of isomers 361a and 361b but now in a much 






Boger and co-workers then developed the synthetic route further in 2015 by synthesising 
enantiomerically pure (−)-kopsinine and its unnatural enantiomer ent-(+)-kopsinine.123 Starting with 
a racemic mixture of alcohol 359 the enantiomers were separated using semi-preparative chiral 
HPLC to give (+)-359 and ent-(−)-359. These were then converted to (−)-kopsinine and ent-(+)-
kopsinine respectively. The synthetic route for (−)-kopsinine is shown in Scheme 149 and it’s 
important to mention that some alterations were made to the original synthetic route. This can be 
seen in the last few steps where iodide (−)-363 was used for the SmI2 cyclisation reaction to give 
(−)-364. The amide moiety was then reduced with borane to give (−)-365 and the Cbz group was 




















To this date there have been no other reported syntheses of kopsinine. Looking at the previous 
routes used, in particular the work done by the Boger group, shows the potential that cycloaddition 
reactions provide a useful way to access the main core of kopsinine. This is further exemplified 
when looking at older synthetic routes where the ethyl bridge in kopsinine is usually inserted using 
a [4+2] cycloaddition reaction with phenyl vinyl sulfone. In addition, previous work done in the 
Coldham group has allowed the efficient synthesis of aspidospermidine, which is structurally 




4.3 Aims  
In line with previous work done in the group we wanted to investigate whether we could apply the 
cascade cycloaddition process developed to synthesise kopsinine. To achieve this the synthetic 
route shown in Scheme 150 was devised. Starting with aldehyde 366 and carrying out similar 
reactions previously done in the group would allow 369 to be accessed. Subsequent deprotonation 
and addition of methyl cyanoformate would then give 370 which could hopefully be converted to 
kopsinine using similar work done by Kuehne and Seaton.124,125 Before any work could be done, 

















4.4 Synthesis of aldehyde 366 and cycloaddition reactions 
To synthesise aldehyde 366 we wanted to use the synthetic route shown in Scheme 151. 
Deprotonation of (phenylthio)acetonitrile 371 and quenching with bromide 372 would give access 
to nitrile 373, which could then be deprotonated again and through the addition 1-bromo-3-
chloropropane would give nitrile 374. Reduction of the nitrile group using DIBAL-H would then 
generated desired aldehyde 366.112  
Bromide 372 was synthesised in 4 steps using a method previously done in the group (Scheme 
152).112 Cyclopropanol 376 was isolated in a yield of 84% from a Kulinkovich reaction using ethyl 
3-bromopropanoate 375. Subsequent reaction of cyclopropanol 376 with N-bromosuccinimide 
then gave ketone 377 in 78% yield. It was pleasing to find that this reaction worked well in 
dichloromethane, rather than using carbon tetrachloride which was commonly used throughout the 
literature.126 Ketone 377 was converted to ketal 378 by heating with ethylene glycol in benzene 
with the addition of TsOH. Finally, an elimination reaction on ketal 378 using potassium tert-





Having isolated bromide 372 we were now able to prepare nitrile 373. Some of the initial work was 
originally carried out by a MChem student in the group under my supervision in the laboratory.127 
Unfortunately, by applying reaction conditions used previously in the group, nitrile 373 was only 
isolated in 25% yield.128 The reaction also gave a similar yield of nitrile 373 (27%) when repeated 
using only one equivalent of the nitrile starting material, rather than four equivalents (Scheme 153). 





Fortunately, repeating the reaction using two equivalents of lithium diisopropylamide (LDA) gave 
an increased yield of 46% for nitrile 373 with recovered bromide 372 (Scheme 154). To our 
disappointment, when scaling up the reaction the same result was not achieved as only a 6% yield 
of nitrile 373 was isolated. Furthermore, no bromide starting material was recovered and instead 










Other methods to synthesise nitrile 373 were investigated as well. Repeating the reaction and 
changing the base to sodium bis(trimethylsilyl)amide gave nitrile 373 in lower yield of  34%. In 
comparison, using methyl magnesium chloride and applying similar alkylation conditions as found 
by the O’Leary group gave a much lower yield of nitrile 373 (7%), however bromide 372 was 







The final method attempted is shown in Scheme 156 where bromide 372 was premixed with 
sodium iodide before it was added to the reaction. This hopefully would have allowed the more 
reactive alkyl iodide to be generated, but instead a low 27% yield of nitrile 373 was isolated with 
bromide 372 being recovered in 29% yield. Recovery of bromide 372 indicated that formation of 
the corresponding alkyl iodide may not have occurred as well as expected, however any iodide 









It was then decided to carry on with the synthetic route towards aldehyde 366. Alkylation of nitrile 
373 with 1-bromo-3-chloropropane gave nitrile 374 in 54% yield and subsequent reduction using 









At this point, in an attempt to increase the overall yield of nitrile 374 we decided to swap around 
the alkylation reactions. This is summarised in Scheme 158 where (phenylthio)acetonitrile 371 was 
alkylated with 1-bromo-3-chloropropane to give nitrile 380 in 56% yield. However, disappointingly 
the next alkylation step with bromide 372 was unsuccessful generating none of the desired product 














With aldehyde 366 in hand we then attempted the key cycloaddition reaction to obtain compound 
367. After multiple attempts of heating aldehyde 366 with glycine using various reaction conditions 
none of the desired cycloadduct 367 was formed (Scheme 159, Table 8). The reaction was carried 
out using different catalyst loadings of CSA and when changing the reaction solvent to o-xylene, 
and heating at a higher temperature the same results were achieved. TLC and LCMS analysis of 
all crude reaction mixtures showed that aldehyde 366 was still present and no desired cycloadduct 









Entry CSA mol% Temperature Solvent Outcome 
1 0 110 °C PhMe No Product 
2 0.1 110 °C PhMe No Product 
3 0.2 110 °C PhMe No Product 






Due to unsuccessful results obtained using aldehyde 366 it was then decided to investigate an 
alternative route to kopsinine using a different aldehyde in the hope that a cycloaddition reaction 
would take place.  
4.5 Alternative routes towards kopsinine using different aldehydes   
In order to continue applying the cascade chemistry developed in the group towards the total 
synthesis of kopsinine it was clear that the new aldehyde to be investigated needed to have a 
similar structure to aldehyde 366, otherwise the main core of kopsinine would not be able to be 
synthesised. As a result of this there were very few changes that could have been made to 
aldehyde 366 to enable a cycloaddition reaction to take place, but the most obvious one was to 
replace the phenyl sulfide group. Taking inspiration from the work done by the Boger group a 
simple replacement for this group could be a TBDMS protected ethyl alcohol chain.123 Ultimately, 
this would result in aldehyde 381 (Scheme 160) and a different method would be required to insert 
the ethyl bridge in kopsinine. 




The next strategy that was applied towards the synthesis of kopsinine is shown in Scheme 161. 
Starting with aldehyde 381 and applying similar reaction conditions as used previously in the 
Coldham group could allow imine 384 to be obtained.112 A subsequent deprotonation and addition 
of methyl cyanoformate would then hopefully give compound 385.124,125 Due to the nature in which 
the bicyclic structure of kopsinine is formed using the methods developed by the Boger group, it 
may also be beneficial to protect the basic nitrogen centre in compound 385 to prevent any 
unwanted side reactions taking place.123 Using a carboxybenzyl (Cbz) protecting group would give 




bridge would allow the kopsinine precursor 365 to be isolated. Finally, removal of the Cbz group 
would then give kopsinine.  
To synthesise aldehyde 381 the route shown in Scheme 162 was devised. This route is very similar 
to the synthesis of aldehyde 366 where starting with nitrile 388 and alkylating with bromide 372 
would give nitrile 389. Repeating the alkylation reaction with 1-bromo-3-chloropropane would then 




As nitrile 388 was not commercially available it needed to be synthesised. Starting with 2-
bromoethanol 391, bromide 392 was obtained in 77% yield via a reaction with TBDMSCl in the 
presence of imidazole. This was then reacted with acetonitrile to give the desired nitrile 388 in a 





   
With nitrile 388 in hand we could now start the synthesis of aldehyde 381 (Scheme 164). Alkylation 
of nitrile 388 with bromide 372 gave nitrile 389 in a good 81% yield. Subsequent alkylation of nitrile 
389 with 1-bromo-3-chloropropane then gave nitrile 390 in a slightly lower yield of 69%. Finally, 
reduction of the nitrile group using DIBAL-H gave the desired aldehyde 381 in 74% yield. It was 
pleasing to see that unlike using (phenylthio)acetonitrile 371 the first alkylation reaction to give 

















Having isolated aldehyde 381 we now wanted to subject it to the cycloaddition conditions used 
previously to see whether we could generate the desired cycloadduct 382.112 Heating aldehyde 
381 with glycine in the presence of 10 mol% CSA and toluene unfortunately failed to give any of 
the desired product. TLC analysis of the crude product indicated that the aldehyde 381 was present 
and had not been consumed in the reaction. Furthermore, repeating the reaction in o-xylene or 












We initially thought there may have been a problem with the first step of the reaction where glycine 
reacts with the aldehyde to generate an imine. To potentially overcome this problem the reaction 
in Scheme 165 was repeated with the addition of magnesium sulfate to remove any water formed 
during the imine formation. Unfortunately, the same result was obtained and TLC analysis showed 
that the aldehyde starting material was present in the crude product. Carrying out the reaction 
using a large excess glycine (8 equivalents) was also unsuccessful and TLC analysis showed that 
starting material was still present. These results are summarised in Scheme 166. 
 








Moving forward, we thought that there may have been a potential problem with the cyclisation step. 
If the initial imine formed wasn’t cyclising onto the chloride then no azomethine ylide was going to 
be formed, therefore no cycloaddition reaction would occur. To aid the cyclisation step the 
cycloaddition reaction was repeated with the addition of TBAI to allow the desired alkyl iodide to 
Entry Temperature Solvent Outcome 
1 110 °C PhMe No Product 
2 120 °C DMF No Product 






be formed in-situ (Scheme 167). Unfortunately, no desired product was isolated and only aldehyde 
381 was recovered. 
 
   
 
 
Before trying alternative methods to form the desired azomethine ylide we also investigated 
increasing the concentration of CSA in the reaction. The CSA added to the reaction was originally 
meant to aid the imine formation between the aldehyde and glycine via coordination to the carbonyl 
group. Furthermore, the acid could also coordinate to one of the ketal oxygen atoms to allow 
activation of the alkene towards cycloaddition. If coordination was occurring at a different position, 
in particular the TBDMS protected alcohol, then imine formation or alkene activation would not 
take place. To test this theory the cycloaddition reaction was repeated with 1.1 equivalents of CSA 
in the reaction (Scheme 168). Unfortunately, TLC analysis of the crude reaction mixture showed 
many spots indicating the aldehyde starting material may have decomposed during the reaction. 
LCMS analysis also shown no desired product formation.  




We wanted to investigate alternative methods to form the azomethine ylide. Looking at the previous 
work done by the Pearson group we were interested in applying their methods using 
(trimethylsilyl)methylamine 394 in the hope that the desired cycloaddition reaction would occur 






Due to the high cost of (trimethylsilyl)methylamine 394 we wanted to first synthesise this reagent. 
Looking in the literature there were very few methods available. Starting with 
chloromethyltrimethylsilane 398 we were able to synthesise the corresponding organoazide 399 
in 63% yield. However, in an attempt to reduce azide 399 using LiAlH4 none of the desired amine 
394 was isolated (Scheme 170).131    
 
 
As an alternative we tried to access amine 394 using the Gabriel synthesis.132 This is summarised 
in Scheme 171 where compound 400 was synthesised in quantitative yield from chloride 398. 
Unfortunately, subsequent reduction of compound 400 using hydrazine failed to give any of the 








Moving on we then investigated trying to form intermediate 395 through the aza-wittig reaction of 
organoazide 399 with aldehyde 381.133 To our disappointment when applying the reaction 
conditions shown in Scheme 172 none of the desired product 381 was isolated and the starting 
aldehyde 381 was recovered. This was unexpected considering in the first step the formation of 
nitrogen gas was observed indicating the desired iminophosphorane (TMSCH2N=PPh3) and 








The results obtained so far attempting to carry out cycloaddition reactions on aldehyde 381 
seemed discouraging. However, the use of the TBDMS protected ethyl alcohol side chain seemed 
like a useful way to install the ethyl bridge in kopsinine. As a result, in a final attempt to achieve a 
successful cycloaddition reaction we decided to modify aldehyde 381 by replacing the TBDMS 





173). If a successful cycloaddition reaction could be carried out on aldehyde 401 then the 
cycloadduct 402 could be isolated. Subsequent ozonolysis and reduction reactions would then 
result in alcohol 403.134 This could then be TBDMS protected to give the original cycloadduct 382 








Similar to the previous synthetic routes we first needed to synthesise the starting aldehyde 401. 
To achieve this we devised the synthetic route shown in Scheme 174 where 4-pentenenitrile 404 
was first alkylated with bromide 372 to give nitrile 405. Another alkylation reaction with 1-bromo-3-
chloropropane would then give nitrile 406, which could then be reduced with DIBAL-H to give the 





Although nitrile 404 was commercially available it was decided to synthesise it from 4-bromobutene 
407. Heating with potassium cyanide gave the desired nitrile 404 in 62% yield (Scheme 175).135 
Having isolated nitrile 404 we could now carry on with the synthesis of aldehyde 401. Alkylation of 
nitrile 404 with bromide 372 gave nitrile 405 in 39% yield. Subsequent alkylation with 1-bromo-3-
chloropropane then gave nitrile 406 in a good yield of 82%. Reduction of the nitrile group using 










Aldehyde 401 was then subjected to the original cycloaddition reaction conditions with glycine 
(Scheme 176). Unfortunately, no desired product 402 was isolated and TLC analysis of the crude 
reaction mixture indicated that aldehyde 401 may have decomposed during the reaction. LCMS 









As aldehyde 401 was very similar in structure to aldehyde 286, which was used to successfully 
synthesise aspidospermidine, it was surprising to see that the cycloaddition reaction with aldehyde 
401 failed to give any of the desired product 402. We potentially thought there may have been a 
problem with the cyclisation step, therefore aldehyde 401 was converted to aldehyde 408 using a 
Finkelstein reaction with sodium iodide.128 Aldehyde 408 was isolated in a yield of 84%, however 
subjecting it to the same cycloaddition reaction conditions failed to give any of the desired 







In a final attempt to promote a cycloaddition reaction we decided to investigate forming a different 
azomethine ylide. Heating aldehyde 401 with glycine ethyl ester hydrochloride in the presence of 





analysis of the crude reaction mixture confirmed that no product had been formed and that the 
starting material had decomposed during the reaction. 




As a result of the unsuccessful results obtained throughout the multiple attempts of the 
cycloaddition reaction using various aldehyde substrates it was decided to stop work towards the 
synthesis of kopsinine.  
4.6 Conclusions and Future Work   
Although we have managed to successfully synthesise three aldehyde precursor molecules in an 
attempt to access the main core of kopsinine, we were unable to achieve the desired cycloaddition 
reaction with glycine. Therefore we were not able to achieve our main goal of applying the cascade 
chemistry developed in the group towards the total synthesis of kopsinine.  
We were unsure why none of the cycloaddition reactions were successful and due to the number 
of steps involved in the cascade reaction it was difficult to identify which step was not working in 
the reactions. However, as most reactions gave the aldehyde starting material back this was 
potentially an indication that either the imine formation or the cyclisation was problematic with these 
substrates. In particular, for substrates 366 and 381 the aldehyde group may have been too 
hindered by the presence of the phenyl sulfide group and TBDMS protected ethyl alcohol chain 
respectively. Presumably as a result, no imine formation could take place.  
In the cases that led to decomposition, activation of the alkene function group may allow a 
cycloaddition reaction to take place. Previously in the group this has been achieved using a Grubbs 




poses a new problem as if a cycloaddition reaction were to take place then the activating group 
would need to be removed, introducing another step into the synthetic route (Scheme 179).   
 

















Chapter 5 – Experimental 
General Experimental Details 
All reagents were obtained from commercial suppliers and were used without further purification 
unless otherwise stated. Dry solvents were obtained from a Grubbs dry solvent system (model: 
SPS-200-6 or SPS-400-6). Diisopropylamine was freshly distilled from CaH2.  Thin layer 
chromatography (TLC) analysis was performed on Merck silica gel 60 F254 plates and visualised 
by UV irradiation at 254 nm or by staining with an alkaline KMnO4 dip. Flash column 
chromatography was carried out on VWR silica gel (40-63 micron mesh). Petrol refers to petroleum 
ether, b.p. 4060 C. Furthermore, unless stated, the 1H proton NMR spectra were recorded on a 
Bruker Avance 400, a Bruker Avance III 400, a Bruker Avance III HD 400 (all 400 MHz) or a Bruker 
Avance III HD 500 (500 MHz) instrument, at 30 °C in deuterochloroform, hexadeuterodimethyl-
sulfoxide or deuterium oxide. All chemical shifts are expressed in parts-per-million (ppm) with 
respect to the residual solvent peaks. Coupling constants (J) are given in Hertz (Hz) to the nearest 
0.5 Hz and were corrected. The following abbreviations are used singularly or in combination to 
indicate the multiplicity of signals: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, m 
= multiplet, br = broad. Diastereotopic protons are assigned as CH unless otherwise stated. 13C 
NMR were recorded on the above instruments at 100 MHz. Low and high resolution (accurate 
mass) mass spectra were recorded on a Micromass Autospec for Electron Impact (EI) and on a 
Walter LCT instrument for electrospray (ES) with Time of Flight (TOF) analysis. Infrared (IR) 
spectra were recorded on a Perkin-Elmer Spectrum RX Fourier Transform IR System. Only 
selected peaks are reported and absorption maxima are given in cm-1. Melting points were 









To a stirred solution of bromoacetyl bromide (2.2 mL, 25 mmol) in CH2Cl2 (90 mL) at 0 C was 
added dimethylamine (15 mL, 30 mmol, 2 M in THF), followed by Et3N (4.1 mL, 30 mmol). The 
reaction mixture was warmed to rt and left to stir for 1 h. The mixture was diluted with CH2Cl2 
(100 mL) and aqueous HCl (100 mL, 2 M). The organic layer was separated and washed with 
saturated aqueous NaHCO3 (100 mL), brine (100 mL), dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to give bromide 102 (2.1 g, 50 %) as a brown oil; Rf 0.11 
[petrol–EtOAc (1:1)]; 1H NMR (400 MHz, CDCl3) δ = 3.86 (2H, s, CH2), 3.10 (3H, s, CH3), 2.98 (3H, 
s, CH3); 13C NMR (100 MHz, CDCl3) δ = 166.8 (CO), 38.1 (CH3), 36.0 (CH3), 26.1 (CH2). Data 




To a stirred solution of aniline (20.0 mL, 215 mmol) in THF (300 mL) was added K2CO3 (25 g, 
179 mmol) followed by allyl bromide (16.0 mL, 179 mmol). The mixture was heated at 85 °C for 
16 h then cooled to rt and filtered. The filtrate was diluted with water (300 mL) and EtOAc (200 mL). 
The aqueous layer was separated and washed further using EtOAc (2 x 200 mL). The organic 
extracts were combined and washed further with water (3 x 200 mL), dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to give the crude product as a yellow oil. The 
crude product was purified by column chromatography on silica gel, eluting with petrol–EtOAc 
(99:1) to give the aniline 91 (9.3 g, 39%) as a pale yellow oil; Rf 0.59 [petrol–EtOAc (9:1)]; 1H NMR 
(400 MHz, CDCl3) δ = 7.257.20 (2H, m, 2 × CH), 6.806.60 (3H, m, 3 × CH), 6.055.96 (1H, m, 
CH), 5.405.15 (2H, m, CH2), 3.833.81 (3H, m, CH2 & NH); 13C NMR (100 MHz, CDCl3) δ = 148.2 
(C), 135.5 (CH), 129.3 (CH), 117.6 (CH), 116.2 (CH2), 113.0 (CH), 46.6 (CH2). Data consistent 






To a stirred solution of aniline 91 (1.0 g, 7.5 mmol) in o-xylene (5 mL) was added boron trifluoride 
etherate solution (3.1 mL, 11 mmol, 48% w/v). The mixture was heated at 185 C in a sealed tube 
for 2 h. After cooling to rt, the mixture was poured onto aqueous NaOH (10 mL, 10% w/v) and left 
to stir for 30 min. The organic product was extracted using EtOAc (30 mL), washed with brine 
(30 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give 
the crude product as a pale brown oil. The crude product was purified by column chromatography 
on silica gel, eluting with petrol–EtOAc (19:1) to give the aniline 92 (723 mg, 72%) as an orange 
oil; Rf 0.14 [petrol–EtOAc (9:1)]; 1H NMR (400 MHz, CDCl3) δ = 7.157.10 (2H, m, 2 × CH), 
6.826.70 (2H, m, 2 × CH), 6.075.97 (1H, m, CH), 5.225.14 (2H, m, 2 × CH), 3.71 (2H, br s, 2 x 
NH), 3.37 (2H, d, J = 6.0 Hz, CH2);  13C NMR (100 MHz, CDCl3) δ = 144.9 (C), 136.0 (CH), 130.2 
(CH), 127.6 (CH), 124.1 (C), 118.9 (CH), 116.1 (CH2), 115.9 (CH), 36.5 (CH2). Data consistent 




To a stirred solution of aniline 92 (3.1 g, 23 mmol) in DMF (18 mL) was added bromide 102 (1.9 g, 
12 mmol) in DMF (6 mL), followed by dropwise addition of Et3N (1.6 mL, 12 mmol) in DMF (6 mL). 
The mixture was stirred for 1.5 h at rt. The mixture was diluted with EtOAc (200 mL) and saturated 
aqueous NaHCO3 (60 mL). The organic layer was separated, dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to give the crude product as a brown oil. The 
crude product was purified by column chromatography on silica gel, eluting with petrol–EtOAc (9:1) 
to give the amide 104 (1.2 g, 47%) as an orange oil; Rf 0.31 [petrol–EtOAc (1:1)]; FT-IR max 
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(film)/cm-1 3390, 2836, 2344, 1657 (CO), 1498, 1394, 1125, 910, 740; 1H NMR (400 MHz, CDCl3) 
δ = 7.18 (1H, td, J = 7.5, 1.5 Hz, CH), 7.11 (1H, dd, J = 7.5, 1.5 Hz, CH), 6.74 (1H, br d, J = 7.5 Hz, 
CH), 6.55 (1H, d, J = 8.0 Hz, CH), 6.055.95 (1H, m, CH), 5.275.16 (2H, m, CH2), 5.10 (1H, br s, 
NH), 3.90 (2H, s, CH2), 3.40 (2H, d, J = 6.5 Hz, CH2), 3.07 (3H, s, CH3), 3.06 (3H, s, CH3); 13C 
NMR (100 MHz, CDCl3) δ = 169.2 (CO), 145.3 (C), 135.6 (CH), 129.8 (CH), 127.6 (CH), 124.3 
(C), 117.2 (CH), 116.5 (CH2), 110.3 (CH), 45.2 (CH2), 36.4 (CH2), 35.8 (CH3), 35.7 (CH3); HRMS 
m/z (ES) Found: MH+, 219.1494. C13H19N2O requires MH+ 219.1492; LRMS m/z (ES) 146 (15%), 





To a stirred solution of amide 104 (856 mg, 3.92 mmol) in dry THF (4.5 mL) at 78 C was added 
n-BuLi (2.2 mL, 4.7 mmol, 2.1 M in hexanes). After 10 min, Boc2O (1.3 g, 5.9 mmol) in dry THF 
(4.5 mL) was added and the mixture was allowed to warm to rt over 16 h. The reaction mixture 
was diluted with MeOH (10 mL) and was concentrated under reduced pressure to give a crude 
residue that was diluted with EtOAc (200 mL) and saturated aqueous NaHCO3 (60 mL). The 
organic layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to give the crude product as an orange oil. The crude product was purified by 
column chromatography on silica gel, eluting with petrol–EtOAc (3:1) to give the amide 96 (425 mg, 
34%) as a brown oil; Rf 0.17 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2919, 1701 (CO), 1658 
(CO), 1383,1363, 1154, 1025, 726; 1H NMR (400 MHz, CDCl3, rotamer peaks present, asterisks 
denote minor rotamer peaks) δ = 7.60 (1H, d, J = 7.0 Hz, CH), 7.267.16 (3H, m, 3 × CH), 
6.045.87 (1H, m, CH), 5.145.04 (2H, m, CH2), 4.75 (0.7H, d, J = 16.5 Hz, CH), 4.59* (0.3H, d, J 
= 16.5 Hz, CH), 3.833.68 (1H, m, CH), 3.523.31 (2H, m, CH2), 2.01−2.98 (6H, m, 2 × CH3) 1.49* 
(2H, s, t-Bu), 1.37 (7H, s, t-Bu); 13C NMR (100 MHz, CDCl3, rotamer peaks present, asterisks 
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denote minor rotamer peaks) δ = 168.4* (CO), 168.0 (CO), 155.3 (CO), 141.7* (C), 141.5 (C), 
137.6* (C), 137.2* (CH), 137.1 (C), 136.9 (CH), 129.8* (CH), 129.7 (CH), 129.5 (CH), 129.2* (CH), 
127.5* (CH), 127.4 (CH), 130.0 (CH), 116.1 (CH2), 115.9* (CH2), 80.4* (C), 80.3 (C), 52.2* (CH2), 
51.6 (CH2), 36.2 (CH3), 35.9 (CH3), 35.8* (CH2), 35.5 (CH2), 28.2 (CH3); HRMS m/z (ES) Found: 
MH+, 319.2019. C18H27N2O3 requires MH+ 319.2016; LRMS m/z (ES) 146 (10%), 219 (100%), 263 




To a stirred solution of amide 104 (371 mg, 1.70 mmol) in dry THF (1.7 mL) at 10 C was added 
BH3•THF complex solution (1.7 mL, 1.7 mmol, 1 M). The mixture was allowed to stir for 2 h at rt 
and then was cooled to 10 C. EOH (1 mL), aqueous NaOH (0.33 mL, 6 M) and H2O2 (0.66 mL, 
30 % w/v) were added dropwise. The mixture was warmed slowly to rt and was heated at 50 C 
for 1 h. After cooling to rt, aqueous potassium carbonate (20 mL, 2 M) was added and the organic 
product was extracted using EtOAc (50 mL). The organic product was washed with brine (10 mL), 
dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude 
product as a pale brown oil. The crude product was purified by column chromatography on silica 
gel, eluting with CH2Cl2MeOH (99:1) to give the alcohol 106 (162 mg, 40%) as a yellow oil; Rf 
0.12 [CH2Cl2MeOH (97:3)]; FT-IR max (film)/cm-1 3410 (O-H), 2933, 2869, 1641 (CO), 1504, 
1453, 1396, 1132, 1051, 749, 728; 1H NMR (400 MHz, CDCl3) δ = 7.197.08 (2H, m, 2 × CH), 6.73 
(1H, t, J = 7.5 Hz, CH), 6.54 (1H, d, J = 7.5 Hz, CH), 5.09 (1H, br s, NH), 3.92 (2H, s, CH2), 3.70 
(2H, t, J = 6.0 Hz, CH2), 3.07 (3H, s, CH3), 3.06 (3H, s, CH3), 2.73 (2H, t, J = 6.0 Hz, CH2), 1.951.88 
(2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 169.5 (CO), 145.1 (C), 129.8 (CH), 127.2 (CH), 
126.5 (C), 117.5 (CH), 110.4 (CH), 61.8 (CH2), 45.2 (CH2), 35.9 (CH3), 35.8 (CH3), 32.1 (CH2), 
28.0 (CH2); HRMS m/z (ES) Found: MH+, 237.1602. C13H21N2O2 requires MH+ 237.1598; LRMS 






To a stirred solution of 2-aminobenzyl alcohol (20 g, 162 mmol) in MeOH (160 mL) at 0 C was 
added concentrated sulfuric acid (10 mL, 179 mmol, 95% w/w) slowly over a period of 5 min. The 
mixture was heated at 50 C for 7 h and then was cooled to 0 C. The mixture was neutralised with 
saturated aqueous NaHCO3 solution and the organic product was extracted with CH2Cl2 (250 mL), 
dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude 
product as a brown oil. The crude product was purified by column chromatography on silica gel, 
eluting with petrol–EtOAc (9:1) to give the ether 109 (17 g, 76%) as a yellow oil; Rf 0.37 [petrol–
EtOAc (1:1)]; 1H NMR (400 MHz, CDCl3) δ = 7.16 (1H, td, J = 7.5, 1.5 Hz, CH), 7.09 (1H, dd, J = 
7.5, 1.5 Hz, CH), 6.766.70 (2H, m, 2 × CH), 4.51 (2H, s, CH2), 4.17 (2H, br s, NH2), 3.37 (3H, s, 
CH3); 13C NMR (100 MHz, CDCl3) δ = 146.3 (C), 130.1 (CH), 129.4 (CH), 122.0 (C), 117.9 (CH), 
115.7 (CH), 73.7 (CH2), 57.4 (CH3). Data consistent with the literature.60  
2-(But-3-en-1-yl)aniline (110)  
 
 
To a stirred solution of ether 109 (9.4 g, 69 mmol) in Et2O (70 mL) at 0 C was added 
allylmagnesium bromide (150 mL, 150 mmol, 1 M in Et2O) slowly over a period of 20 min. The 
mixture was warmed to rt over 16 h and then was cooled to 0 C. Aqueous hydrochloric acid 
(50 mL, 2 M) was added dropwise to quench any excess Grignard reagent. The organic solvent 
was removed under reduced pressure and the remaining aqueous layer was adjusted to pH 7 
using saturated aqueous NaHCO3 (50 mL). The organic product was extracted using EtOAc (3 x 
200 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give 
the crude product as a brown oil. The crude product was purified by column chromatography on 
silica gel, eluting with petrol–EtOAc (19:1) to give the aniline 110 (5 g, 50%) as a yellow oil; Rf 0.33 
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[petrol–EtOAc (1:1)]; 1H NMR (400 MHz, CDCl3) δ = 7.267.07 (2H, m, 2 × CH), 6.886.71 (2H, 
m, 2 × CH), 6.015.85 (1H, m, CH), 5.175.00 (2H, m, CH2), 3.66 (2H, br s, NH2), 2.652.56 (2H, 
m, CH2), 2.462.38 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 144.1 (C), 138.2 (CH), 129.4 
(CH), 127.1 (CH), 126.5 (C), 118.8 (CH), 115.6 (CH2), 115.1 (CH), 32.9 (CH2), 30.8 (CH2). Data 




To a stirred solution of aniline 110 (5 g, 34 mmol) in DMF (45 mL) was added bromide 102 (5.6 g, 
34 mmol) in DMF (10 mL), followed by dropwise addition of Et3N (2.4 mL, 17 mmol) in DMF 
(10 mL). The mixture was stirred at rt for 1 h followed by further addition of bromide 102 (5.6 g, 
34 mmol) in DMF (10 mL) and Et3N (2.4 mL, 17 mmol) in DMF (10 mL). After stirring for a further 
1 h at rt, saturated aqueous NaHCO3 (200 mL) was added. The organic product was extracted 
using EtOAc (500 mL), washed with water (2 x 50 mL), dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to give the crude product as an orange oil. The crude 
product was purified by column chromatography on silica gel, eluting with petrol–EtOAc (9:1) to 
give the amide 111 (4.5 g, 57%) as an amorphous white solid; m.p. 6365 C; Rf 0.37 [petrol–
EtOAc (1:1)]; FT-IR max (film)/cm-1 2934, 1640 (CO), 1600, 1575, 1511, 1392, 1129, 907, 743; 
1H NMR (400 MHz, CDCl3) δ = 7.16 (1H, td, J = 7.5, 1.0 Hz, CH), 7.11 (1H, dd, J = 7.5, 1.0 Hz, 
CH), 6.73 (1H, td, J = 7.5, 1.0 Hz, CH), 6.55 (1H, d, J = 7.5 Hz, CH), 6.005.90 (1H, m, CH), 
5.155.01 (3H, m, CH2 & NH), 3.91 (2H, s, CH2), 3.08 (6H, s, 2 × CH3), 2.722.68 (2H, m, CH2), 
2.472.42 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 169.2 (CO), 145.0 (C), 138.2 (CH), 
129.4 (CH), 127.2 (CH), 126.0 (C), 117.1 (CH), 115.1 (CH2), 110.2 (CH), 45.3 (CH2), 35.7 (CH3), 
32.6 (CH2), 30.8 (CH2); HRMS m/z (ES) Found: MH+, 233.1653. C14H21N2O requires MH+ 
233.1648; LRMS m/z (ES) 160 (5%), 233 (100%, MH+). 
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tert-Butyl N-[2-(But-3-en-1-yl)phenyl]carbamate (113) 
 
 
To a stirred solution of aniline 110 (5.8 g, 39 mmol) in THF (36 mL) was added Boc2O (8.6 g, 
39 mmol) and Et3N (5.5 mL, 39 mmol). The reaction was heated under reflux for 24 h and cooled 
to rt. The solvent was removed under reduced pressure and the remaining residue was diluted 
with EtOAc (200 mL), washed with aqueous citric acid (3 x 70 mL, 1 M), brine (50 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as an orange oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (9:1) to give the carbamate 113 (4.7 g, 48%) as a yellow oil; Rf 0.29 [petrol–
EtOAc (9:1)]; FT-IR max (film)/cm-1 2980, 1698 (CO), 1584, 1518, 1443, 1369, 1228, 1154, 1051, 
1025, 907, 750; 1H NMR (400 MHz, CDCl3) δ = 7.76 (1H, d, J = 7.5 Hz, CH), 7.257.06 (3H, m, 3 
× CH), 6.32 (1H, br s, NH), 5.965.86 (1H, m, CH), 5.145.04 (2H, m, CH2), 2.69 (2H, t, J = 8.0 Hz, 
CH2), 2.422.36 (2H, m, CH2), 1.55 (9H, s, t-Bu); 13C NMR (100 MHz, CDCl3) δ = 153.4 (C=O), 
137.6 (CH), 135.7 (C), 131.9 (C), 129.4 (CH), 126.9 (CH), 124.3 (CH), 122.5 (CH), 115.6 (CH2), 
80.4 (C), 33.8 (CH2), 30.8 (CH2), 28.4 (CH3); HRMS m/z (ES) Found: MNa+, 270.1468. 












To a stirred solution of amide 111 (200 mg, 0.860 mmol) in dry THF (0.7 mL) at 40 C was added 
n-BuLi (0.41 mL, 1.03 mmol, 2.5 M in hexanes). After 10 min, Boc2O (282 mg, 1.29 mmol) in dry 
THF (1 mL) was added and the mixture was allowed to warm to rt over 16 h. The mixture was 
diluted with MeOH (5 mL). The solvent was removed under reduced pressure to give the crude 
product as a brown oil. The crude product was purified by column chromatography on silica gel, 
eluting with petrol–EtOAc (3:1) to give the amide 112 (72 mg, 25%) as a brown oil; Rf 0.20 [petrol–
EtOAc (1:1)]; FT-IR max (film)/cm-1 3001, 2713, 1789, 1692 (CO), 1660 (CO), 1491, 1379, 1322, 
1153, 1022, 915, 878, 736, 599; 1H NMR (400 MHz, CDCl3, rotamer peaks present, asterisks 
denote minor rotamer peaks) δ = 7.60 (1H, d, J = 8.0 Hz, CH), 7.277.12 (3H, m, 3 × CH), 
5.955.79 (1H, m, CH), 5.124.95 (2H, m, CH2), 4.80 (0.8H, d, J = 16.5 Hz, CHAHB), 4.64* (0.2H, 
d, J = 16.5 Hz, CHAHB), 3.73* (0.2H, d, J = 16.5 Hz, CHAHB), 3.67 (0.8H, d, J = 16.5 Hz, CHAHB), 
3.01−2.97 (6H, m, 2 × CH3), 2.772.58 (2H, m, CH2), 2.482.27 (2H, m, CH2), 1.47* (2H, s, t-Bu), 
1.35 (7H, s, t-Bu);  13C NMR (100 MHz, CDCl3, rotamer peaks present, asterisks denote minor 
rotamer peaks) δ = 168.3* (CO), 167.8 (CO), 155.4 (CO), 154.6* (CO), 141.7* (C), 141.4 (C), 
139.2* (C), 138.6 (C), 138.5* (CH), 138.1 (CH), 129.6 (CH), 129.3* (CH), 129.2 (CH), 127.5* (CH), 
127.4 (CH), 127.1* (CH), 126.7 (CH), 115.1 (CH2), 114.8* (CH2), 80.2 (C), 52.2* (CH2), 51.6 (CH2), 
36.2* (CH3), 35.9 (CH3), 34.2 (CH2), 30.7* (CH2), 30.5 (CH2), 28.3 (CH3); HRMS m/z (ES) Found: 
MH+, 333.2175. C19H29N2O3 requires MH+ 333.2173; LRMS m/z (ES) 160 (10%), 233 (100%), 277 
(30%), 333 (10%, MH+). 
Method B: 
To a stirred suspension of NaH (97 mg, 4.0 mmol) in dry DMF (1 mL) at 0 C was added carbamate 
113 (1 g, 4.0 mmol) in dry DMF (1 mL) dropwise, followed by bromide 102 (0.9 g, 5.3 mmol) in 
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DMF (1 mL). The mixture was warmed to rt over 16 h. The reaction was quenched with water at 
0 C and diluted with EtOAc (100 mL). The organic layer was separated, dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product as a yellow 
oil. The crude product was purified by column chromatography on silica gel, eluting with petrol–





To a stirred solution of amide 112 (939 mg, 2.82 mmol) in MeOH (14 mL) and water (3.5 mL) was 
added osmium tetroxide (72 mg, 0.28 mmol) and N-methylmorpholine N-oxide (2.1 mL, 7.1 mmol, 
40% wt in water). The mixture was stirred at rt for 16 h and aqueous sodium sulfite (1 mL, 1 M) 
was added. The solvent was removed under reduced pressure and the resulting residue was 
dissolved in EtOAc (100 mL), washed with brine (50 mL), dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure to give the crude diol intermediate. The residue was 
dissolved in MeOH (11 mL) and water (3.3 mL) and cooled to 0 C. Sodium periodate (905 mg, 
4.23 mmol) was added and the mixture was stirred for 2 h at 0 C. The mixture was filtered, and 
the solvent was removed under reduced pressure. The organic product was extracted using 
CH2Cl2 (100 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to give the crude product as an orange oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (1:1) to give the aldehyde 98 (530 mg, 
56%) as a yellow oil; Rf 0.20 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2931, 1698 (CO), 1658 
(CO), 1383, 1317, 1240, 1154, 1022, 870, 758, 595; 1H NMR (400 MHz, CDCl3, rotamer peaks 
present, asterisks denote minor rotamer peaks) δ = 9.82 (1H, s, CH), 7.607.58 (1H, m, CH), 
7.267.18 (3H, m, 3 × CH), 4.72 (0.7H, d, J = 16.5 Hz, CHAHB), 4.60* (0.3H, d, J = 16.5 Hz, CHAHB), 
3.89−3.80 (1H, m, CHAHB), 3.022.77 (10H, m, 2 × CH3 & 2 × CH2), 1.47* (3H, s, t-Bu), 1.37 (6H, 
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s, t-Bu);  13C NMR (100 MHz, CDCl3, rotamer peaks present, asterisks denote minor rotamer 
peaks) δ = 202.2* (CHO), 201.6 (CHO), 168.3* (CO), 167.7 (CO), 155.3 (CO), 154.7* (CO), 
141.7* (C), 141.6 (C), 138.2* (C), 137.5 (C), 129.6 (CH), 129.2* (CH), 129.2* (CH), 128.9 (CH), 
127.8* (CH), 127.7 (CH), 127.6* (CH), 127.2 (CH), 80.6* (C), 80.5 (C), 52.2* (CH2), 51.6 (CH2), 
44.4* (CH2), 44.1 (CH2), 36.2* (CH3), 35.9 (CH3), 28.3 (CH3), 28.2* (CH3), 23.5 (CH2); HRMS m/z 
(ES) Found: MH+, 335.1972. C18H27N2O4 requires MH+ 335.1965; LRMS m/z (ES) 144 (5%), 187 





To a stirred suspension of NaH (97 mg, 4.0 mmol) in dry DMF (1 mL) at 0 C was added carbamate 
113 (1 g, 4 mmol) in dry DMF (1 mL) dropwise, followed by methyl bromoacetate (0.8 g, 5.3 mmol) 
in DMF (1 mL). The mixture was warmed to rt over 16 h. The reaction was quenched with water at 
0 C and diluted with EtOAc (100 mL). The organic layer was separated, dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product as a yellow 
oil. The crude product was purified by column chromatography on silica gel, eluting with petrol–
EtOAc (9:1) to give ester 114 (957 mg, 74%) as a yellow oil; Rf 0.18 [petrol–EtOAc (9:1)]; FT-IR 
max (film)/cm-1 2976, 1755 (CO), 1693 (CO), 1363, 1206, 1151, 1025, 990, 910, 756, 619; 1H 
NMR (400 MHz, CDCl3, rotamer peaks present, asterisks denote minor rotamer peaks) δ = 
7.447.39 (1H, m, CH), 7.297.17 (3H, m, 3 × CH), 5.945.80 (1H, m, CH), 5.094.99 (2H, m, 
CH2), 4.62 (0.7H, d, J = 17.5 Hz, CHAHB), 4.45* (0.3H, d, J = 17.5 Hz, CHAHB), 3.873.74 (4H, m, 
CHAHB & CH3), 2.752.62 (2H, m, CH2), 2.462.27 (2H, m, CH2), 1.50* (3H, s, t-Bu), 1.37 (6H, s, 
t-Bu); 13C NMR (100 MHz, CDCl3, rotamer peaks present, asterisks denote minor rotamer peaks) 
δ = 170.4* (CO), 170.1 (CO), 155.2 (CO), 154.2* (CO), 141.3* (C), 141.1 (C), 139.5* (C), 
138.9 (C), 138.3* (CH), 137.9 (CH), 129.7* (CH), 129.5 (CH), 128.8 (CH), 128.5* (CH), 127.9* 
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(CH), 127.6 (CH), 127.2* (CH), 126.7 (CH), 115.2 (CH2), 114.9* (CH2), 80.9* (C), 80.6 (C), 52.7* 
(CH2), 52.1 (CH3), 51.7 (CH2), 34.2 (CH2), 30.5* (CH2), 30.3 (CH2), 28.2 (CH3); HRMS m/z (ES) 
Found: MNa+, 342.1680. C18H25NO4Na requires MNa+ 342.1676; LRMS m/z (ES) 160 (5%), 220 





To a stirred solution of ester 114 (750 mg, 2.39 mmol) in MeOH (12 mL) and water (3 mL) was 
added osmium tetroxide (60 mg, 0.24 mmol) and N-methylmorpholine N-oxide (1.7 mL, 5.9 mmol, 
40% wt in water). The mixture was stirred at rt for 16 h and aqueous sodium sulfite (1 mL, 1 M) 
was added. The solvent was removed under reduced pressure and the resulting residue was 
dissolved in EtOAc (100 mL), washed with brine (50 mL), dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure to give the crude diol intermediate. The residue was 
dissolved in MeOH (9.2 mL) and water (2.8 mL) and cooled to 0 C. Sodium periodate (905 mg, 
4.23 mmol) was added and the mixture was stirred for 2 h at 0 C. The mixture was filtered, and 
the solvent was removed under reduced pressure. The organic product was extracted using 
CH2Cl2 (100 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to give the crude product as an orange oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (7:3) to give the aldehyde 83 (393 mg, 
52%) as a white amorphous solid; m.p. 5559 C [petrol–EtOAc]; Rf 0.34 [petrol–EtOAc (7:3)]; FT-
IR max (film)/cm-1 2814, 2717, 1745, 1698 (CO), 1494, 1430, 1395, 1355, 1213, 1156, 1044, 739; 
1H NMR (400 MHz, CDCl3, rotamer peaks present, asterisks denote minor rotamer peaks) δ = 9.82 
(1H, s, CH), 7.477.34 (1H, m, CH), 7.287.18 (3H, m, 3 × CH), 4.52 (0.5H, d, J = 17.5 Hz, CHAHB), 
4.40* (0.5H, d, J = 17.5 Hz, CHAHB), 3.97−3.88 (1H, m, CHAHB), 3.77* (1.5H, s, CH3), 3.76 (1.5H, 
s, CH3), 3.032.72 (4H, m, 2 × CH2), 1.48* (4.5H, s, t-Bu), 1.37 (4.55H, s, t-Bu); 13C NMR 
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(100 MHz, CDCl3, rotamer peaks present, asterisks denote minor rotamer peaks) δ = 201.8* 
(CHO), 201.4 (CHO), 170.3* (CO), 170.0 (CO), 155.0 (CO), 154.3* (CO), 141.3* (C), 141.1 
(C), 138.4* (C), 137.8 (C), 129.5* (CH), 129.2 (CH), 128.7 (CH), 128.5* (CH), 128.1* (CH), 127.9 
(CH), 127.6* (CH), 127.3 (CH), 81.2* (C), 80.9 (C) 52.6* (CH2), 52.1 (CH3), 51.7 (CH2), 44.3* (CH2), 
44.1 (CH2), 28.2 (CH3), 28.1* (CH3), 23.4 (CH2); HRMS m/z (ES) Found: MNa+, 344.1476. 
C17H23NO5Na requires MNa+ 344.1468; LRMS m/z (ES) 204 (100%), 222 (10%), 344 (15%, MNa+), 
362 (5%, MK+). 
1,2,3,4-Tetrahydroquinoline-2-carboxylic acid (120) 
 
 
To a stirred solution of quinaldic acid (2.0 g, 11 mmol) in dry MeOH (20 mL) was added PtO2 
(26 mg, 0.12 mmol). The resulting mixture was placed under a hydrogen gas atmosphere (1 atm) 
for 16 h. The mixture was filtered through a pad of celite, and the solvent was removed under 
reduced pressure to give the acid 120 (1.7 g, 83%) as a white gum; 1H NMR (400 MHz, CDCl3) δ 
= 7.016.93 (2H, m, 2 × CH), 6.706.55 (2H, m, 2 × CH), 4.09 (1H, dd, J = 5.0, 3.5 Hz, CH), 
2.882.65 (2H, m, 2 × CH), 2.312.05 (2H, m, 2 × CH); 13C NMR (100 MHz, CDCl3) δ = 178.5 
(CO), 142.1 (C), 129.3 (CH), 127.2 (CH), 121.3 (C), 118.2 (CH), 114.9 (CH), 53.2 (CH), 25.1 




To a stirred solution of isatin (10 g, 68 mmol) in DMF (136 mL) was added methyl iodide (4.2 mL, 
68 mmol), followed by potassium carbonate (10 g, 75 mmol). The mixture was left to stir at rt for 
16 h. The mixture was diluted with CH2Cl2 (600 mL) and water (300 mL). The organic layer was 
separated and washed with water (2 x 300 mL), dried over anhydrous MgSO4, filtered, and 
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concentrated under reduced pressure to give N-methylisatin 122 (8.5 g, 77%) as an orange 
amorphous solid; m.p. 122124 C [CH2Cl2] (lit.140 129130 C [no solvent]); Rf 0.33 [petrol–EtOAc 
(1:1)]; 1H NMR (400 MHz, CDCl3) δ = 7.657.61 (2H, m, 2 × CH), 7.16 (1H, td, J = 7.5, 0.5 Hz, 
CH), 6.936.91 (1H, m, CH), 3.28 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 183.3 (CO), 158.2 
(CO), 151.7 (C), 138.4 (CH), 125.3 (CH), 123.9 (CH), 117.5 (C), 109.9 (CH), 26.2 (CH3). Data 
consistent with the literature.141  
1,2'-Dimethyl-1,2,2',3',3a,3'a,6',7',7a,8',8'a,8'b-dodecahydro-1'H-




To a stirred solution of N-methylisatin 122 (200 mg, 1.24 mmol) in MeOH (3.8 mL) and water 
(1.3 mL) was added L-proline (143 mg, 1.24 mmol) followed by N-methylmaleimide (138 mg, 
1.24 mmol). The mixture was heated under reflux at 90 C for 1 h and cooled to rt. The mixture 
was poured onto a mixture of aqueous NaHCO3 and ice and was stirred for 5 min. The organic 
product was extracted using EtOAc (100 mL), dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to give the crude product as a brown solid. The crude 
product was purified by column chromatography on silica gel, eluting with petrol–EtOAc (1:1) to 
give the lactam 127 (339 mg, 84%) as a white cubes; m.p. 179182 C [petrol–EtOAc]; Rf 0.16 
[petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2961, 2504, 2167, 2037, 1686 (CO), 1610 (CO), 
1465, 1367, 1121, 969, 766, 672, 498; 1H NMR (400 MHz, CDCl3) δ = 7.37 (1H, t, J = 7.5 Hz, CH), 
7.08 (1H, t, J = 7.5 Hz, CH), 6.97 (1H, d, J = 7.5 Hz, CH), 6.87 (1H, d, J = 7.5 Hz, CH), 4.44 (1H, 
q, J = 7.5 Hz, CHA), 3.67 (1H, d, J = 7.5 Hz, CHB), 3.51 (1H, t, J = 7.5 Hz, CHC), 3.20 (3H, s, CH3), 
3.06 (3H, s, CH3), 2.482.33 (2H, m, 2 × CH), 2.051.88 (4H, m, 4 × CH); 13C NMR (100 MHz, 
CDCl3) δ = 176.8 (CO), 176.6 (CO), 175.5 (CO), 144.1 (C), 130.0 (CH), 126.5 (CH), 124.3 (C), 
122.4 (CH), 108.5 (CH), 68.5 (C), 64.7 (CH), 56.0 (CH), 45.7 (CH), 44.5 (CH2), 26.1 (CH2), 26.0 
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(CH3), 25.1 (CH3), 23.6 (CH2); HRMS m/z (ES) Found: MH+, 326.1505. C18H20N3O2 requires MH+ 
326.1499; LRMS m/z (ES) 121 (20%), 214 (10%), 326 (100%, MH+); Found: C, 66.54; H, 5.63; N, 
12.91. C18H19N3O2 requires C, 66.45; H, 5.89; N, 12.91.   




To a stirred solution of quinoline (4.6 mL, 39 mmol) in PhMe (50 mL) was added methyl 
bromoacetate (4.0 mL, 43 mmol). The mixture was heated at 65 C for 16 h and cooled to rt forming 
an orange suspension. The mixture was filtered, washed with Et2O (200 mL), and dried to give 
ester 131 (4.7 g, 43 %) as an orange amorphous solid; m.p. 149151 C [Et2O] (lit.142 152153 C 
[no solvent]); 1H NMR (400 MHz, D2O) δ = 9.139.09 (2H, m, 2 × CH), 8.26 (1H, d, J = 8.5 Hz, 
CH), 8.138.08 (2H, m, 2 × CH), 7.97 (1H, dd, J = 8.5, 6.0 Hz, CH), 7.917.87 (1H, m, CH), 5.89 
(2H, s, CH2), 3.72 (3H, s, CH3); 13C NMR (100 MHz, D2O) δ = 167.7 (CO), 150.2 (CH), 149.6 
(CH), 138.6 (C), 136.7 (CH), 131.0 (CH), 130.3 (CH), 130.0 (C), 121.7 (CH), 117.7 (CH), 57.7 
(CH2), 53.9 (CH3). Data consistent with the literature.142 




To a stirred solution of quinoline (1.8 mL, 16 mmol) in PhMe (20 mL) was added bromide 102 
(2.8 g, 17 mmol). The mixture was heated at 65 C for 16 h and cooled to rt forming a light brown 
suspension. The mixture was filtered, washed with Et2O (200 mL), and dried to give amide 132 
(2.2 g, 47 %) as an off-white amorphous solid; m.p. 175177 C [Et2O]; FT-IR max (film)/cm-1 3407, 
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2911, 1653 (CO), 1586, 1528, 1405, 1369, 1147, 804, 771, 597, 507; 1H NMR (400 MHz, D2O) δ 
= 9.119.03 (2H, m, 2 × CH), 8.26 (1H, dd, J = 8.0, 1.0 Hz, CH), 8.107.86 (4H, m, 4 × CH), 6.02 
(2H, s, CH2), 3.18 (3H, s, CH3), 2.89 (3H, s, CH3); 13C NMR (100 MHz, D2O) δ = 165.5 (CO), 
150.0 (CH), 149.2 (CH), 138.9 (C), 136.4 (CH), 130.8 (CH), 130.2 (CH), 129.9 (C), 121.6 (CH), 
117.9 (CH), 58.4 (CH2), 36.4 (CH3), 35.9 (CH3); HRMS m/z (ES) Found: M+−Br, 215.1181. 






To a stirred suspension of ester 131 (141 mg, 0.500 mmol) in MeOH (3 mL) was added N-
methylmaleimide (56 mg, 0.50 mmol) followed by Et3N (0.07 mL, 0.5 mmol). The mixture was 
heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced pressure to 
obtain the crude product as an orange solid. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (3:1) to give ester 133 (120 mg, 77%) as 
pale yellow needles; m.p. 182185 C [petrol–EtOAc]; Rf 0.26 [petrol–EtOAc (1:1)]; FT-IR max 
(film)/cm-1 2934, 1701 (CO), 1638 (CO), 1494, 1430, 1374, 1351, 1290, 1136, 1016, 753, 622; 
1H NMR (400 MHz, CDCl3) δ = 7.09 (1H, td, J = 7.5, 1.5 Hz, CH), 6.96 (1H, dd, J = 7.5, 1.5 Hz, 
CH), 6.73 (1H, td, J = 7.5, 1.0 Hz, CH), 6.48 (1H, br d, J = 8.0 Hz, CH), 6.39 (1H, dd, J = 10.0, 
2.0 Hz, CH), 6.07 (1H, dd, J = 10.0, 2.0 Hz, CH), 5.13 (1H, dt, J = 7.5, 2.0 Hz, CHA), 4.82 (1H, s, 
CHB), 3.82 (3H, s, CH3), 3.593.52 (2H, m, CHC & CHD), 2.98 (3H, s, CH3); 13C NMR (100 MHz, 
CDCl3) δ = 176.6 (CO), 175.8 (CO), 170.5 (CO), 141.1 (C), 129.2 (CH), 127.4 (CH), 126.5 
(CH), 121.9 (C), 120.9 (CH), 119.0 (CH), 110.9 (CH), 60.8 (CH), 59.7 (CH), 52.7 (CH3), 47.7 (CH), 
47.0 (CH), 25.5 (CH3); HRMS m/z (ES) Found: MH+, 313.1188. C17H17N2O4 requires MH+ 
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313.1183; LRMS m/z (ES) 313 (100%, MH+), 335 (15%, MNa+); Found: C, 65.04; H, 5.24; N, 8.58. 







To a stirred suspension of amide 132 (295 mg, 1.00 mmol) in MeOH (6 mL) was added N-
methylmaleimide (111 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The mixture was 
heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced pressure to 
obtain the crude product as an orange solid. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (1:1) to give amide 134 (282 mg, 87%) as 
an off-white amorphous solid; m.p. 155158 C [petrol–EtOAc]; Rf 0.07 [petrol–EtOAc (1:1)]; FT-
IR max (film)/cm-1 2671, 1696 (CO), 1655 (CO), 1489, 1436, 1290, 1139, 1116, 753, 612; 1H 
NMR (400 MHz, CDCl3) δ = 7.076.92 (2H, m, 2 × CH), 6.726.66 (1H, m, CH), 6.426.38 (1H, m, 
CH), 6.176.08 (2H, m, 2 × CH), 5.41 (1H, dt, J = 8.0, 2.0 Hz, CHA), 4.96 (1H, s, CHB), 3.523.49 
(1H, m, CHC), 3.423.39 (4H, m, CHD & CH3), 3.07 (3H, s, CH3), 2.97 (3H, s, CH3); 13C NMR 
(100 MHz, CDCl3) δ = 177.5 (CO), 176.0 (CO), 169.5 (CO), 141.7 (C), 129.1 (CH), 127.4 (CH), 
126.4 (CH), 122.4 (C), 121.4 (CH), 118.7 (CH), 110.1 (CH), 60.7 (CH), 59.3 (CH), 47.9 (CH), 47.5 
(CH), 37.1 (CH3), 35.9 (CH3), 25.4 (CH3); HRMS m/z (ES) Found: MH+, 326.1506. C18H20N3O3 










To a stirred solution of ester 133 (100 mg, 0.320 mmol) in EtOAc (6 mL) was added 10% Pd/C 
(17 mg, 0.016 mmol). The mixture was stirred at rt under a hydrogen gas atmosphere (1 atm) for 
48 h. The mixture was filtered through a pad of celite and the filtrate was concentrated under 
reduced pressure to give the crude product as a yellow solid. The crude product was purified using 
a silica gel plug, eluting with petrol–EtOAc (1:1) to give ester 115 (85 mg, 85%) as an off-white 
amorphous solid; m.p. 163165 C [petrol–EtOAc]; Rf 0.26 [petrol–EtOAc (1:1)]; FT-IR max 
(film)/cm-1 2929, 1701 (CO), 1640 (CO), 1499, 1436, 1282, 1142, 1006, 755, 617, 587; 1H NMR 
(400 MHz, CDCl3) δ = 7.087.02 (2H, m, 2 × CH), 6.73 (1H, td, J = 7.5, 1.0 Hz, CH), 6.54 (1H, d, 
J = 7.5 Hz, CH), 4.91 (1H, s, CHA), 4.174.09 (1H, m, CHB), 3.77 (3H, s, CH3), 3.533.49 (2H, m, 
CHC & CHD), 3.052.96 (4H, m, CH & CH3), 2.882.81 (1H, m, CH), 2.472.41 (1H, m, CH), 
1.631.52 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 176.8 (CO), 175.6 (CO), 171.2 (CO), 
142.3 (C), 129.3 (CH), 127.1 (CH), 122.5 (C), 118.7 (CH), 112.2 (CH), 61.0 (CH), 58.0 (CH), 52.4 
(CH3), 48.6 (CH), 47.2 (CH), 27.6 (CH2), 25.3 (CH3), 25.2 (CH2); HRMS m/z (ES) Found: MH+, 













To a stirred solution of amide 134 (100 mg, 0.310 mmol) in EtOAc (6 mL) was added 10% Pd/C 
(17 mg, 0.016 mmol). The mixture was stirred at rt under a hydrogen gas atmosphere (1 atm) for 
48 h. The mixture was filtered through a pad of celite and the filtrate was concentrated under 
reduced pressure to give the crude product as a green solid. The crude product was purified using 
a silica gel plug, eluting with EtOAc to give amide 116 (73 mg, 73%) as a brown amorphous solid; 
m.p. 195197 C [petrol–EtOAc]; Rf 0.07 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2929, 1701 
(CO), 1640 (CO), 1499, 1436, 1282, 1142, 1006, 755, 617, 587; 1H NMR (400 MHz, CDCl3) δ = 
7.056.99 (2H, m, 2 × CH), 6.68 (1H, t, J = 7.5 Hz, CH), 6.21 (1H, d, J = 7.5 Hz, CH), 5.10 (1H, s, 
CHA), 4.494.43 (1H, m, CHB), 3.51 (1H, t, J = 8.5 Hz, CHC), 3.42 (3H, s, CH3), 3.34 (1H, d, J = 
8.5 Hz, CHD), 3.112.97 (7H, m, CH & 2 × CH3), 2.882.80 (1H, m, CH), 2.472.40 (1H, m, CH), 
1.661.55 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 177.7 (CO), 175.9 (CO), 170.5 (CO), 
142.9 (C), 129.4 (CH), 127.0 (CH), 122.4 (C), 118.3 (CH), 111.1 (CH), 59.0 (CH), 58.8 (CH), 48.8 
(CH), 47.5 (CH), 37.0 (CH3), 35.8 (CH3), 27.7 (CH2), 25.4 (CH2), 25.2 (CH3); HRMS m/z (ES) 












To a suspension of amide 134 (163 mg, 0.500 mmol) in dry THF (2 mL) was added 2,3-dichloro-
5,6-dicyano-p-benzoquinone (227 mg, 1.00 mmol). The mixture was heated under reflux for 10 min 
and cooled to rt. The solvent was removed under reduced pressure and the mixture was diluted 
with CH2Cl2 (100 mL) and filtered. The filtrate was concentrated under reduced pressure to obtain 
the crude product that was purified by column chromatography on silica gel eluting with petrol–
EtOAc (3:2) to give amide 135 (92 mg, 57%) as an yellow amorphous solid; m.p. 262264 C 
[petrol–EtOAc]; Rf 0.40 [petrol–EtOAc (1:4)]; FT-IR max (film)/cm-1 3054, 2933, 1752, 1693 (C=O), 
1632 (C=O), 1567, 1427, 1392, 1348, 979, 958, 818, 757, 736; 1H NMR (400 MHz, CDCl3) δ = 
7.87 (1H, d, J = 8.5 Hz, CH), 7.76 (1H, d, J = 8.0 Hz, CH), 7.66 (1H, d, J = 9.5 Hz, CH), 7.60 (1H, 
t, J = 8.0 Hz, CH), 7.54–7.46 (2H, m, 2 × CH), 3.34 (3H, s, CH3), 3.29 (3H, s, CH3), 3.12 (3H, s, 
CH3); 13C NMR (100 MHz, CDCl3) δ = 164.2 (C=O), 164.0 (C=O), 162.1 (C=O), 133.6 (C), 129.8 
(CH), 129.6 (C), 129.5 (CH), 127.8 (CH), 126.0 (CH), 125.0 (C), 124.4 (C), 118.4 (C), 117.3 (CH), 
116.8 (CH), 110.9 (C), 38.5 (CH3), 35.5 (CH3), 24.2 (CH3); HRMS m/z (ES) Found: MH+, 322.1186. 
C18H16N3O3 requires MH+ 315.1186; LRMS m/z (ES) 201 (25%), 221 (10%), 274 (40%), 322 (55%, 









To a stirred solution of malononitrile (363 mg, 5.50 mmol) in absolute EtOH (12 mL) was added 
anisaldehyde (0.6 mL, 5 mmol) followed by saturated aqueous NaHCO3 (1.5 mL). The mixture was 
stirred at rt for 1 h. The mixture was filtered to collect the crude product which was recrystallized 
in absolute EtOH to give arylidenemalononitrile 138a (681 mg, 74%) as yellow needles; m.p. 
111113 C [EtOH] (lit.143 116118 C [no solvent]); Rf 0.55 [petrol–EtOAc (1:1)]; 1H NMR (400 
MHz, CDCl3) δ = 7.957.92 (2H, m, 2 × CH), 7.68 (1H, s, CH), 7.067.02 (2H, m, 2 × CH), 3.94 
(3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 164.9 (C), 158.9 (CH), 133.5 (CH), 124.1 (C), 115.2 




To a stirred solution of malononitrile (363 mg, 5.50 mmol) in absolute EtOH (12 mL) was added 4-
chlorobenzaldehyde (0.7 g, 5 mmol) followed by saturated aqueous NaHCO3 (1.5 mL). The mixture 
was stirred at rt for 1 h. The mixture was filtered to collect the crude product which was 
recrystallized in absolute EtOH to give arylidenemalononitrile 138b (700 mg, 74%) as white 
needles; m.p. 156158 C [EtOH] (lit.143 167168 C [no solvent]); Rf 0.67 [petrol–EtOAc (1:1)]; 1H 
NMR (400 MHz, CDCl3) δ = 7.907.86 (2H, m, 2 × CH), 7.76 (1H, s, CH), 7.567.53 (2H, m, 2 × 
CH); 13C NMR (100 MHz, CDCl3) δ = 158.3 (CH), 141.2 (C), 131.9 (CH), 130.1 (CH), 129.3 (C), 








To a stirred solution of malononitrile (363 mg, 5.50 mmol) in absolute EtOH (12 mL) was added 
benzaldehyde (0.5 mL, 5 mmol) followed by saturated aqueous NaHCO3 (1.5 mL). The mixture 
was stirred at rt for 1 h. The mixture was filtered to collect the crude product which was 
recrystallized in absolute EtOH to give arylidenemalononitrile 138c (137 mg, 18%) as white 
needles; m.p. 8385 C [EtOH] (lit.143 8485 C [no solvent]); Rf 0.63 [petrol–EtOAc (1:1)]; 1H NMR 
(400 MHz, CDCl3) δ = 7.957.92 (2H, m, 2 × CH), 7.81 (1H, s, CH), 7.697.64 (1H, m, CH), 
7.597.55 (2H, m, 2 × CH); 13C NMR (100 MHz, CDCl3) δ = 160.0 (CH), 134.7 (CH), 130.9 (C), 






To a stirred suspension of ester 131 (282 mg, 1.00 mmol) in MeOH (6 mL) was added 
arylidenemalononitrile 138a (184 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The 
mixture was heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced 
pressure to obtain the crude product that was purified by column chromatography on silica gel 
eluting with petrol–EtOAc (9:1) to give ester 139 (245 mg, 64%) as yellow needles; m.p. 
130133 C [petrol–EtOAc]; Rf 0.59 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2944, 2221, 1737 
(CO), 1604 (CC), 1571, 1510, 1257, 1177, 1021, 835, 755, 569, 525; 1H NMR (400 MHz, DMSO-
d6) δ = 7.577.54 (2H, m, 2 × CH), 7.217.19 (1H, m, CH), 7.077.03 (3H, m, 3 × CH), 6.79 (1H, 
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dd, J = 10.0, 2.0 Hz, CH), 6.736.69 (1H, m, CH), 6.39 (1H, d, J = 8.0 Hz, CH), 5.89 (1H, dd, J = 
10.0, 2.5 Hz, CH), 5.62 (1H, dd, J = 2.5, 2.0 Hz, CHA), 4.91 (1H, d, J = 8.5 Hz, CHB), 4.57 (1H, d, 
J = 8.5 Hz, CHC), 3.80 (3H, s, CH3), 3.67 (3H, s, CH3); 13C NMR (100 MHz, DMSO-d6, one CH 
missing/overlapping) δ = 171.0 (CO), 160.4 (C), 141.5 (C), 130.7 (CH), 130.4 (CH), 128.2 (CH), 
124.7 (C), 119.2 (C), 119.1 (CH), 116.3 (CH), 114.9 (CH), 112.9 (2 × CN), 110.7 (CH), 68.5 (CH), 
63.0 (CH), 55.7 (CH), 53.6 (CH3), 53.2 (CH3), 49.3 (C); HRMS m/z (ES) Found: MH+, 386.1502. 






To a stirred suspension of ester 131 (282 mg, 1.00 mmol) in MeOH (6 mL) was added 
arylidenemalononitrile 138b (189 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The 
mixture was heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced 
pressure to obtain the crude product that was purified by column chromatography on silica gel 
eluting with petrol–EtOAc (9:1) to give ester 140 (260 mg, 67%) as a yellow amorphous solid; m.p. 
9598 C [petrol–EtOAc]; Rf 0.67 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2954, 2489, 2162 
(CN), 1740 (CO, 1648 (CC), 1594, 1453, 1254, 1198, 735, 699; 1H NMR (400 MHz, CDCl3) δ 
= 7.497.47 (4H, m, 4 × CH), 7.16 (1H, td, J = 7.5, 1.5 Hz, CH), 7.02 (1H, dd, J = 7.5, 1.5 Hz, CH), 
6.826.74 (2H, m, 2 × CH), 6.40 (1H, dd, J = 10.0, 1.5 Hz, CH), 5.81 (1H, dd, J = 10.0, 2.5 Hz, 
CH), 5.64 (1H, dd, J = 2.5, 1.5 Hz, CHA), 4.70 (1H, d, J = 8.5 Hz, CHB), 4.05 (1H, d, J = 8.5 Hz, 
CHC), 3.81 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 171.4 (CO), 141.0 (C), 136.3 (C), 131.3 
(CH), 130.6 (CH), 129.8 (2 × CH), 129.7 (C), 128.5 (CH), 119.9 (CH), 119.3 (C), 114.8 (CH), 112.4 
(CN), 111.3 (CN), 109.8 (CH), 69.9 (CH), 64.6 (CH), 55.7 (CH), 53.3 (CH3), 48.5 (C); HRMS m/z 
(ES) Found: MH+, 390.1007. C22H17N3O235Cl requires MH+ 390.1004; Found: MH+, 392.0989. 
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C22H17N3O237Cl requires MH+ 392.0974; LRMS m/z (ES) 390 (100%, MH+ for 35Cl), 392 (35%, MH+ 






To a stirred suspension of ester 131 (282 mg, 1.00 mmol) in MeOH (6 mL) was added 
arylidenemalononitrile 138c (154 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The 
mixture was heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced 
pressure to obtain the crude product that was purified by column chromatography on silica gel 
eluting with petrol–EtOAc (9:1) to give ester 141 (274 mg, 77%) as a yellow amorphous solid; m.p. 
111113 C [petrol–EtOAc]; Rf 0.63 [petrol–EtOAc (1:1)];  FT-IR max (film)/cm-1 3200, 2952, 2491, 
2154 (CN), 1735 (CO), 1647 (CC), 1594, 1451, 1203, 727, 701; 1H NMR (400 MHz, CDCl3) δ 
= 7.577.49 (5H, m, 5 × CH), 7.16 (1H, td, J = 7.5, 1.5 Hz, CH), 7.02 (1H, dd, J = 7.5, 1.5 Hz, CH), 
6.826.74 (2H, m, 2 × CH), 6.42 (1H, dd, J = 8.0, 2.0 Hz, CH), 5.82 (1H, dd, J = 8.0, 2.5 Hz, CH), 
5.66 (1H, dd, J = 2.5, 2.0 Hz, CHA), 4.77 (1H, d, J = 8.5 Hz, CHB), 4.08 (1H, d, J = 8.5 Hz, CHC), 
3.81 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 171.6 (CO), 141.1 (C), 131.2 (C), 131.2 (CH), 
130.5 (CH), 130.1 (CH), 129.5 (CH), 128.4 (CH), 128.4 (CH), 119.8 (CH), 119.3 (C), 114.9 (CH), 
112.6 (CN), 111.4 (CN), 109.8 (CH), 69.9 (CH), 64.6 (CH), 56.3 (CH), 53.2 (CH3), 48.6 (C); HRMS 












To a stirred suspension of amide 132 (295 mg, 1.00 mmol) in MeOH (6 mL) was added 
arylidenemalononitrile 138a (184 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The 
mixture was heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced 
pressure to obtain the crude product that was purified by column chromatography on silica gel 
eluting with petrol–EtOAc (9:1) to give amide 142 (140 mg, 35%) as a light brown amorphous solid; 
m.p. 133135 C [petrol–EtOAc]; Rf 0.32 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 2936, 2498, 
2156 (CN), 1643 (CO), 1515, 1490, 1456, 1399, 1371, 1255, 1178, 1136, 1119, 1027, 829, 784, 
743, 621, 542; 1H NMR (400 MHz, DMSO-d6) δ = 7.707.67 (2H, m, 2 × CH), 7.117.02 (4H, m, 4 
× CH), 6.75 (1H, dd, J = 10.0, 2.0 Hz, CH), 6.67 (1H, td, J = 7.5, 1.0 Hz, CH), 6.10 (1H, d, J = 
7.5 Hz, CH), 5.89 (1H, dd, J = 10.0, 2.0 Hz, CH), 5.68 (1H, t, J = 2.0 Hz, CHA), 5.27 (1H, d, J = 
7.5 Hz, CHB), 4.22 (1H, d, J = 7.5 Hz, CHC), 3.81 (3H, s, CH3), 2.83 (3H, s, CH3), 2.71 (3H, s, CH3); 
13C NMR (100 MHz, DMSO-d6, one CH missing/overlapping) δ = 170.0 (CO), 160.5 (C), 141.5 
(C), 130.9 (CH), 130.5 (CH), 128.0 (CH), 124.6 (C), 119.7 (C), 118.6 (CH), 117.0 (CH), 114.9 (CH), 
113.3 (2 × CN), 110.5 (CH), 69.6 (CH), 59.2 (CH), 55.7 (CH3), 55.4 (CH), 48.8 (C), 37.1 (CH3), 
36.1 (CH3); HRMS m/z (ES) Found: MH+, 399.1825. C24H23N4O2 requires MH+ 399.1816; LRMS 











To a stirred suspension of amide 132 (295 mg, 1.00 mmol) in MeOH (6 mL) was added 
arylidenemalononitrile 138b (189 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The 
mixture was heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced 
pressure to obtain the crude product that was purified by column chromatography on silica gel 
eluting with petrol–EtOAc (9:1) to give amide 143 (245 mg, 61%) as a light brown amorphous solid; 
m.p. 120123 C; Rf 0.51 [40-60 petroleum ether/ethyl acetate (1:1)]; FT-IR max (film)/cm-1 3054, 
2936, 2489, 2162, 2026, 1645 (CO), 1492, 1459, 1402, 1374, 1136, 1088, 1011, 830, 778, 742, 
622, 507; 1H NMR (400 MHz, DMSO-d6) δ = 7.837.80 (2H, m, 2 × CH), 7.617.57 (2H, m, 2 × 
CH), 7.117.03 (2H, m, 2 × CH), 6.76 (1H, dd, J = 10.0, 1.5 Hz, CH), 6.68 (1H, td, J = 7.5, 1.0 Hz, 
CH), 6.13 (1H, d, J = 8.0 Hz, CH), 5.91 (1H, dd, J = 10.0, 2.0 Hz, CH), 5.70 (1H, t, J = 2.0 Hz, 
CHA), 5.34 (1H, d, J = 7.5 Hz, CHB), 4.41 (1H, d, J = 7.5 Hz, CHC), 2.84 (3H, s, CH3), 2.71 (3H, s, 
CH3); 13C NMR (100 MHz, DMSO-d6) δ = 169.6 (CO), 141.4 (C), 134.9 (C), 132.3 (C), 131.5 (CH), 
130.6 (CH), 130.5 (CH), 129.6 (CH), 128.0 (CH), 119.8 (C), 118.7 (CH), 116.9 (CH), 113.1 (2 × 
CN), 110.6 (CH), 69.7 (CH), 58.9 (CH), 54.7 (CH), 48.6 (C), 37.1 (CH3), 36.1 (CH3); HRMS m/z 
(ES) Found: MH+, 403.1322. C23H20N4O35Cl requires MH+ 403.1320; Found: MH+, 405.1310. 
C23H20N4O37Cl requires MH+ 405.1291; LRMS m/z (ES) 403 (100%, MH+ for 35Cl), 405 (35%, MH+ 











To a stirred suspension of amide 132 (295 mg, 1.00 mmol) in MeOH (6 mL) was added 
arylidenemalononitrile 138c (154 mg, 1.00 mmol) followed by Et3N (0.14 mL, 1.0 mmol). The 
mixture was heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced 
pressure to obtain the crude product that was purified by column chromatography on silica gel 
eluting with petrol–EtOAc (9:1) to give amide 144 (243 mg, 66%) as a light brown amorphous solid; 
m.p. 8790 C [petrol–EtOAc]; Rf 0.28 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 3034, 2492, 2162 
(CN), 1650 (CO), 1571, 1597, 1489, 1464, 1400, 1374, 1236, 1134, 740, 699, 625; 1H NMR 
(400 MHz, DMSO-d6) δ = 7.787.72 (2H, m, 2 × CH), 7.537.45 (3H, m, 3 × CH), 7.117.03 (2H, 
m, 2 × CH), 6.77 (1H, dd, J = 10.0, 2.0 Hz, CH), 6.68 (1H, td, J = 7.5, 0.5 Hz, CH), 6.14 (1H, d, J 
= 7.5 Hz, CH), 5.91 (1H, dd, J = 10.0, 2.0 Hz, CH), 5.71 (1H, t, J = 2.0 Hz, CHA), 5.33 (1H, d, J = 
7.5 Hz, CHB), 4.29 (1H, d, J = 7.5 Hz, CHC), 2.83 (3H, s, CH3), 2.69 (3H, s, CH3); 13C NMR 
(100 MHz, DMSO-d6) δ = 169.8 (CO), 141.5 (C), 133.1 (C), 130.5 (CH), 130.5 (CH), 130.1 (CH), 
129.6 (CH), 129.6 (CH), 128.1 (CH), 119.8 (C), 118.7 (CH), 116.9 (CH), 113.2 (2 × CN), 110.5 
(CH), 69.7 (CH), 59.0 (CH), 55.7 (CH), 48.7 (C), 37.0 (CH3), 36.1 (CH3); HRMS m/z (ES) Found: 












To a solution of 6-chloroquinoline (2.0 g, 12 mmol) in PhMe (16 mL) was added methyl 
bromoacetate (1.3 mL, 14 mmol). The mixture was heated at 65 °C for 16 h and cooled to rt. The 
mixture was filtered, washed with Et2O (50 mL), and dried to give ester 146 (417 mg, 11%) as a 
red amorphous solid; m.p. 184188 °C [Et2O]; FT-IR max (film)/cm-1: 1744 (C=O), 1216 , 1201, 
1170; 1H NMR (400 MHz, D2O) δ = 9.16−9.00 (2H, m, CH), 8.28 (1H, d, J = 2.4 Hz, CH), 8.08-7.98 
(3H, m, CH), 5.90 (2H, s, CH2), 3.72 (3H, s, CH3); 13C NMR (100 MHz, D2O) δ = 167.3 (C=O), 
150.6 (CH), 148.6 (CH), 137.1 (C), 136.8 (CH), 136.0 (C), 130.6 (C), 129.2 (CH), 122.8 (CH), 119.8 
(CH), 57.9 (CH2), 53.9 (CH3); HRMS m/z (ES) Found: M+−Br, 236.0475. C12H1135ClNO2 requires 
M+−Br 236.0473; Found: M+−Br, 238.0445. C12H1137ClNO2 requires M+−Br 238.0473; LRMS m/z 
(ES) 236 (100%, M+−Br for 35Cl), 238 (30%, M+−Br for 37Cl). 




To a solution of 6-chloroquinoline (714 mg, 4.36 mmol) in PhMe (6 mL) was added bromide 102 
(0.52 mL, 4.8 mmol). The mixture was heated at 65 °C for 16 h and cooled to rt. The mixture was 
filtered, washed with Et2O (50 mL), and dried to give amide 147 (368 mg, 26%) as a pale yellow 
powder; m.p. 238240 °C [Et2O]; FT-IR max (film)/cm-1: 3017 (C-H), 1643 (C=O), 1526, 1401, 
1383, 1362, 1257, 1239, 1156, 1041, 900, 852, 798; 1H NMR (400 MHz, D2O) δ = 9.13−9.05 (2H, 
m, CH), 8.34 (1H, d, J = 6.0 Hz, CH), 8.08−8.03 (3H, m, CH), 6.07 (2H, s, CH2), 3.23 (3H, s, CH3), 
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2.95 (3H, s, CH3); 13C NMR (100 MHz, D2O) δ = 165.2 (C=O), 150.4 (CH), 148.3 (CH), 137.5 (C), 
136.6 (CH), 135.9 (C), 130.6 (C), 129.2 (CH), 122.8 (CH), 120.0 (CH), 58.8 (CH2), 36.4 (CH3), 35.9 
(CH3); HRMS m/z (ES) Found: M+−Br, 249.0789. C13H1435ClN2O requires M+−Br 249.0789; Found: 
M+−Br, 251.0764. C13H1437ClN2O requires M+−Br 251.0760; LRMS m/z (ES) 249 (100%, M+−Br for 







To a stirred suspension of ester 146 (200 mg, 0.630 mmol) in MeOH (4 mL) was added N-
methylmaleimide (70 mg, 0.63 mmol) followed by Et3N (0.08 mL, 0.6 mmol). The mixture was 
heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced pressure to 
obtain the crude product that was purified by column chromatography on silica gel, eluting with 
pentane−EtOAc (3:1) to give ester 148 (125 mg, 57%) as a yellow powder; m.p. 158161 °C 
[pentane−EtOAc]; Rf  0.38 [petrol−EtOAc (1:1)]; FT-IR max /cm-1: 2954 (C=O), 1781 (C=O), 1697 
(C=O), 1596, 1489, 1431, 1380, 1285, 1209, 1176 (C-O), 1127, 807 (C-Cl), 759; 1H NMR 
(400 MHz, DMSO-d6) δ = 7.05−6.97 (2H, m, 2 × CH), 6.50 (1H, d, J = 8.0 Hz, CH), 6.38 (1H, dd, 
J = 10.0, 2.5 Hz, CH), 6.04 (1H, dd, J = 10.0, 2.5 Hz, CH), 4.85 (1H, dt, J = 7.5, 2.5 Hz, CHA), 4.76 
(1H, s, CHB), 3.72 (3H, s, CH3), 3.71−3.59 (2H, m, CHC & CHD), 2.81 (3H, s, CH3); 13C NMR 
(100 MHz, DMSO-d6) δ = 177.5 (C=O), 176.4 (C=O), 170.4 (C=O), 140.8 (C), 128.7 (CH), 126.7 
(CH), 125.1 (CH), 123.8 (CH), 123.4 (C), 122.1 (C), 113.1 (CH), 60.6 (CH3), 59.5 (CH3) 53.0 (CH), 
47.9 (CH), 47.3 (CH), 25.4 (CH); HRMS m/z (ES) Found: MH+, 347.0789. C17H1635ClN2O4 requires 
MH+ 347.0793; Found: MH+, 349.0771. C17H1637ClN2O4 requires MH+ 349.0764; LRMS m/z (ES) 









To a stirred suspension of amide 147 (200 mg, 0.600 mmol) in MeOH (4 mL) was added N-
methylmaleimide (67 mg, 0.60 mmol) followed by Et3N (0.08 mL, 0.6 mmol). The mixture was 
heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced pressure to 
obtain the crude product that was purified by column chromatography on silica gel, eluting with 
pentane−EtOAc (1:1) to give amide 149 (143 mg, 66%) as a yellow powder; m.p. 182184 °C 
[pentane−EtOAc]; Rf  0.17 [petrol−EtOAc (1:1)];  FT-IR max /cm-1: 2943, 2814, 1696 (C=O), 1653 
(C=O), 1489, 1383, 1292, 1126, 1059, 870, 812, 759; 1H NMR (400 MHz, DMSO-d6) δ = 7.00−6.94 
(2H, m, 2 × CH), 6.35 (1H, dd, J = 10.0, 2.5 Hz, CH), 6.21 (1H, d, J = 8.5 Hz, CH), 6.06 (1H, dd, J 
= 10.0, 2.5 Hz, CH), 5.11 (1H, dt, J = 7.0, 2.5 Hz, CHA), 4.87 (1H, s, CHB), 3.65−3.52 (2H, m, CHC 
& CHD), 3.28 (3H, s, CH3), 2.88 (3H, s, CH3), 2.84 (3H, s, CH3); 13C NMR (100 MHz, DMSO-d6) δ 
= 177.3 (C=O), 175.8 (C=O), 169.1 (C=O), 140.4 (C), 128.4 (CH), 126.9 (CH), 125.5 (CH), 123.9 
(C), 121.5 (C), 123.0 (CH), 111.3 (CH), 60.6 (CH), 59.2 (CH), 47.5 (CH), 47.5 (CH), 37.1 (CH3), 
35.9 (CH3), 25.5 (CH3); HRMS m/z (ES) Found: MH+, 360.1110. C18H1935ClN3O3 requires MH+ 
360.1109; Found: MH+, 362.1091. C18H1937ClN3O3 requires MH+ 362.1080; LRMS m/z (ES) 360 










To a stirred solution of 6-bromoquinoline (2.0 mL, 14 mmol) in PhMe (18 mL) was added bromide 
102 (2.6 g, 16 mmol). The mixture was heated at 65 C for 16 h and cooled to rt forming an orange 
suspension. The mixture was filtered, washed with Et2O (100 mL), and dried to give amide 152 
(2.4 g, 45 %) as a pale orange amorphous solid; m.p. 248250 C [Et2O]; FT-IR max (film)/cm-1 
3072, 3013, 1642 (C=O), 1592, 1553, 1403, 1383, 1358, 1263, 1155, 887, 845, 798; 1H NMR 
(400 MHz, D2O) δ = 9.21 (1H, d, J = 6.0 Hz, CH), 9.16 (1H, d, J = 8.5 Hz, CH), 8.62 (1H, d, J = 2.0 
Hz, CH), 8.30 (1H, dd, J = 9.5, 2.0 Hz, CH), 8.15 (1H, dd, J = 8.5, 6.0 Hz, CH), 8.07 (1H, d, J = 9.5 
Hz, CH), 6.15 (2H, s, CH2), 3.31 (3H, s, CH3), 3.03 (3H, s, CH3); 13C NMR (100 MHz, D2O) δ = 
165.2 (C=O), 150.5 (CH), 148.2 (CH), 139.2 (CH), 137.8 (C), 132.6 (CH), 130.9 (C), 124.0 (C), 
122.7 (CH), 119.8 (CH), 58.7 (CH2), 36.4 (CH3), 35.9 (CH3); HRMS m/z (ES) Found: M+−Br, 293.0. 
C13H1479BrN2O requires M+−Br 293.0284; Found: M+−Br, 295.0. C13H1481BrN2O requires M+−Br 
295.0264; LRMS m/z (ES) 293 (100%, M+−Br for 79Br), 294 (15%), 295 (100%, M+−Br for 81Br), 














To a stirred suspension of amide 152 (200 mg, 0.538 mmol) in MeOH (3 mL) was added N-
methylmaleimide (60 mg, 0.54 mmol) followed by Et3N (0.08 mL, 0.5 mmol). The mixture was 
heated under reflux for 1 h and cooled to rt. The solvent was removed under reduced pressure to 
obtain the crude product as an orange solid. The crude product was purified by column 
chromatography on silica gel, eluting with EtOAc to give amide 153 (145 mg, 67%) as an off-white 
amorphous solid; m.p. 196198 C [EtOAc]; Rf 0.19 [EtOAc]; FT-IR max (film)/cm-1 3011, 2935, 
1695 (C=O), 1645 (C=O), 1587, 1486, 1439, 1383, 1288, 1149, 817, 745; 1H NMR (400 MHz, 
CDCl3) δ = 7.08 (1H, dd, J = 8.5, 2.0 Hz, CH), 7.02 (1H, d, J = 2.0 Hz, CH), 6.29 (1H, dd, J = 10.0, 
2.0 Hz, CH), 6.13 (1H, d, J = 10.0 Hz, CH), 5.96 (1H, d, J = 8.0 Hz, CH), 5.36 (1H, d, J = 8.0 Hz, 
CHA), 4.85 (1H, s, CHB), 3.48 (1H, t, J = 8.0 Hz, CHC), 3.41–3.33 (4H, m, CHD & CH3), 3.03 (3H, 
s, CH3), 2.97 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 177.2 (C=O), 175.7 (C=O), 169.0 
(C=O), 140.8 (C), 131.3 (CH), 129.7 (CH), 125.4 (CH), 124.3 (C), 122.9 (CH), 111.7 (CH), 110.6 
(C), 60.6 (CH), 59.2 (CH), 47.6 (CH), 47.5 (CH), 37.0 (CH3), 35.9 (CH3), 25.5 (CH3); HRMS m/z 
(ES) Found: MH+, 404.0593. C18H1979BrN3O3 requires MH+ 404.0604; Found: MH+, 406.0584. 
C18H1981BrN3O3 requires M+ 406.0584; LRMS m/z (ES) 404 (100%, MH+ for 79Br), 405 (20%), 406 












A mixture of amide 153 (91 mg, 0.23 mmol), phenyl boronic acid (36 mg, 0.30 mmol), 
tetrakis(triphenylphosphine)palladium(0) (14 mg, 0.012 mmol) and Na2CO3 (105 mg, 0.988 mmol) 
in PhMe (0.2 mL), H2O (0.2 mL), and EtOH (0.1 mL) was heated at 75 C for 16 h. After cooling to 
rt, the mixture was filtered through a pad of celite. The filtrate was diluted with water (10 mL) and 
CH2Cl2 (25 mL). The organic layer was separated and washed with brine (10 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as brown oil. The crude product was purified by column chromatography on silica gel, eluting with 
petrol–EtOAc (1:4) to give amide 150 (55 mg, 61%) as an off-white amorphous solid; m.p. 
200202 C [petrol–EtOAc]; Rf 0.17 [petrol−EtOAc (1:3)]; FT-IR max (film)/cm-1 3061, 2960, 2822, 
1708 (C=O), 1642 (C=O), 1482, 1431, 1378, 1288, 1131, 769, 703; 1H NMR (400 MHz, CDCl3) δ 
= 7.47 (2H, dd, J = 8.0, 1.0 Hz, 2 × CH), 7.37 (2H, t, J = 7.5 Hz, 2 × CH), 7.30–7.23 (2H, m, 2 × 
CH), 7.17 (1H, d, J = 2.0 Hz, CH), 6.45 (1H, dd, J = 10.0, 2.5 Hz, CH), 6.21 (1H, d, J = 8.0 Hz, 
CH), 6.14 (1H, dd, J = 10.0, 2.0 Hz, CH), 5.42 (1H, dt, J = 8.0, 2.0 Hz, CHA), 4.98 (1H, s, CHB), 
3.51 (1H, t, J = 8.0 Hz, CHC), 3.43–3.37 (4H, m, CHD & CH3), 3.05 (3H, s, CH3), 2.96 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3, one CH missing/overlapping) δ = 177.4 (C=O), 175.9 (C=O), 169.4 
(C=O), 141.2 (C), 141.0 (C), 131.9 (C), 128.7 (CH), 127.7 (CH), 126.42 (CH), 126.37 (CH), 126.1 
(CH), 122.7 (C), 121.9 (CH), 110.5 (CH), 60.8 (CH), 59.4 (CH), 47.9 (CH), 47.6 (CH), 37.1 (CH3), 
35.9 (CH3), 25.4 (CH3); HRMS m/z (ES) Found: MH+, 402.1821. C24H24N3O3 requires MH+ 







To a stirred suspension of cyanoacetic acid (2.2 g, 26 mmol) in CH2Cl2 (100 mL) at 0 °C was added 
oxalyl chloride (2.0 mL, 24 mmol), followed by DMF (12 drops). The mixture was warmed up to rt. 
After 3 h, N-methylaniline (2.2 mL, 20 mmol) in CH2Cl2 (80 mL) was added, followed by dropwise 
addition of Et3N (7.0 mL, 70 mmol) at 0 °C. The mixture was warmed to rt and stirred for 17 h. 
Water (40 mL) was added, and the organic layer was separated and washed with aqueous HCl 
(40 mL, 1 M). The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to give the crude product as a pale orange solid. The crude product was purified 
by column chromatography on silica gel, eluting with petrol–EtOAc (1:1) to give amide 157 (3.4 g, 
98%) as an off-white amorphous solid; m.p. 7476 C [petrol–EtOAc] (lit.144 7679 C [EtOH]); Rf 
0.24 [petrol–EtOAc (1:1)]; 1H NMR (400 MHz, CDCl3) δ = 7.58–7.39 (3H, m, 3 × CH), 7.33–7.20 
(2H, m, 2 × CH), 3.34 (3H, s, CH3), 3.25 (2H, s, CH2); 13C NMR (100 MHz, CDCl3) δ = 161.7 (C=O), 
142.4 (C), 130.5 (CH), 129.1 (CH), 127.1 (CH), 114.1 (CN), 37.9 (CH3), 25.4 (CH2). Data consistent 




To a stirred solution of amide 157 (1 g, 6 mmol) in MeCN (29 mL) was added tert-butyl nitrite 
(3.5 mL, 29 mmol), Cs2CO3 (3.7 g, 12 mmol), glacial acetic acid (1.6 mL, 29 mmol) and 4 Å MS 
(2.9 g). The mixture was stirred at 100 °C for 6 h. Na2S2O4 (3.5 g, 20 mmol) in a mixture of EtOH 
(57 mL) and water (115 mL) was added and the mixture was heated for a further 2 h at 90 °C. After 
cooling the mixture to rt the organic product was extracted using EtOAc (2 × 250 mL) and washed 
with aqueous NaHCO3 (150 mL), brine (150 mL), dried over anhydrous MgSO4, filtered, and 
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concentrated under reduced pressure to give the crude product as an orange solid. The crude 
product was flushed through a silica gel plug, eluting with petrol–EtOAc (3:2) to give crude nitrile 




To a solution of crude nitrile 158 (567 mg, 3.06 mmol) in dry THF (12 mL) was added NaBH4 
(579 mg, 15.3 mmol). The reaction mixture was heated at 50 °C for 1 h. After cooling to rt the 
mixture was diluted with water (50 mL) and EtOAc (150 mL). The organic layer was separated and 
washed with brine (50 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a red oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (1:1) to give amine 159 (370 mg, 75%) as 
orange oil which crystallised on standing to give an orange solid. m.p. 52–54 C [petrol–EtOAc]; 
Rf 0.23 [petrol–EtOAc (1:1)]; 1H NMR (400 MHz, DMSO-d6) δ = 6.96 (1H, d, J = 8.5 Hz, CH), 6.90–
6.81 (1H, m, CH), 6.78–6.68 (2H, m, 2 × CH), 6.05 (1H, br s, NH), 3.77 (2H, s, CH2), 3.23 (3H, s, 
CH3); 13C NMR (100 MHz, DMSO-d6) δ = 165.8 (C=O), 137.1 (C), 129.0 (C), 123.6 (CH), 118.6 





To a solution of amine 159 (100 mg, 0.617 mmol) in dry PhMe (2.5  mL) was added CSA (14 mg, 
0.060 mmol). The mixture was heated under reflux for 17 h under air. After cooling to rt, the mixture 
was diluted with EtOAc (150 mL) and water (50 mL). The organic layer was separated, washed 
with brine (50 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a yellow solid. The crude product was purified by column 
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chromatography on silica gel, eluting with petrol–EtOAc (1:1) to give a mixture (ratio 1:1.2) of amine 
159 and imine 161 as an orange solid (24 mg, 24%). Data for imine 161: 1H NMR (400 MHz, 
DMSO-d6) δ = 8.24 (1H, s, CH), 7.82 (1H, dd, J = 8.0, 1.5 Hz, CH), 7.71–7.63 (1H, m, CH), 7.62–
7.55 (1H, m, CH), 7.44–7.35 (1H, m, CH), 3.60 (3H, s, CH3); 13C NMR (100 MHz, DMSO-d6) δ = 
154.8 (C=O), 150.6 (CH), 133.6 (C), 133.1 (C), 131.5 (CH), 130.0 (CH), 123.9 (CH), 115.4 (CH), 






To a solution of amine 159 (75 mg, 0.46 mmol) in dry PhMe (2.5 mL) was added benzaldehyde 
(0.03 mL, 0.3 mmol), N-methylmaleimide (34 mg, 0.31 mmol), CSA (11 mg, 0.046 mmol) and 4 Å 
MS (200 mg). The mixture was heated under reflux for 16 h under an argon atmosphere and cooled 
to rt. The mixture was filtered and concentrated under reduced pressure. The organic product was 
extracted using EtOAc (150 mL) and washed with water (2 x 20 mL), brine (20 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as a brown oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (17:3) to give cycloadduct 160 (77 mg, 69%) as a pale yellow amorphous solid; 
m.p. 210212 C [petrol–EtOAc]; Rf 0.13 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 3072, 2955, 
2163, 1982, 1698 (C=O), 1648 (C=O), 1592 (C=O), 1525, 1380, 1252, 1130, 1037, 996, 854, 739, 
711; 1H NMR (400 MHz, CDCl3) δ = 7.48–7.30 (5H, m, 5 × CH), 7.03–6.78 (3H, m, 3 × CH), 6.59 
(1H, dd, J = 8.0, 1.0 Hz, CH), 5.57 (1H, d, J = 1.5 Hz, CHA), 4.76 (1H, d, J = 7.0 Hz, CHB), 3.81 
(1H, t, J = 7.0 Hz, CHC), 3.57 (1H, dd, J = 7.0, 1.5 Hz, CHD), 3.49 (3H, s, CH3), 2.80 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ = 177.0 (C=O), 174.8 (C=O), 162.8 (C=O), 138.1 (C), 132.5 (C), 
129.3 (CH), 128.0 (CH), 127.6 (C), 125.9 (CH), 124.1 (CH), 119.6 (CH), 114.7 (CH), 111.8 (CH), 
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65.7 (CH), 61.5 (CH), 51.5 (CH), 48.9 (CH), 28.9 (CH3), 25.3 (CH3); HRMS m/z (ES) Found: MH+, 








To a solution of amine 159 (75 mg, 0.46 mmol) in dry PhMe (2.5 mL) was added 4-
nitrobenzaldehyde (47 mg, 0.31 mmol), N-methylmaleimide (34 mg, 0.31 mmol), CSA (11 mg, 
0.046 mmol) and 4 Å MS (200 mg). The mixture was heated under reflux for 16 h under an argon 
atmosphere and cooled to rt. The mixture was filtered and concentrated under reduced pressure. 
The organic product was extracted using EtOAc (150 mL) and washed with water (2 x 20 mL), 
brine (20 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to 
give the crude product as a orange oil. The crude product was purified by column chromatography 
on silica gel, eluting with petrol–EtOAc (1:1) to give cycloadduct 164 (58 mg, 46%) as a pale yellow 
amorphous solid; m.p. 248250 C [petrol–EtOAc]; Rf 0.09 [petrol–EtOAc (1:1)]; FT-IR max 
(film)/cm-1; 3076, 2984, 1705 (C=O), 1674 (C=O), 1592, 1432, 1392, 1381, 1287, 746; 1H NMR 
(400 MHz, CDCl3) δ = 8.30 (2H, d, J = 8.5 Hz, 2 × CH), 7.62 (2H, d, J = 8.5 Hz, 2 × CH), 7.07–
6.84 (3H, m, 3 × CH), 6.49 (1 H, d, J = 7.5 Hz, CH), 5.58 (1H, s, CHA), 4.72 (1H, d, J = 7.0 Hz, 
CHB), 3.86 (1 H, t, J = 7.0 Hz, CHC), 3.59–3.47 (4H, m, CHD & CH3), 2.82 (3H, s, CH3); 13C NMR 
(100 MHz, CDCl3) δ = 176.3 (C=O), 174.3 (C=O), 162.2 (C=O), 147.7 (C), 145.8 (C), 131.9 (C), 
127.7 (C), 127.2 (CH), 124.6 (CH), 124.2 (CH), 120.4 (CH), 115.1 (CH), 111.8 (CH), 65.8 (CH), 
61.7 (CH), 51.5 (CH), 48.8 (CH), 29.0 (CH3), 25.5 (CH3); HRMS m/z (ES) Found: MH+, 407.1356. 









To a solution of amine 159 (75 mg, 0.46 mmol) in dry PhMe (2.5 mL) was added 4-
methoxybenzaldehyde (0.04 mL, 0.3 mmol), N-methylmaleimide (34 mg, 0.31 mmol), CSA (11 mg, 
0.046 mmol) and 4 Å MS (200 mg). The mixture was heated under reflux for 16 h under an argon 
atmosphere and cooled to rt. The mixture was filtered and concentrated under reduced pressure. 
The organic product was extracted using EtOAc (150 mL) and washed with water (2 x 20 mL), 
brine (20 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to 
give the crude product as a brown oil. The crude product was purified by column chromatography 
on silica gel, eluting with petrol–EtOAc (1:1) to give cycloadduct 165 (32 mg, 27%) as an off-white 
amorphous solid; m.p. 198200 C [petrol–EtOAc]; Rf 0.13 [petrol–EtOAc (1:1)]; FT-IR max 
(film)/cm-1 3063, 2935, 2835, 1778, 1698 (C=O), 1670 (C=O), 1596, 1511, 1432, 1383, 1248, 1179, 
1027, 830; 1H NMR (400 MHz, CDCl3) δ = 7.31 (2H, d, J = 8.5 Hz, 2 × CH), 7.00–6.88 (4H, m, 4 × 
CH), 6.83 (1H, td, J = 8.0, 1.5 Hz, CH), 6.61 (1H, d, J = 8.0 Hz, CH), 5.53 (1H, br s, CHA), 4.73 
(1H, d, J = 7.0 Hz, CHB), 3.83 (3H, s, CH3), 3.80 (1H, t, J = 7.0 Hz, CHC), 3.55 (1H, dd, J = 7.0, 
2.0 Hz, CHD), 3.48 (3H, s, CH3), 2.78 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 177.0 (C=O), 
174.8 (C=O), 162.8 (C=O), 159.3 (C), 132.6 (C), 129.9 (C), 127.6 (C), 127.2 (CH), 124.1 (CH), 
119.6 (CH), 114.7 (CH), 114.6 (CH), 111.8 (CH), 65.4 (CH), 61.5 (CH), 55.4 (CH3), 51.5 (CH), 48.8 
(CH), 28.8 (CH3), 25.2 (CH3); HRMS m/z (ES) Found: MH+, 392.1616. C22H22N3O4 requires MH+ 









To a solution of amine 159 (75 mg, 0.46 mmol) in dry PhMe (2.5 mL) was added 2-
thiophenecarbaldehyde (0.03 mL, 0.3 mmol), N-methylmaleimide (34 mg, 0.31 mmol), CSA 
(11 mg, 0.046 mmol) and 4 Å MS (200 mg). The mixture was heated under reflux for 16 h under 
an argon atmosphere and cooled to rt. The mixture was filtered and concentrated under reduced 
pressure. The organic product was extracted using EtOAc (150 mL) and washed with water (2 x 
20 mL), brine (20 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a brown oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (1:1) to give cycloadduct 166 (67 mg, 59%) 
as an off-white amorphous solid; m.p. 248250 C [petrol–EtOAc]; Rf 0.14 [petrol–EtOAc (1:1)]; 
FT-IR max (film)/cm-1 3103, 2945, 1780, 1698 (C=O), 1670 (C=O), 1593, 1471, 1418, 1282, 1093, 
979, 755; 1H NMR (400 MHz, CDCl3) δ = 7.30 (1H, dd, J = 5.0, 1.0 Hz, CH), 7.09 (1H, dt, J = 3.5, 
1.0 Hz, CH), 7.03 (1H, dd, J = 5.0, 3.5 Hz, CH), 6.99–6.94 (2H, m, 2 × CH), 6.90–6.81 (2H, m, 2 × 
CH), 5.85 (1H, br s, CHA), 4.74 (1H, d, J = 7.5 Hz, CHB), 3.84 (1H, t, J = 7.5 Hz, CHC), 3.68 (1H, 
dd, J = 7.5, 1.0 Hz, CHD), 3.45 (3H, s, CH3), 2.72 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 
176.3 (C=O), 174.5 (C=O), 162.8 (C=O), 141.9 (C), 132.1 (C), 128.1 (C), 127.3 (CH), 125.8 (CH), 
125.7 (CH), 124.0 (CH), 121.0 (CH), 114.9 (CH), 112.3 (CH), 62.5 (CH), 61.4 (CH), 51.5 (CH), 
48.0 (CH), 28.9 (CH3), 25.2 (CH3); HRMS m/z (ES) Found: MH+, 368.1000. C19H18N3O3S requires 









To a solution of amine 159 (75 mg, 0.46 mmol) in dry PhMe (2.5 mL) was added 
cyclohexanecarbaldehyde (0.04 mL, 0.3 mmol), N-methylmaleimide (34 mg, 0.31 mmol), CSA 
(11 mg, 0.046 mmol) and 4 Å MS (200 mg). The mixture was heated under reflux for 16 h under 
an argon atmosphere and cooled to rt. The mixture was filtered and concentrated under reduced 
pressure. The organic product was extracted using EtOAc (150 mL) and washed with water (2 x 
20 mL), brine (20 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as an orange oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (17:3) to give cycloadduct 167 (35 mg, 
31%) as an off-white amorphous solid; m.p. 248250 C [petrol–EtOAc]; Rf 0.21 [petrol–EtOAc 
(1:1)]; FT-IR max (film)/cm-1 2924, 2848, 1701 (C=O), 1670 (C=O), 1596, 1479, 1430, 1399, 1298, 
1280, 737; 1H NMR (400 MHz, CDCl3) δ = 6.99–6.86 (2H, m, 2 × CH), 6.80–6.73 (2H, m, 2 × CH), 
4.46 (1H, d, J = 7.0 Hz, CHB), 4.22 (1H, d, J = 10.0 Hz, CHA), 3.67 (1H, t, J = 7.0 Hz, CHC), 3.45 
(3H, s, CH3), 3.27 (1H, d, J = 7.0 Hz, CHD), 2.51 (3H, s, CH3), 2.03–1.88 (3H, m, 3 × CH), 1.82–
1.71 (2H, m, 2 × CH), 1.54–1.41 (1H, m, CH), 1.37–1.00 (5H, m, 5 × CH); 13C NMR (100 MHz, 
CDCl3) δ = 177.7 (C=O), 175.4 (C=O), 162.4 (C=O), 134.1 (C), 127.0 (C), 124.2 (CH), 119.6 (CH), 
114.9 (CH), 111.3 (CH), 70.7 (CH), 61.5 (CH), 49.0 (CH), 46.2 (CH), 39.7 (CH), 30.2 (CH2), 30.0 
(CH2), 28.8 (CH3), 26.2 (CH2), 25.9 (CH2), 25.8 (CH2), 24.9 (CH3); HRMS m/z (ES) Found: MH+, 










To a solution of amine 159 (75 mg, 0.46 mmol) in dry PhMe (2.5 mL) was added benzaldehyde 
(0.03 mL, 0.3 mmol), N-phenylmaleimide (53 mg, 0.31 mmol), CSA (11 mg, 0.046 mmol) and 4 Å 
MS (200 mg). The mixture was heated under reflux for 16 h under an argon atmosphere and cooled 
to rt. The mixture was filtered and concentrated under reduced pressure. The organic product was 
extracted using EtOAc (150 mL) and washed with water (2 x 20 mL), brine (20 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as an orange oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (17:3) to give cycloadduct 169 (51 mg, 39%) as an off-white amorphous solid; 
m.p. 248250 C [petrol–EtOAc]; Rf 0.33 [petrol–EtOAc (1:1)]; FT-IR max (film)/cm-1 3064, 2924, 
1707 (C=O), 1670 (C=O), 1593, 1504, 1394, 1303, 1191, 738; 1H NMR (400 MHz, CDCl3) δ = 
7.56–7.31 (8H, m, 8 × CH), 7.05–6.88 (3H, m, 3 × CH), 6.84 (1H, d, J = 7.5 Hz, CH), 6.76–6.69 
(2H, m, 2 × CH), 5.87 (1H, br s, CHA), 4.71 (1H, d, J = 7.5 Hz, CHB), 3.94 (1H, t, J = 7.5 Hz, CHC), 
3.81 (1H, dd, J = 7.5, 1.5 Hz, CHD), 3.48 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 176.1 (C=O), 
173.9 (C=O), 162.3 (C=O), 138.0 (C), 133.2 (C), 131.4 (C), 129.3 (CH), 129.0 (CH), 128.8 (CH), 
128.2 (CH), 127.8 (C), 126.2 (CH), 125.9 (CH), 124.4 (CH), 120.3 (CH), 115.2 (CH), 112.0 (CH), 
67.3 (CH), 62.1 (CH), 51.3 (CH), 49.3 (CH), 28.9 (CH3); HRMS m/z (ES) Found: MH+, 424.1659. 










To a suspension of cycloadduct 160 (128 mg, 0.354 mmol) in THF (1.4 mL) was added 2,3-
dichloro-5,6-dicyano-p-benzoquinone (161 mg, 0.708 mmol). The mixture was heated under reflux 
for 5 min and cooled to rt. The solvent was removed under reduced pressure and the mixture was 
diluted with CH2Cl2 (100 mL) and filtered. The filtrate was concentrated under reduced pressure to 
obtain the crude product as a brown solid. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (1:4) to give pyrroloquinoxalinone 170 
(106 mg, 84%) as a white amorphous solid; m.p. 282284 C [petrol–EtOAc]; Rf 0.18 [petrol–
EtOAc (1:4)]; FT-IR max (film)/cm-1 3062, 2931, 1766 (C=O), 1714 (C=O), 1665 (C=O), 1419, 1361, 
983, 737; 1H NMR (400 MHz, CDCl3) δ = 7.70–7.50 (5H, m, 5 × CH), 7.45–7.32 (3H, m, 3 × CH), 
7.01–6.89 (1H, m, CH), 3.74 (3H, s, CH3), 3.14 (3H, s, CH3); 13C NMR (100 MHz, CDCl3, one 
quaternary carbon signal missing) δ = 163.7 (C=O), 162.0 (C=O), 153.6 (C=O), 131.5 (C), 130.3 
(CH), 129.6 (CH), 129.2 (C), 129.2 (CH), 127.4 (CH), 124.2 (C), 124.1 (C), 122.4 (CH), 121.9 (C), 
120.6 (C), 118.8 (CH), 116.0 (CH), 29.1 (CH3), 24.4 (CH3). HRMS m/z (ES) Found: MH+, 358.1194. 













To a suspension of cycloadduct 166 (20 mg, 0.050 mmol) in THF (0.2 mL) was added 2,3-dichloro-
5,6-dicyano-p-benzoquinone (23 mg, 0.10 mmol). The mixture was heated under reflux for 5 min 
and cooled to rt. The solvent was removed under reduced pressure and the mixture was diluted 
with CH2Cl2 (50 mL) and filtered. The filtrate was concentrated under reduced pressure to obtain 
the crude product as a brown solid. The crude product was purified by column chromatography on 
silica gel, eluting with petrol–EtOAc (1:1) to give oxidised pyrroloquinoxalinone 171 (12 mg, 61%) 
as a white amorphous solid; m.p. 314316 C [petrol–EtOAc]; Rf 0.37 [petrol–EtOAc (1:4)]; FT-IR 
max (film)/cm-1 3094, 2914, 2850, 1762 (C=O), 1708 (C=O), 1665 (C=O), 1424, 1362, 979, 736; 
1H NMR (400 MHz, CDCl3) δ = 7.67 (1H, dd, J = 5.0, 1.0 Hz, CH), 7.46 (1H, d, J = 9.0 Hz, CH), 
7.44–7.38 (3H, m, 3 × CH), 7.27 (1H, dd, J = 5.0, 3.5 Hz, CH), 7.07–6.98 (1H, m, 1H), 3.74 (3H, 
s, CH3), 3.15 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 163.4 (C=O), 161.9 (C=O), 153.4 
(C=O), 131.5 (C), 131.0 (CH), 129.9 (CH), 129.0 (C), 128.1 (CH), 127.6 (CH), 125.8 (C), 124.3 
(C), 122.7 (CH), 122.4 (C), 121.7 (C), 121.0 (C), 118.3 (CH), 116.0 (CH), 29.1 (CH3), 24.5 (CH3). 
HRMS m/z (ES) Found: MH+, 364.0765. C19H14N3O3S requires MH+ 364.0750; LRMS m/z (ES) 









To a stirred solution of 2-nitroaniline (5.0 g, 36 mmol) in DMF (36 mL) at 0 C, was added sodium 
hydride (956 mg, 39.8 mmol) and the mixture was left to stir for 10 min. Methyl iodide (2.25 mL, 
36.2 mmol) in DMF (18 mL) was added dropwise to the mixture and once addition was complete, 
the mixture was warmed up to rt over 16 h. The mixture was diluted with water (200 mL) and EtOAc 
(500 mL). The organic layer was separated, dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to give the crude product as an orange oil. The crude 
product was purified by column chromatography on silica gel, eluting with petrol–EtOAc (19:1) to 
give aniline 178 (4.3 g, 78%) as a pale orange oil; Rf 0.21 [petrol–EtOAc (9:1)]; 1H NMR (400 MHz, 
CDCl3) δ = 8.14 (1H, dd, J = 8.5, 1.5 Hz, CH), 8.04 (1H, br s, NH), 7.477.43 (1H, m, CH), 6.83 
(1H, d, J = 8.5 Hz, CH), 6.666.60 (1H, m, CH), 3.01 (3H, d, J = 5.0 Hz, CH3); 13C NMR (100 MHz, 
CDCl3) δ = 146.4 (C), 136.3 (CH), 126.8 (CH), 125.4 (C), 115.2 (CH), 113.4 (CH), 29.7 (CH3). Data 




To a stirred suspension of sodium borohydride (492 mg, 13.0 mmol) and 10% Pd/C (0.5 g, 
0.5 mmol) in THF (20 mL) at 0 C was added aniline 178 (989 mg, 6.50 mmol) in MeOH (10 mL) 
dropwise. The mixture was left to stir for 30 min at rt and filtered through a pad of celite. The solvent 
was removed under reduced pressure to give the crude product which was partitioned between 
EtOAc (200 mL) and water (100 mL). The organic layer was separated, dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product as a brown 
oil. The crude product was then purified by column chromatography on silica gel, eluting with 
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petrol–EtOAc (7:3) to give amine 179 (626 mg, 79%) as a pale brown oil; Rf 0.32 [petrol–EtOAc 
(3:2)]; 1H NMR (400 MHz, CDCl3) δ = 6.976.90 (1H, m, CH), 6.786.72 (3H, m, 3 × CH), 3.40 
(3H, br s, 3 x NH), 2.91 (3H, s, CH3). 13C NMR (100 MHz, CDCl3) δ = 139.0 (C), 134.1 (C), 120.8 




To a stirred solution of amine 179 (100 mg, 0.819 mmol) in glacial acetic acid (16 mL) was added 
alloxan monohydrate (131 mg, 0.819 mmol) followed by boric acid (51 mg, 0.82 mmol). The mixture 
was heated at 120 C for 1 h and then cooled to rt. The acetic acid was removed under reduced 
pressure to give the crude product that was flushed through a silica gel plug, eluting with 
CH2Cl2MeOH (97:3) to obtain the crude isoalloxazine 180 as an orange solid (101 mg). The 




To a stirred suspension of crude isoalloxazine 180 (101 mg, 0.438 mmol) in DMF (12 mL) was 
added Cs2CO3 (228 mg, 0.701 mmol) followed by methyl iodide (0.08 mL, 1 mmol). The mixture 
was left to stir at rt for 1 h. The solvent was removed under reduced pressure to give the crude 
product which was partitioned between CH2Cl2 (50 mL) and water (100 mL). The organic layer was 
separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to 
give the crude product as an orange solid. The crude product was purified by column 
chromatography on silica gel eluting with CH2Cl2MeOH (97:3) to give isoalloxazine 181 (60 mg, 
30%) as a yellow amorphous solid; m.p. >250 C (decomposition); Rf 0.17 [CH2Cl2MeOH (97:3)]; 
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FT-IR max (film)/cm-1 3070, 2760, 1706, 1646 (CO), 1609, 1586, 1549. 1460, 1420, 1271, 1204, 
1181, 1044, 960, 766, 711, 634, 547; 1H NMR (400 MHz, DMSO-d6) δ = 8.208.17 (1H, m, CH), 
7.997.97 (2H, m, 2 × CH), 7.707.66 (1H, m, CH), 4.00 (3H, s, CH3), 3.29 (3H, s, CH3); 13C NMR 
(100 MHz, DMSO-d6) δ = 160.0 (CO), 155.6 (CO), 150.0 (C), 138.2 (C), 135.5 (CH), 135.3 (C), 
133.7 (C), 132.1 (CH), 126.6 (CH), 121.8 (CH), 32.2 (CH3), 28.5 (CH3); HRMS m/z (ES) Found: 




To a stirred solution of 2-nitroaniline (2.0 g, 15 mmol) in acetone (30 mL) at rt was added sodium 
hydroxide (0.72 g, 18 mmol). The mixture was heated under reflux for 15 min and benzyl bromide 
(2.1 mL, 18 mmol) was added dropwise over a period of 5 min. The mixture was heated under 
reflux for a further 1 h and then cooled to rt. The mixture was diluted with water (100 mL) and the 
organic product was extracted with EtOAc (150 mL), washed with brine (150 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as an orange oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (19:1) to give amine 182 (1.4 g, 41%) as an orange amorphous solid; m.p. 
6365 C [petrol–EtOAc] (lit.148 7678 C [no solvent]); Rf 0.29 [petrol–EtOAc (9:1)]; 1H NMR 
(400 MHz, CDCl3) δ = 8.47 (1H, br s, NH), 8.23 (1H, dd, J = 8.5, 1.5 Hz, CH), 7.437.31 (6H, m, 6 
× CH), 6.84 (1H, dd, J = 8.5, 1.5 Hz), 6.726.67 (1H, m, CH), 4.58 (2H, d, J = 5.5 Hz, CH2); 13C 
NMR (100 MHz, CDCl3, one quaternary carbon signal missing) δ = 145.3 (C), 137.4 (C), 136.2 
(CH), 129.0 (CH), 127.7 (CH), 127.1 (CH), 126.9 (CH), 115.8 (CH), 114.2 (CH), 47.1 (CH2). Data 








To a stirred suspension of sodium borohydride (331 mg, 8.76 mmol) and 10% Pd/C (0.2 g, 
0.19 mmol) in THF (30 mL) at 0 C was added amine 182 (1.0 g, 4.4 mmol) in MeOH (45 mL) and 
THF (15 mL) dropwise. Once addition was complete the mixture was left to stir for 30 min at rt and 
then filtered through a pad a celite. The solvent was removed under reduced pressure to give the 
crude product as a brown gum. The crude product was purified using a silica gel plug, eluting with 
petrol–EtOAc (1:1) to give amine 183 (837 mg, 79%) as a brown oil; Rf 0.58 [petrol–EtOAc (1:1)]; 
1H NMR (400 MHz, CDCl3) δ = 7.457.28 (5H, m, 5 × CH), 6.876.70 (4H, m, 4 × CH), 4.35 (2H, 
s, CH2), 3.73 (1H, br s, NH), 3.38 (2H, br s, NH2); 13C NMR (100 MHz, CDCl3) δ = 139.4 (C), 137.8 
(C), 134.2 (C), 128.6 (CH), 127.8 (CH), 127.3 (CH), 120.8 (CH), 118.9 (CH), 116.6 (CH), 112.0 




To a suspension of alloxan monohydrate (565 mg, 3.53 mmol) and boric acid (218 mg, 3.53 mmol) 
in glacial acetic acid (10 mL) at rt was added amine 183 (700 mg, 3.53 mmol) in glacial acetic acid 
(14 mL). The mixture was stirred at rt for 1 h and then heated at 50 C for 16 h under an argon 
atmosphere. The mixture was cooled to rt and the acetic acid was removed under reduced 








To a stirred suspension of crude isoalloxazine 184 (2.5 g, 3.5 mmol) in DMF (24 mL), was added 
potassium carbonate (1.7 g, 12 mmol) followed by methyl iodide (0.77 mL, 12 mmol). The mixture 
was stirred at rt for 1 h. The solvent was removed under reduced pressure to give the crude product 
which was partitioned between CH2Cl2 (150 mL) and water (50 mL). The organic layer was 
separated and the aqueous layer was washed further with CH2Cl2 (2 x 150 mL). The combined 
organic extracts were dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a yellow solid. The crude product was purified by using 
column chromatography on silica gel eluting with CH2Cl2MeOH (97:3) to give isoalloxazine 185 
(830 mg, 74%) as a yellow amorphous solid; m.p. >250 C (decomposition); Rf 0.33 
[CH2Cl2MeOH (97:3)]; FT-IR max (film)/cm-1 3038, 1708, 1641 (CO), 1547, 1514, 1491, 1465, 
1445, 1271, 1221, 1176, 1144, 1042, 957, 788, 731; 1H NMR (400 MHz, DMSO-d6) δ = 8.21 (1H, 
d, J = 8.0 Hz, CH), 7.85 (1H, t, J = 8.0 Hz, CH), 7.72 (1H, d, J = 8.0 Hz, CH), 7.63 (1H, t, J = 8.0 Hz, 
CH), 7.387.25 (5H, m, 5 × CH), 5.94 (2H, br s, CH2), 3.31 (3H, s, CH3); 13C NMR (100 MHz, 
DMSO-d6) δ = 160.1 (CO), 155.8 (CO), 150.2 (C), 138.9 (C), 135.6 (C), 135.3 (CH), 135.2 (C), 
132.7 (C), 132.3 (CH), 129.1 (CH), 128.0 (CH), 127.3 (CH), 126.6 (CH), 117.2 (CH), 47.4 (CH2), 
28.5 (CH3); HRMS m/z (ES) Found: MH+, 319.1197. C18H15N4O2 requires MH+ 319.1190; LRMS 










To a solution of isoalloxazine 185 (100 mg, 0.314 mmol) in acetic anhydride (5 mL) and glacial 
acetic acid (5 mL) under an argon atmosphere was added cH2SO4 (5 drops). Activated zinc (5.0 g, 
77 mmol) was added slowly over 1 h and the mixture was left to stir for 16 h at rt. The mixture was 
filtered through a plug of cotton wool which was rinsed through with hot glacial acetic acid (25 mL) 
and the solvent was removed under reduced pressure. The residue obtained was diluted with 
NH4OH (50 mL, 1 M) and cooled to 0 °C for 1 h. The mixture was filtered and the filtrate was 
neutralised with glacial acetic acid. The organic product was extracted using CH2Cl2 (100 mL), 
dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give 
isoalloxazine 190 (76 mg, 67%) as a pale green amorphous solid; m.p. >250 C (decomposition); 
Rf 0.17 [CH2Cl2−MeOH (97:3)]; FT-IR max (film)/cm-1 3116, 3012, 2977, 1702, 1632 (C=O), 1486, 
1392, 1352, 1329, 1269, 1057, 1007, 984, 757, 722, 689, 611; 1H NMR (400 MHz, DMSO-d6) = 
11.70 (1H, s, NH), 7.41 (1H, d, J = 7.0 Hz, CH), 7.36–7.28 (2H, m, 2 × CH), 7.27–7.18 (3H, m, 3 × 
CH), 7.17–7.05 (3H, m, 3 × CH), 5.21 (2H, d, J = 6.0 Hz, CH2), 3.16 (3H, s, CH3), 2.06 (3H, s, 
CH3); 13C NMR (100 MHz, DMSO-d6, four quaternary carbon signals missing) δ = 158.7 (C=O), 
151.0 (C), 136.9 (C), 129.1 (CH), 127.9 (CH), 127.0 (CH), 126.5 (CH), 126.3 (CH), 123.3 (CH), 
116.2 (CH), 97.2 (C), 48.1 (CH2), 27.6 (CH3), 21.5 (CH3); HRMS m/z (ES) Found: MH+, 363.1456. 







3-Methylbut-2-enoyl chloride (193) 
 
 
To a solution of 3,3-dimethylacrylic acid (3.0 g, 30 mmol) in CH2Cl2 (25 mL) at 0 °C was added 
oxalyl chloride (2.8 mL, 33 mmol) dropwise. The mixture was warmed to rt and stirred for 1 h. The 
solvent was then removed under reduced pressure to give the crude product which was washed 
with CHCl3 (3 × 100 mL). The washings were combined and the solvent was removed under 
reduced pressure to give the final crude acid chloride 193 as a pale yellow oil (3.5 g). The material 
was used without further purification. 
3-Methylbut-2-enoyl 3-methylbut-2-enoate (194) 
 
 
To a stirred suspension of NaH (0.3 g, 11 mmol) in THF (20 mL) at 0 °C was added 3,3-
dimethylacrylic acid (1.0 g, 10 mmol) in THF (10 mL). The mixture was warmed to rt over 2 h and 
crude acid chloride 193 (1.2 g, 10 mmol) was added in THF (6 mL). After stirring for a further 1.5 h 
the solvent was removed under reduced pressure and diluted with Et2O (50 mL). The mixture was 
filtered through a pad of celite and concentrated under reduced pressure to give anhydride 194 
(1.2 g, 66%) as a pale yellow oil; 1H NMR (400 MHz, CDCl3) δ = 5.73 (s, 2H), 2.24 (s, 6H), 1.98 (s, 
6H); 13C NMR (100 MHz, CDCl3) δ = 162.8 (C=O), 162.1 (C), 115.3 (CH), 27.8 (CH3), 20.8 (CH3); 











To a solution of isoalloxazine 185 (200 mg, 0.628 mmol) in glacial acetic acid (10 mL) under an 
argon atmosphere was added cH2SO4 (10 drops) followed by anhydride 194 (2.0 g, 11 mmol). 
Activated zinc (10.0 g, 153 mmol) was added slowly over 1 h and the mixture was left to stir for 
16 h at rt. The mixture was filtered through a plug of cotton wool which was rinsed through with hot 
glacial acetic acid (100 mL) and the solvent was removed under reduced pressure. The residue 
obtained was diluted with NH4OH (50 mL, 1 M) and cooled to 0 °C for 1 h. The mixture was filtered 
and the filtrate was neutralised with glacial acetic acid. The organic product was extracted using 
CH2Cl2 (200 mL), washed with saturated aqueous NaHCO3 (2 × 50 mL), dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product as a yellow 
oil. The crude product was purified by column chromatography on silica gel, eluting with 
CH2Cl2−MeOH (19:1) to give isoalloxazine 195 (90 mg, 36%) as a yellow amorphous solid; m.p. 
110-113 °C [CH2Cl2−MeOH]; Rf 0.23 [CH2Cl2−MeOH (97:3)]; FT-IR max (film)/cm-1 3199, 3063, 
2959, 2516, 2158, 2029, 1703, 1627, 1576, 1486, 1445, 1383, 1359, 1262, 1151, 1048, 985, 847, 
799; 1H NMR (400 MHz, CDCl3) δ = 10.63 (1H, s, NH), 7.66–7.50 (1H, m, CH), 7.37–7.24 (3H, m, 
3 × CH), 7.18–7.04 (4H, m, 4 × CH), 6.83 (1H, d, J = 8.0 Hz, CH), 5.95–5.87 (1H, s, CH), 5.16 (2H, 
s, CH2), 3.27 (3H, s, CH3), 2.15 (3H, s, CH3), 1.85 (3H, s, CH3); 13C NMR (100 MHz, CDCl3) δ = 
167.0 (C=O), 158.2 (C=O), 153.6 (C=O), 151.6 (C), 147.2 (C), 137.7 (C), 134.6 (C), 131.0 (C), 
129.2 (CH), 128.1 (CH), 126.8 (CH), 126.4 (CH), 126.0 (CH), 123.9 (CH), 115.7 (CH), 115.1 (CH), 
97.8 (C), 48.5 (CH2), 27.7 (CH3), 27.5 (CH3), 20.7 (CH3); HRMS m/z (ES) Found: MH+, 403.1768. 







To a suspension of magnesium (0.66 g, 27 mmol) in THF (48 mL) under an argon atmosphere was 
added 5-bromo-1-pentene (3.0 mL, 25 mmol) dropwise. The mixture was heated under reflux for 
3 h and cooled to rt. Upon cooling the mixture to −78 °C CuBr (3.7 g, 25 mmol) was added and the 
mixture was stirred for 10 min. 4-Chlorobutyryl chloride (3.0 mL, 27 mmol) was added dropwise 
and the mixture was warmed to rt over 17 h. The reaction was quenched with saturated aqueous 
NH4Cl (10 mL) and diluted with Et2O (100 mL). The organic layer was separated, dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as a pale green oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (49:1) to give ketone 219 (3.5 g, 79%) as a colourless oil; Rf 0.17 [petrol–EtOAc 
(19:1)]; 1H NMR (400 MHz, CDCl3) δ = 5.85–5.71 (1H, m, CH), 5.07–4.96 (2H, m, CH2), 3.59 (2H, 
t, J = 6.5 Hz, CH2), 2.62 (2H, t, J = 7.0 Hz, CH2), 2.45 (2H, t, J = 7.5 Hz, CH2), 2.12–2.01 (4H, m, 
2 × CH2), 1.76–1.66 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 209.8 (C=O), 137.9 (CH), 115.3 
(CH2), 44.6 (CH2), 42.1 (CH2), 39.3 (CH2), 33.1 (CH2), 26.3 (CH2), 22.8 (CH2). Data consistent with 
the literature.95 
Methyl octahydro-1H-cyclopenta[h]pyrrolizine-5-carboxylate (232) 
 
 
To a mixture of ketone 219 (200 mg, 1.15 mmol) in PhMe (14 mL) was added glycine methyl ester 
hydrochloride (216 mg, 1.72 mmol), N,N-diisopropylethylamine (0.60 mL, 3.44 mmol) and 
anhydrous MgSO4 (1 g). The mixture was heated under reflux for 17 h and was cooled to rt. The 
solvent was removed under reduced pressure to give the crude product as a brown oil. The crude 
product was purified by column chromatography on silica gel, eluting with CH2Cl2–MeOH–NH3 
(49:1:0.5) to give cycloadduct 232 (127 mg, 53%) as a brown oil; Rf 0.17 [CH2Cl2–MeOH–NH3 
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(49:1:0.3)]; FT-IR max (film)/cm-1 2949, 2864, 1738 (C=O), 1449, 1434, 1196, 1155, 1104, 917, 
733; 1H NMR (400 MHz, CDCl3) δ = 3.90–3.84 (1H, m, CH), 3.74 (3H, s, CH3), 3.01–2.93 (1H, m, 
CH), 2.61–2.52 (1H, m, CH), 2.30–2.19 (2H, m, 2 × CH), 1.93–1.63 (9H, m, 9 × CH), 1.52–1.40 
(1H, m, CH), 1.35–1.23 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 172.9 (C=O), 82.3 (C), 64.6 
(CH), 51.6 (CH3), 49.6 (CH2), 48.7 (CH), 41.7 (CH2), 39.7 (CH2), 34.7 (CH2), 33.2 (CH2), 26.3 
(CH2), 26.0 (CH2); HRMS m/z (ES) Found: MH+, 210.1495. C12H20NO2 requires MH+ 210.1489; 




To a mixture of cycloadduct 232 (258 mg, 1.23 mmol) in THF (21 mL) at 0 °C was added LiAlH4 
(108 mg, 2.84 mmol). The mixture was stirred for 45 min at 0 °C and cooled further to −10 °C. After 
5 min, the reaction was quenched with saturated aqueous NaHCO3 (3 mL) and water (3 mL) and 
was warmed to rt. The mixture was filtered through a pad of celite and rinsed with Et2O (3 × 30 mL). 
The organic layer was separated, washed with brine (30 mL), dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to give alcohol 238 (159 mg, 71%) as a 
colourless oil; Rf 0.01 [CH2Cl2–MeOH–NH3 (49:1:0.3)]; FT-IR max (film)/cm-1 3225 (O−H), 2943, 
2862, 1449, 1045, 909, 728; 1H NMR (400 MHz, CDCl3) δ = 3.92 (1H, br s, OH), 3.81 (1H, dd, J = 
11.0, 8.0 Hz, CH), 3.68 (1H, dd, J = 11.0, 5.5 Hz, 1H), 3.41–3.27 (1H, m, CH), 2.93–2.83 (1H, m, 
CH), 2.63–2.47 (1H, m, CH), 2.09 (1H, q, J = 8.0 Hz, 1H), 1.97–1.56 (9H, m, 9 × CH), 1.46–1.34 
(2H, m, 2 × CH), 1.33–1.19 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 81.7 (C), 62.9 (CH), 62.8 
(CH2), 50.3 (CH), 47.0 (CH2), 41.7 (CH2), 40.8 (CH2), 33.8 (CH2), 33.3 (CH2), 26.5 (CH2), 25.9 
(CH2); HRMS m/z (ES) Found: MH+, 182.1542. C11H20NO requires MH+ 182.1539; LRMS m/z (ES) 











To a suspension of 4-bromobenzoic acid (455 mg, 2.26 mmol) in CH2Cl2 (4 mL) was added oxalyl 
chloride (0.21 mL, 2.5 mmol). The mixture was cooled to 0 °C and DMF (10 drops) was added. 
The mixture was warmed to rt and was stirred for 1 h. The solvent was removed under reduced 
pressure to give a residue that was dissolved in CH2Cl2 (13 mL). To the mixture was added alcohol 
238 (205 mg, 1.13 mmol) and 4-(dimethylamino)pyridine (276 mg, 2.26 mmol) at 0 °C, followed by 
Et3N (0.47 mL, 3.4 mmol). The mixture was stirred for 1 h at 0 °C and was diluted with saturated 
aqueous NaHCO3 (20 mL) and CH2Cl2 (100 mL). The organic layer was separated, dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as a pale orange oil. The crude product was purified by column chromatography on silica gel, 
eluting with CH2Cl2–MeOH–NH3 (97:3:1) to give ester 239 (243 mg, 59%) as a pale orange oil; Rf 
0.23 [CH2Cl2–MeOH–NH3 (49:1:0.3)]; FT-IR max (film)/cm-1 2948, 2858, 1718 (C=O), 1589, 1396, 
1265, 1104, 1070, 1012, 846, 753; 1H NMR (400 MHz, CDCl3) δ = 7.94 (2H, d, J = 8.5 Hz, 2 × 
CH), 7.60 (2H, d, J = 8.5 Hz, 2 × CH), 4.66–4.42 (2H, m, CH2), 3.59 (1H, td, J = 12.0, 6.0 Hz, CH), 
2.99–2.85 (1H, m, CH), 2.74–2.61 (1H, m, CH), 2.17 (1H, q, J = 7.5 Hz, CH), 2.03–1.60 (9H, m, 9 
× CH), 1.58–1.23 (3H, m, 3 × CH); 13C NMR (100 MHz, CDCl3) δ = 166.0 (C=O), 131.7 (CH), 131.3 
(CH), 129.0 (C), 128.1 (C), 82.0 (C), 65.3 (CH2), 59.3 (CH), 50.1 (CH), 47.9 (CH2), 42.0 (CH2), 
40.8 (CH2), 33.9 (CH2), 33.7 (CH2), 26.4 (CH2), 26.3 (CH2); HRMS m/z (ES) Found: MH+, 
364.0908. C18H2379BrNO2 requires MH+ 364.0907; Found: MH+, 366.0893. C18H2381BrNO2 requires 







      
 
To a mixture of ester 239 (169 mg, 0.464 mmol) in CH2Cl2 (2 mL) was added HCl (2.3 mL, 
4.6 mmol, 2 M in Et2O) at rt. After 5 min, the mixture was concentrated under reduced pressure to 
give salt 240 (186 mg, quantitative yield) as a white amorphous solid; m.p. 215218 C [CH2Cl2]; 
FT-IR max (film)/cm-1 2953, 2394, 1710, 1590, 1397, 1274, 1119, 1011, 761, 683; 1H NMR 
(400 MHz, DMSO-d6) δ = 11.46 (1H, br s, NH), 8.17 (2H, d, J = 8.5 Hz, 2 × CH), 7.73 (2H, d, J = 
8.5 Hz, 2 × CH), 4.62 (1H, dd, J = 13.0, 3.5 Hz, CH), 4.45 (1H, dd, J = 13.0, 9.5 Hz, CH), 4.20–
4.06 (1H, m, CH), 3.40–3.23 (2H, m, 2 × CH), 2.48–2.34 (2H, m, 2 × CH), 2.27–2.14 (1H, m, CH), 
2.10–1.73 (8H, m, 8 × CH), 1.62–1.42 (2H, m, 2 × CH); 13C NMR (100 MHz, DMSO-d6) δ = 165.2 
(C=O), 132.5 (CH), 132.2 (CH), 128.7 (C), 128.3 (C), 88.6 (C), 62.1 (CH2), 60.7 (CH), 48.3 (CH), 
48.0 (CH2), 38.3 (CH2), 38.1 (CH2), 32.9 (CH2), 31.3 (CH2), 26.6 (CH2), 25.5 (CH2); HRMS m/z 
(ES) Found: M+−Cl, 364.0922. C18H2379BrNO2 requires M+−Cl 364.0907; Found: M+−Cl, 366.0904. 
C18H2381BrNO2 requires M+−Cl 366.0886; LRMS m/z (ES) 364 (100%, M+−Cl for 79Br), 366 (100%, 




To a suspension of magnesium (0.26 g, 11 mmol) in THF (19 mL) under an argon atmosphere was 
added 6-bromo-1-hexene (1.3 mL, 10 mmol) dropwise. The mixture was heated under reflux for 
3 h and cooled to rt. Upon cooling the mixture to −78 °C CuBr (1.4 g, 10 mmol) was added and the 
176 
 
mixture was stirred for 10 min. 4-Chlorobutyryl chloride (1.2 mL, 11 mmol) was added dropwise 
and the mixture was warmed to rt over 17 h. The reaction was quenched with saturated aqueous 
NH4Cl (5 mL) and diluted with Et2O (100 mL). The organic layer was separated, dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as a pale green oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (19:1) to give ketone 222 (1.3 g, 69%) as a colourless oil; Rf 0.33 [petrol–EtOAc 
(9:1)]; 1H NMR (400 MHz, CDCl3) δ = 5.87–5.74 (1H, m, CH), 5.07–4.94 (2H, m, CH2), 3.59 (2H, 
t, J = 6.5 Hz, CH2), 2.62 (2H, t, J = 7.0 Hz, CH2), 2.45 (2H, t, J = 7.5 Hz, CH2), 2.12–2.02 (4H, m, 
2 × CH2), 1.66–1.57 (2H, m, CH2), 1.45–1.35 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 209.9 
(C=O), 138.4 (CH), 114.7 (CH2), 44.6 (CH2), 42.8 (CH2), 39.2 (CH2), 33.5 (CH2), 28.4 (CH2), 26.3 




To a suspension of magnesium (0.26 g, 11 mmol) in THF (19 mL) under an argon atmosphere was 
added 5-bromo-1-pentene (1.2 mL, 10 mmol) dropwise. The mixture was heated under reflux for 
3 h and cooled to rt. Upon cooling the mixture to −78 °C CuBr (1.4 g, 10 mmol) was added and the 
mixture was stirred for 10 min. 5-Chlorovaleroyl chloride (1.4 mL, 11 mmol) was added dropwise 
and the mixture was warmed to rt over 17 h. The reaction was quenched with saturated aqueous 
NH4Cl (5 mL) and diluted with Et2O (100 mL). The organic layer was separated, dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude product 
as a pale green oil. The crude product was purified by column chromatography on silica gel, eluting 
with petrol–EtOAc (19:1) to give ketone 241 (1.5 g, 79%) as a colourless oil; Rf 0.27 [petrol–EtOAc 
(9:1)]; 1H NMR (400 MHz, CDCl3) δ = 5.85–5.72 (1H, m, CH), 5.07–4.96 (2H, m, CH2), 3.55 (2H, 
t, J = 6.5 Hz, CH2), 2.50–2.39 (4H, m, 2 × CH2), 2.07 (2H, q, J = 7.0 Hz, CH2), 1.85–1.67 (6H, m, 
3 × CH2); 13C NMR (100 MHz, CDCl3) δ = 210.2 (C=O), 137.9 (CH), 115.2 (CH2), 44.6 (CH2), 41.9 
(CH2), 41.8 (CH2), 33.1 (CH2), 32.0 (CH2), 22.8 (CH2), 21.1 (CH2). Data consistent with the 
literature.95    
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A stirred mixture of phthalide (5.0 g, 37 mmol), benzyltriethylammonium chloride (0.9 g, 3.7 mmol) 
and H3BO3 (0.2 g, 4 mmol) was heated at 130 °C until all the phthalide had melted. To the mixture 
was added thionyl chloride (3.5 mL, 49 mmol) over a period of 4 h. Once addition was complete 
the mixture was heated for a further 5 h at 130 °C. After cooling to rt excess thionyl chloride was 
removed under reduced pressure to give the crude acid chloride 249 (6.3 g, 89%) as a yellow oil. 
The material was used without further purification. 




To a suspension of magnesium (0.26 g, 11 mmol) in THF (19 mL) under an argon atmosphere was 
added 5-bromo-1-pentene (1.2 mL, 10 mmol) dropwise. The mixture was heated under reflux for 
3 h and cooled to rt. Upon cooling the mixture to −78 °C CuBr (1.4 g, 10 mmol) was added and the 
mixture was stirred for 10 min. Crude acid chloride 249 (2.0 g, 11 mmol) was added dropwise and 
the mixture was warmed to rt over 17 h. The reaction was quenched with saturated aqueous NH4Cl 
(5 mL) and diluted with Et2O (100 mL). The organic layer was separated, dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product as a pale 
green oil. The crude product was purified by column chromatography on silica gel, eluting with 
petrol–EtOAc (97:3) to give ketone 242 (598 mg, 27%) as a yellow oil; Rf 0.38 [petrol–EtOAc (9:1)]; 
FT-IR max (film)/cm-1 3070, 2975, 2936, 2865, 1686 (C=O), 1642, 1572, 1448, 1365, 1265, 1233, 
994, 912, 753, 739, 678; 1H NMR (400 MHz, CDCl3) δ = 7.70 (1H, d, J = 7.5 Hz, CH), 7.59–7.39 
(3H, m, 3 × CH), 5.89–5.77 (1H, m, CH), 5.12–4.99 (2H, m, CH2), 4.94 (2H, s, CH2), 3.01–2.92 
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(2H, m, CH2), 2.24–2.13 (2H, m, CH2), 1.93–1.80 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 
204.0 (C=O), 138.0 (CH), 137.9 (C), 137.0 (C), 131.6 (CH), 131.0 (CH), 128.6 (CH), 128.3 (CH), 
115.4 (CH2), 44.2 (CH2), 40.6 (CH2), 33.1 (CH2), 23.2 (CH2); HRMS m/z (ES) Found: M+, 222.0814. 
C13H15O35Cl requires M+ 222.0811; Found: M+, 224.0788. C13H15O37Cl requires M+ 224.0782; 




To a mixture of isochroman (3.8 mL, 30 mmol) in CH2Cl2 (300 mL) was added 
benzyltriethylammonium chloride (20 g, 90 mmol) and KMnO4 (14 g, 90 mmol). The mixture was 
heated under reflux for 6 h and cooled to rt. Upon cooling the mixture to 0 °C aqueous NaHSO3 
(300 mL, 1M) was added, followed by CH2Cl2 (500 mL) and the organic layer was separated. 
Drying over anhydrous MgSO4, filtering, and concentrating under reduced pressure gave the crude 
product as a pale yellow oil. The crude product was purified by column chromatography on silica 
gel, eluting with petrol–EtOAc (7:3) to give lactone 253 (3.1 g, 70%) as a colourless oil; Rf 0.24 
[petrol–EtOAc (7:3)]; 1H NMR (400 MHz, CDCl3) δ = 8.08 (1H, d, J = 7.5 Hz, CH), 7.54 (1H, t, J = 
7.5 Hz, CH), 7.39 (1H, t, J = 7.5 Hz, CH), 7.27 (1H, d, J = 7.5 Hz, CH), 4.53 (2H, t, J = 6.0 Hz, 
CH2), 3.06 (2H, t, J = 6.0 Hz, CH2); 13C NMR (100 MHz, CDCl3) δ = 165.1 (C=O), 139.6 (C), 133.7 
(CH), 130.4 (CH), 127.7 (CH), 127.3 (CH), 125.3 (C), 67.3 (CH2), 27.8 (CH2). Data consistent with 












A mixture of lactone 253 (3.1 g, 21 mmol) and phosphorus pentachloride (8.7 g, 42 mmol) was 
heated at 100 °C for 16 h and was then cooled to rt. The mixture was filtered through a pad of 
cotton wool to give the crude acid chloride 250 (3.9 g, 92%) as a yellow oil. The material was used 





To a suspension of magnesium (0.23 g, 9.3 mmol) in THF (16 mL) under an argon atmosphere 
was added 5-bromo-1-pentene (1.0 mL, 8.7 mmol) dropwise. The mixture was heated under reflux 
for 3 h and was cooled to rt. Upon cooling the mixture to −78 °C CuBr (1.3 g, 8.7 mmol) was added 
and the mixture was stirred for 10 min. Crude acid chloride 250 (1.9 g, 9.3 mmol) was added 
dropwise and the mixture was warmed to rt over 17 h. The reaction was quenched with saturated 
aqueous NH4Cl (5 mL) and diluted with Et2O (100 mL). The organic layer was separated, dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude 
product as an orange oil. The crude product was purified by column chromatography on silica gel, 
eluting with petrol–EtOAc (49:1) to give ketone 243 (186 mg, 9%) as a yellow oil; Rf 0.43 [petrol–
EtOAc (9:1)]; FT-IR max (film)/cm-1 3070, 2973, 2934, 2871, 1681 (C=O), 1639, 1571, 1444, 1279, 
1230, 914, 753, 707, 651; 1H NMR (400 MHz, CDCl3) δ = 7.71 (1H, d, J = 7.5 Hz, CH), 7.46 (1H, 
td, J = 7.5, 1.5 Hz, CH), 7.40–7.33 (2H, m, 2 × CH), 5.90–5.76 (1H, m, CH), 5.12–4.97 (2H, m, 
CH2), 3.81 (2H, t, J = 7.0 Hz, CH2), 3.27 (2H, t, J = 7.0 Hz, CH2), 2.95 (2H, t, J = 7.0 Hz, CH2), 
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2.22–2.11 (2H, m, CH2), 1.85 (quin, J = 7.5 Hz, CH2); 13C NMR (100 MHz, CDCl3) δ = 204.0 (C=O), 
138.2 (C), 137.9 (CH), 137.9 (C), 132.4 (CH), 131.4 (CH), 128.9 (CH), 127.0 (CH), 115.4 (CH2), 
45.3 (CH2), 40.6 (CH2), 37.5 (CH2), 33.1 (CH2), 23.3 (CH2); HRMS m/z (ES) Found: MH+, 
237.1046. C14H18O35Cl requires MH+ 237.1041; Found: MH+, 239.1021. C14H18O37Cl requires MH+ 





To a mixture of ketone 242 (255 mg, 1.15 mmol) in PhMe (14 mL) was added hydroxylamine 
hydrochloride (119 mg, 1.72 mmol) and N,N-diisopropylethylamine (0.6 mL, 3.44 mmol). The 
mixture was heated under reflux for 17 h and was cooled to rt. The solvent was removed under 
reduced pressure to give the crude product as a brown solid. The crude product was purified by 
column chromatography on silica gel, eluting with CH2Cl2–MeOH (49:1) to give oxime 260 (79 mg, 
29%) as an orange solid; m.p. 5254 C [CH2Cl2–MeOH]; Rf 0.33 [CH2Cl2–MeOH (19:1)]; FT-IR 
max (film)/cm-1 3228 (O−H), 3065, 2936, 2865, 1640, 1435, 1301, 1201, 999, 958, 912, 761; 1H 
NMR (400 MHz, CDCl3) δ = 10.15 (1H, br s, OH), 7.53–7.33 (4H, m, 4 × CH), 5.92–5.70 (1H, m, 
CH), 5.11–4.92 (2H, m, CH2), 4.57 (2H, s, CH2), 2.96–2.81 (2H, m, CH2), 2.13 (2H, q, J = 7.0 Hz, 
CH2), 1.68 (2H, quin, J = 7.0 Hz, CH2); 13C NMR (100 MHz, CDCl3) δ = 160.4 (C), 139.0 (C), 137.9 
(CH), 136.2 (C), 131.2 (CH), 129.0 (CH), 128.3 (CH), 128.3 (CH), 115.2 (CH2), 64.8 (CH2), 33.8 
(CH2), 27.7 (CH2), 25.4 (CH2). Mass spectrometry results showed no peaks corresponding to 









To a solution of ketone 241 (0.76 g, 4.0 mmol) in CH2Cl2 (200 mL) was added phenyl vinyl sulfone 
(1.4 g, 8.0 mmol). The mixture was degassed with argon and heated under reflux. Grubbs 2nd 
generation catalyst (170 mg, 0.200 mmol) in CH2Cl2 (10 mL) was added dropwise and the mixture 
was left to stir for a further 24 h before being exposed to air and cooled to rt. DMSO (0.7 mL, 
10 mmol) was added and the mixture was stirred for a further 24 h. The mixture was concentrated 
under reduced pressure to give the crude product as a dark brown residue. The crude product was 
purified by column chromatography on silica gel, eluting with petrol–EtOAc (17:3) to give ketone 
261 (1.0 g, 76%) as a pale brown oil; Rf 0.23 [petrol–EtOAc (3:2)]; FT-IR max (film)/cm-1 3059, 
2942, 1710 (C=O), 1626, 1447, 1306, 1144, 1085, 815, 752, 688, 590, 550; 1H NMR (400 MHz, 
CDCl3) δ = 7.91–7.84 (2H, m, 2 × CH), 7.66–7.60 (1H, m, CH), 7.58–7.52 (2H, m, 2 × CH), 6.99–
6.91 (1H, m, CH), 6.34 (1H, dt, J = 15.0, 1.5 Hz, CH), 3.53 (2H, t, J = 6.5 Hz, CH2), 2.46–2.39 (4H, 
m, 2 × CH2), 2.30–2.21 (2H, m, CH2), 1.81–1.65 (6H, m, 3 × CH2); 13C NMR (100 MHz, CDCl3) δ 
= 209.2 (C=O), 145.9 (CH), 140.6 (C), 133.3 (CH), 131.1 (CH), 129.3 (CH), 127.6 (CH), 44.6 (CH2), 
41.8 (CH2), 41.3 (CH2), 31.9 (CH2), 30.6 (CH2), 21.4 (CH2), 21.0 (CH2); HRMS m/z (ES) Found: 
MH+, 329.0987. C16H22O3S35Cl requires MH+ 329.0973; Found: MH+, 331.0958. C16H22O3S37Cl 
requires MH+ 331.0943; LRMS m/z (ES) 329 (85%, MH+ for 35Cl), 331 (30%, MH+ for 37Cl), 346 
(100%, MNH4+ for 35Cl), 348 (40%, MNH4+ for 37Cl), 351 (80%, MNa+ for 35Cl), 353 (25%, MNa+ for 









To a mixture of ketone 219 (166 mg, 0.950 mmol) in PhMe (14 mL) was added benzylhydrazine 
dihydrochloride (222 mg, 1.14 mmol) and N,N-diisopropylethylamine (0.75 mL, 4.3 mmol). The 
mixture was heated under reflux for 17 h and was cooled to rt. The solvent was removed under 
reduced pressure to give the crude product as a brown solid. The crude product was purified by 
column chromatography on silica gel, eluting with CH2Cl2–MeOH (49:1) to give compound 274 
(110 mg, 48%) as an orange oil; Rf 0.56 [CH2Cl2–MeOH (19:1)]; FT-IR max (film)/cm-1 3067, 2933, 
2826, 1495, 1451, 1354, 913, 736, 697; 1H NMR (400 MHz, CDCl3) δ = 7.42–7.22 (5H, m, 5 × CH), 
5.94–5.80 (1H, m, CH), 5.09–4.95 (2H, m, CH2), 4.19 (2H, s, CH2), 2.60 (2H, dd, J = 7.0, 4.0 Hz, 
CH2), 2.22–2.01 (6H, m, 3 × CH2), 1.95–1.84 (2H, m, CH2), 1.71–1.59 (2H, m, CH2); 13C NMR 
(100 MHz, CDCl3) δ = 149.4 (C), 138.7 (CH), 138.1 (C), 129.2 (CH), 128.1 (CH), 127.1 (CH), 114.6 
(CH2), 63.2 (CH2), 46.3 (CH2), 37.5 (CH2), 33.5 (CH2), 26.23 (CH2), 24.0 (CH2), 20.2 (CH2); HRMS 





To a mixture of ketone 219 (168 mg, 0.960 mmol) in PhMe (14 mL) was added acetylhydrazine 
(142 mg, 1.92 mmol). The mixture was heated under reflux for 17 h and was cooled to rt. The 
solvent was removed under reduced pressure to give the crude product as a brown solid. The 
crude product was purified by column chromatography on silica gel, eluting with CH2Cl2–MeOH 
(49:1) to give cycloadduct 275 (114 mg, 61%) as a pale yellow oil; Rf 0.37 [CH2Cl2–MeOH (9:1)]; 
FT-IR max (film)/cm-1 3479, 2949, 2866, 1651, 1409, 1218, 1127, 949, 918, 618, 591; 1H NMR 
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(400 MHz, CDCl3) δ = 3.97 (1H, dd, J = 12.0, 2.0 Hz, CH), 3.39 (1H, dd, J = 12.0, 8.0 Hz, CH), 
3.28 (1H, dt, J = 10.0, 6.0 Hz, CH), 2.65 (1H, dt, J = 10.0, 8.0 Hz, CH), 2.41–2.30 (1H, m, CH), 
2.18 (3H, s, CH3), 2.03–1.67 (7H, m, 7 × CH), 1.63–1.38 (3H, m, 3 × CH); 13C NMR (100 MHz, 
CDCl3) δ = 170.8 (C=O), 82.0 (C), 55.9 (CH2), 50.8 (CH), 49.2 (CH2), 40.4 (CH2), 37.4 (CH2), 33.3 
(CH2), 26.0 (CH2), 24.4 (CH2), 21.3 (CH3); HRMS m/z (ES) Found: MH+, 195.1496. C11H19N2O 




To a mixture of ketone 241 (181 mg, 0.960 mmol) in PhMe (14 mL) was added acetylhydrazine 
(142 mg, 1.92 mmol) and TBAI (37 mg, 0.10 mmol). The mixture was heated under reflux for 17 h 
and was cooled to rt. The solvent was removed under reduced pressure to give the crude product 
as a brown solid. The crude product was purified by column chromatography on silica gel, eluting 
with CH2Cl2–MeOH (49:1) to give cycloadduct 277 (90 mg, 45%) as a pale yellow oil; Rf 0.37 
[CH2Cl2–MeOH (9:1)]; FT-IR max (film)/cm-1 3454, 2935, 2864, 1645, 1443, 1416, 1276, 1200, 
902, 629, 595; 1H NMR (400 MHz, CDCl3) δ = 3.70–3.55 (2H, m, 2 × CH), 2.99 (1H, d, J = 10.5 Hz, 
CH), 2.74–2.66 (1H, m, CH), 2.48–2.36 (1H, m, CH), 2.16 (3H, s, CH3), 1.87–1.49 (11H, m, 11 × 
CH), 1.37–1.24 (1H, m, CH); 13C NMR (100 MHz, CDCl3) δ = 169.8 (C=O), 75.6 (C), 53.0 (CH2), 
48.0 (CH2), 43.0 (CH), 39.5 (CH2), 33.8 (CH2), 30.3 (CH2), 24.6 (CH2), 21.6 (CH2), 21.3 (CH2), 21.0 
(CH3); HRMS m/z (ES) Found: MH+, 209.1650. C12H21N2O requires MH+ 209.1648; LRMS m/z 










To cycloadduct 275 (43 mg, 0.22 mmol) was added BH3•THF complex solution (2.2 mL, 2.2 mmol, 
1 M). The mixture was heated under reflux for 17 h and was cooled to rt. The reaction was 
quenched with MeOH (10 mL) and the mixture was concentrated under reduced pressure to give 
the crude product as a colourless. The crude product was purified by column chromatography on 
silica gel, eluting with CH2Cl2–MeOH–NH3 (9:1:0.5) to give diamine 281 (22 mg, 55%) as a pale 
yellow oil; Rf 0.11 [CH2Cl2–MeOH–NH3 (9:1:0.5)]; FT-IR max (film)/cm-1 3391 (N-H), 3269, 2958, 
2873, 1634, 1539, 1455, 1302, 1112, 731; 1H NMR (400 MHz, CDCl3) δ = 5.00 (2H, br s, 2 × NH), 
3.26–3.12 (1H, m, CH), 3.03–2.83 (2H, m, 2 × CH), 2.83–2.69 (3H, m, 3 × CH), 2.09–1.96 (2H, m, 
2 × CH), 1.92–1.83 (3H, m, 3 × CH), 1.82–1.69 (4H, m, 4 × CH), 1.64–1.53 (1H, m, CH), 1.50–
1.41 (1H, m, CH), 1.18 (3H, t, J = 7.0 Hz, CH3); 13C NMR (100 MHz, CDCl3) δ = 73.5 (C), 50.6 
(CH2), 45.3 (CH2), 43.4 (CH), 43.2 (CH2), 38.4 (CH2), 37.3 (CH2), 28.4 (CH2), 25.1 (CH2), 21.6 
(CH2), 14.1 (CH3); HRMS m/z (ES) Found: MH+, 183.1860. C11H23N2 requires MH+ 183.1856; 
LRMS m/z (ES) 183 (100%, MH+). 
1-(2-Bromoethyl)cyclopropan-1-ol (376)  
 
 
To a solution of ethyl 3-bromopropionate (4.6 mL, 36 mmol) in Et2O (36 mL) was added Ti(OiPr)4 
(1.1 mL, 3.6 mmol) and cooled to 0 °C. A solution of EtMgBr in Et2O [prepared from magnesium 
(2.0 g, 81 mmol) and bromoethane (6.0 mL, 81 mmol) in Et2O (39 mL), stirred at reflux for 1 h] was 
added dropwise. The mixture was warmed to rt and stirred for 16 h. The reaction was quenched 
with water (150 mL) and the mixture was diluted with 5% v/v aqueous H2SO4 (150 mL) and EtOAc 
(300 mL). The organic layer was separated, dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to give the crude product as a brown oil. The crude product 
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was purified by column chromatography on silica gel, eluting with petrol−EtOAc (4:1) to give 
cyclopropanol 376 (5 g, 84%) as a yellow oil; Rf 0.43 [petrol–EtOAc (7:3)]; 1H NMR (400 MHz, 
CDCl3) δ = 3.64 (2H, t, J = 7.5 Hz, CH2), 2.23–2.11 (3H, m, OH & CH2), 0.86–0.81 (2H, m, CH2), 
0.59–0.54 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 55.0 (C), 41.3 (CH2), 29.9 (CH2), 13.6 




To a solution of cyclopropanol 376 (5.0 g, 30 mmol) in CH2Cl2 (60 mL) was added N-
bromosuccinimide (5.4 g, 30 mmol) at 0 °C. The mixture was warmed to rt and stirred for 1 h. The 
solvent was removed under reduced pressure to give the crude product as an orange solid. The 
crude product was purified by column chromatography on silica gel, eluting with petrol−EtOAc (7:3) 
to give ketone 377 (5.7 g, 78%) as an orange oil; Rf 0.52 [petrol–EtOAc (7:3)]; 1H NMR (400 MHz, 
CDCl3) δ = 3.56 (4H, t, J = 6.5 Hz, 2 × CH2), 3.05 (4H, t, J = 6.5 Hz, 2 × CH2); 13C NMR (100 MHz, 




To a solution of ketone 377 (4.4 g, 18 mmol) in benzene (160 mL) was added ethylene glycol (1.1 
mL, 20 mmol) followed by TsOH.H2O (169 mg, 0.888 mmol). The mixture was heated at reflux for 
16 h with a Dean-Stark trap and cooled to rt. The solvent was removed under reduced pressure to 
give the crude product as a dark brown oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol−EtOAc (49:1) to give ketal 378 (2.5 g, 49%) as a 
colourless oil which crystallised on standing to give a white solid; m.p. 48−50 °C [petrol−EtOAc] 
(lit.112 65 C [no solvent]); Rf 0.60 [petrol–EtOAc (7:3)]; 1H NMR (400 MHz, CDCl3) δ = 3.99 (4H, 
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s, 2 × CH2), 3.43–3.37 (4H, m, 2 × CH2), 2.30–2.22 (4H, m, 2 × CH2); 13C NMR (100 MHz, CDCl3) 




To a solution of ketal 378 (8.2 g, 29 mmol) in PhMe (32 mL) was added KOtBu (3.8 g, 34 mmol) in 
THF (32 mL) at 0 °C using a syringe pump (0.2 mLmin-1). Once addition was complete the mixture 
was allowed to warm up to rt and stirred for 1 h. The mixture was diluted with saturated aqueous 
NH4Cl (80 mL) and EtOAc (300 mL). The organic layer was separated, dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product as a yellow 
oil. The crude product was purified by column chromatography on silica gel, eluting with 
petrol−EtOAc (19:1) to give bromide 372 (3 g, 51%) as a colourless oil; Rf 0.62 [petrol–EtOAc 
(7:3)]; 1H NMR (400 MHz, CDCl3) δ = 5.71 (1H, dd, J = 17.0, 10.5 Hz, CH), 5.41 (1H, dd, J = 17.0, 
1.5 Hz, CHAHB), 5.22 (1H, dd, J = 10.5, 1.5 Hz, CHAHB), 4.00–3.84 (4H, m, 2 × CH2), 3.45–3.38 
(2H, m, CH2), 2.35–2.27 (2H, m, CH2); 13C NMR (100 MHz, CDCl3) δ = 136.8 (CH), 116.4 (CH2), 
108.0 (C), 64.7 (CH2), 41.5 (CH2), 26.4 (CH2). Data consistent with the literature.112 
2-(Phenylsulfanyl)acetonitrile (371)  
 
To a solution of bromoacetonitrile (7 mL, 0.1 mol) in DMF (227 mL) was added thiophenol (9.3 mL, 
91 mmol) at 0 °C followed by K2CO3 (25 g, 0.18 mmol). The mixture was stirred for 2.5 h and 
warmed to rt. The mixture was filtered through a pad of celite and the filtrate was diluted with Et2O 
(250 mL) and water (200 mL). The organic layer was separated, washed with brine (100 mL), dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give nitrile 371 
(8.6 g, 64%) as a colourless oil; Rf 0.45 [petrol–EtOAc (7:3)]; 1H NMR (400 MHz, DMSO-d6) δ = 
7.53–7.48 (2H, m, 2 × CH), 7.47–7.39 (2H, m, 2 × H), 7.37–7.31 (1H, m, CH), 4.25 (2H, s, CH2); 
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13C NMR (100 MHz, DMSO-d6) δ = 133.3 (C), 130.0 (CH), 129.9 (CH), 128.0 (CH), 118.4 (CN), 





To a solution of diisopropylamine (0.15 mL, 1.0 mmol) in THF (0.5 mL) was added n-BuLi (0.4 mL, 
1 mmol, 2.5 M in hexanes) at −78 °C. After 10 min, nitrile 371 (72 mg, 0.50 mmol) in THF (0.2 mL) 
was added. After 10 min, bromide 372 (100 mg, 0.483 mmol) in THF (0.2 mL) was added and the 
mixture was allowed to warm to rt over 1 h. The mixture was diluted with saturated aqueous NH4Cl 
(5 mL) and Et2O (50 mL). The organic layer was separated, dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure to give the crude product as a brown oil. The crude 
product was purified by column chromatography on silica gel, eluting with petrol−EtOAc (19:1) to 
give nitrile 373 (61 mg, 46%) as a colourless oil; Rf 0.50 [petrol–EtOAc (7:3)]; FT-IR max (film)/cm-
1 3061, 2951, 2887, 2232, 1477, 1436, 1196, 1042, 945, 746, 692; 1H NMR (400 MHz, CDCl3) δ = 
7.66–7.58 (2H m, 2 × CH), 7.45–7.37 (3H, m, 3 × CH), 5.71 (1H, dd, J = 17.0, 10.5 Hz, CH), 5.40 
(1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.22 (1H, dd, J = 10.5, 1.5 Hz, CHAHB), 3.99–3.83 (5H, m, 2 × 
CH2 & CH), 2.06–1.92 (4H, m, 2 × CH2); 13C NMR (100 MHz, CDCl3) δ = 137.0 (CH), 134.7 (CH), 
130.6 (C), 129.5 (CH), 129.4 (CH), 119.3 (CN), 116.4 (CH2), 108.3 (C), 64.7 (CH2), 64.6 (CH2), 
36.9 (CH), 34.5 (CH2), 26.7 (CH2); HRMS m/z (ES) Found: MH+, 276.1054. C15H17NO2S requires 
MH+ 276.1053; Found:  MNa+, 298.0872. C15H17NO2SNa requires MNa+ 298.0872; LRMS m/z (ES) 










To a solution of diisopropylamine (0.07 mL, 0.5 mmol) in THF (0.5 mL) was added n-BuLi (0.19 mL, 
0.48 mmol, 2.5 M in hexanes) at −78 °C. After 10 min, nitrile 373 (123 mg, 0.447 mmol) in THF 
(0.5 mL) was added dropwise. After 20 min, 1-bromo-3-chloropropane (0.05 mL, 0.5 mmol) was 
added and the mixture was stirred for a further 30 min at −78 °C. The mixture was allowed to warm 
to rt over 1 h and was diluted with saturated aqueous NH4Cl (3 mL) and Et2O (15 mL). The organic 
layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as an orange oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol−EtOAc (19:1) to give nitrile 374 (91 mg, 54%) as 
a colourless oil; Rf 0.47 [petrol–EtOAc (7:3)]; FT-IR max (film)/cm-1 3057, 2962, 2889, 2227, 1477, 
1438, 1406, 1304, 1284, 1204, 1043, 992, 943, 914, 751, 697, 649; 1H NMR (400 MHz, CDCl3) δ 
= 7.73–7.67 (2H, m, 2 × CH), 7.52–7.38 (3H, m, 3 × CH), 5.72 (1H, dd, J = 17.0, 10.5 Hz, CH), 
5.40 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.21 (1H, dd, J = 10.5, 1.5 Hz, CHAHB), 3.99–3.85 (4H, m, 
2 × CH2), 3.64–3.53 (2H, m, CH2), 2.20–1.81 (8H, m, 4 × CH2); 13C NMR (100 MHz, CDCl3) δ = 
137.2 (CH), 137.1 (CH), 130.4 (CH), 129.3 (CH), 128.9 (C), 120.6 (CN), 116.2 (CH2), 108.1 (C), 
64.7 (CH2), 64.68 (CH2), 48.5 (C), 44.2 (CH2), 34.2 (CH2), 32.7 (CH2), 30.5 (CH2), 27.6 (CH2); 
HRMS m/z (ES) Found: MH+, 352.1144. C18H23NO2S35Cl requires MH+ 352.1133; Found: MH+, 
354.1128. C18H23NO2S37Cl requires MH+ 354.1103; LRMS m/z (ES) 352 (100%, MH+ for 35Cl), 354 










To a solution of nitrile 374 (99 mg, 0.28 mmol) in CH2Cl2 (3 mL) was added DIBAL-H (0.56 mL, 
0.56 mmol, 1 M in hexanes) at −78 °C. The mixture was stirred for 1 h and aqueous oxalic acid 
(1 mL, 0.5 M) was added dropwise. After 20 min, the mixture was allowed to warm to rt before a 
further portion of aqueous oxalic acid (1 mL, 0.5 M) and Et2O (20 mL) was added. The organic 
layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a colourless oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (19:1) to give aldehyde 366 (42 mg, 42%) 
as a colourless oil; Rf 0.38 [petrol–EtOAc (7:3)]; FT-IR max (film)/cm-1 3057, 2955, 2931, 2882, 
1713 (C=O), 1472, 1440, 1277, 1184, 1038, 990, 948, 748, 690; 1H NMR (400 MHz, CDCl3) δ = 
9.34 (1H, s, CHO), 7.54–7.23 (5H, m, 5 × CH), 5.77–5.66 (1H, m, CH), 5.39 (1H, dd, J = 17.0, 
1.5 Hz, CHAHB), 5.24–5.17 (1H, m, CHAHB), 4.01–3.84 (4H, m, 2 × CH2), 3.64–3.48 (2H, m, CH2), 
2.14–1.54 (8H, m, 4 × CH2); 13C NMR (100 MHz, CDCl3) δ = 194.8 (C=O), 137.2 (CH), 137.1 (CH), 
129.8 (CH), 129.1 (CH), 128.7 (C), 116.1 (CH2), 108.3 (C), 64.7 (CH2), 48.5 (C), 44.8 (CH2), 32.1 
(CH2), 26.9 (CH2), 26.7 (CH2), 23.5 (CH2); HRMS m/z (ES) Found: MH+, 377.0955. C18H24O3S35Cl 
requires MH+ 377.0949; Found: MH+, 379.0929. C18H24O3S37Cl requires MH+ 379.0919; LRMS 










To a solution of diisopropylamine (0.65 mL, 4.6 mmol) in THF (3 mL) was added n-BuLi (1.7 mL, 
4.2 mmol, 2.5 M in hexanes) at −78 °C. After 10 min, nitrile 371 (0.6 g, 4 mmol) in THF (1.5 mL) 
was added dropwise. After 10 min, 1-bromo-3-chloropropane (0.40 mL, 17 mmol) was added and 
the mixture was stirred for a further 10 min at −78 °C. The mixture was allowed to warm to rt over 
1 h and was diluted with saturated aqueous NH4Cl (15 mL) and Et2O (200 mL). The organic layer 
was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to give the crude product as a brown oil. The crude product was purified by column chromatography 
on silica gel, eluting with petrol–EtOAc (19:1) to give nitrile 380 (505 mg, 56%) as a colourless oil; 
Rf 0.59 [petrol–EtOAc (7:3)]; FT-IR max (film)/cm-1 3059, 2957, 2917, 2867, 2235, 1580, 1476, 
1441, 1304, 1284, 1065, 1025, 751, 691, 649; 1H NMR (400 MHz, CDCl3) δ = 7.66–7.62 (2H, m, 
2 × CH), 7.45–7.40 (3H, m, 3 × CH), 3.80–3.72 (1H, m, CH), 3.63–3.58 (2H, m, CH2), 2.16–1.97 
(4H, m, 2 × CH2); 13C NMR (100 MHz, CDCl3) δ = 134.8 (CH), 130.2 (C), 129.8 (CH), 129.6 (CH), 
118.8 (CN), 43.6 (CH2), 36.5 (CH), 29.8 (CH2), 29.6 (CH2). HRMS m/z (ES) Found: MNa+, 
248.0281. C11H12NS35ClNa requires MNa+ 248.0271; Found: MNa+, 250.0249. C11H12NS37ClNa 
requires MNa+ 250.0242; LRMS m/z (ES) 248 (100%, MNa+ for 35Cl), 250 (35%, MNa+ for 37Cl). 
(2-Bromoethoxy)(tert-butyl)dimethylsilane (392)  
 
 
To a solution of imidazole (3.7 g, 55 mmol) in DMF (7.5 mL) was added tert-butyldimethylsilyl 
chloride (6.4 g, 42 mmol) at rt and the mixture was stirred for 30 min. 2-bromoethanol (3.0 mL, 
42 mmol) was added and the mixture was stirred for 16 h at rt. The mixture was diluted with Et2O 
(150 mL) and water (50 mL). The organic layer was separated, dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to give the crude product as a colourless oil. 
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The crude product was purified by column chromatography on silica gel, eluting with petrol–EtOAc 
(19:1) to give compound 392 (7.8 g, 77%) as a colourless oil; Rf 0.68 [petrol–EtOAc (4:1)]; 1H NMR 
(400 MHz, CDCl3) δ = 3.92 (2H, t, J = 6.5 Hz, CH2), 3.42 (2H, t, J = 6.5 Hz, CH2), 0.93 (9H, s, 3 × 
CH3), 0.11 (6H, s, 2 × CH3); 13C NMR (100 MHz, CDCl3) δ = 63.5 (CH2), 33.2 (CH2), 25.8 (CH3), 




To a solution of diisopropylamine (6.2 mL, 44 mmol) in THF (42 mL) was added n-BuLi (17 mL, 42 
mmol, 2.4 M in hexanes) at −78 °C. After 10 min, acetonitrile (4.4 mL, 84 mmol) was added 
dropwise. After 10 min, compound 392 (5 g, 21 mmol) was added and the mixture was stirred for 
a further 30 min at −78 °C. The mixture was allowed to warm to rt over 1 h and was diluted with 
saturated aqueous NH4Cl (100 mL) and Et2O (200 mL). The organic layer was separated, dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude 
product as a pale yellow oil. The crude product was purified by column chromatography on silica 
gel, eluting with petrol–EtOAc (19:1) to give nitrile 388 (2.5 g, 60%) as a colourless oil; Rf 0.29 
[petrol–EtOAc (9:1)]; 1H NMR (400 MHz, CDCl3) δ = 3.74 (2H, t, J = 5.5 Hz, CH2), 2.47 (2H, t, J = 
7.0 Hz, CH2), 1.92–1.82 (2H, m, CH2), 0.92 (9H, s, 3 × CH3), 0.09 (6H, s, 2 × CH3); 13C NMR 
(100 MHz, CDCl3) δ = 119.7 (CN), 60.6 (CH2), 28.5 (CH2), 25.8 (CH3), 18.2 (C), 13.7 (CH2), −5.5 












To a solution of diisopropylamine (3.0 mL, 21 mmol) in THF (15 mL) was added n-BuLi (10 mL, 
21 mmol, 2.1 M in hexanes) at −78 °C. After 10 min, nitrile 388 (8.5 g, 42 mmol) in THF (3 mL) 
was added dropwise. After 10 min, bromide 372 (2.2 g, 11 mmol) in THF (3 mL) was added and 
the mixture was stirred for a further 30 min at −78 °C. The mixture was allowed to warm to rt over 
1 h and was diluted with saturated aqueous NH4Cl (100 mL) and Et2O (200 mL). The organic layer 
was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to give the crude product as a yellow oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (19:1) to give nitrile 389 (2.7 g, 81%) as a 
colourless oil; Rf 0.39 [petrol–EtOAc (4:1)]; FT-IR max (film)/cm-1 2952, 2930, 2888, 2855, 1469, 
1407, 1249, 1098, 1049, 933, 830, 777; 1H NMR (400 MHz, CDCl3) δ = 5.73 (1H, dd, J = 17.0, 
10.5 Hz, CH), 5.40 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.21 (1H, dd, J = 10.5, 1.5 Hz, CHAHB), 
3.99–3.87 (4H, m, 2 × CH2), 3.77 (2H, t, J = 6.0 Hz, CH2), 2.92–2.83 (1H, m, CH), 2.02–1.69 (6H, 
m, 3 × CH2), 0.91 (9H, s, 3 × CH3), 0.09 (3H, s, CH3), 0.08 (3H, s, CH3); 13C NMR (100 MHz, 
CDCl3) δ = 137.2 (CH), 122.0 (CN), 116.1 (CH2), 108.4 (C), 64.7 (CH2), 64.5 (CH2), 59.8 (CH2), 
35.3 (CH2), 35.2 (CH2), 27.9 (CH), 26.1 (CH2), 25.9 (CH3), 18.2 (C), -5.45 (CH3), −5.47 (CH3); 
HRMS m/z (ES) Found: MH+, 326.2156. C17H32NO3Si requires MH+ 326.2146; LRMS m/z (ES) 











To a solution of diisopropylamine (2.4 mL, 17 mmol) in THF (15 mL) was added n-BuLi (7.9 mL, 
17 mmol, 2.1 M in hexanes) at −78 °C. After 10 min, nitrile 389 (2.7 g, 8.3 mmol) in THF (2 mL) 
was added dropwise. After 20 min, 1-bromo-3-chloropropane (1.6 mL, 17 mmol) was added and 
the mixture was stirred for a further 30 min at −78 °C. The mixture was allowed to warm to rt over 
1 h and was diluted with saturated aqueous NH4Cl (60 mL) and Et2O (150 mL). The organic layer 
was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to give the crude product as a yellow oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (19:1) to give nitrile 390 (2.3 g, 69%) as a 
colourless oil; Rf 0.43 [petrol–EtOAc (4:1)]; FT-IR max (film)/cm-1 2955, 2931, 2884, 2856, 1470, 
1405, 1252, 1095, 1044, 940, 834, 775; 1H NMR (400 MHz, CDCl3) δ = 5.73 (1H, dd, J = 17.0, 
10.5 Hz, CH), 5.40 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.22 (1H, dd, J = 10.5, 1.5 Hz, CHAHB), 
4.00–3.87 (4H, m, 2 × CH2), 3.82 (2H, t, J = 6.5 Hz, CH2), 3.58 (2H, t, J = 6.5 Hz, CH2), 2.00–1.69 
(10H, m, 5 × CH2), 0.92 (9H, s, 3 × CH3), 0.09 (6H, s, 2 × CH3); 13C NMR (100 MHz, CDCl3) δ = 
137.2 (CH), 123.1 (CN), 116.2 (CH2), 108.3 (C), 64.6 (CH2), 59.3 (CH2), 44.6 (CH2), 38.6 (C), 38.3 
(CH2), 34.0 (CH2), 32.6 (CH2), 30.0 (CH2), 27.6 (CH2), 25.9 (CH3), 18.2 (C), −5.4 (CH3); HRMS m/z 
(ES) Found: MH+, 402.2244. C20H37NO3Si35Cl requires MH+ 402.2226; Found: MH+, 404.2224. 
C20H37NO3Si37Cl requires MH+ 404.2196; LRMS m/z (ES) 402 (100%, MH+ for 35Cl), 404 (35%, 










To a solution of nitrile 390 (350 mg, 0.871 mmol) in CH2Cl2 (8.7 mL) was added DIBAL-H (1.7 mL, 
1.7 mmol, 1 M in hexanes) at −78 °C. The mixture was stirred for 1 h and aqueous oxalic acid 
(2 mL, 0.5 M) was added dropwise. After 20 min, the mixture was allowed to warm to rt before a 
further portion of aqueous oxalic acid (4 mL, 0.5 M) and Et2O (100 mL) was added. The organic 
layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a colourless oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (19:1) to give aldehyde 381 (262 mg, 74%) 
as a colourless oil; Rf 0.46 [petrol–EtOAc (4:1)]; FT-IR max (film)/cm-1 2952, 2926, 2886, 2859, 
1724 (C=O), 1471, 1459, 1257, 1092, 1045, 938, 834, 776; 1H NMR (400 MHz, CDCl3) δ = 9.42 
(1H, s, CHO), 5.71 (1H, dd, J = 17.0, 10.5 Hz, CH), 5.38 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.20 
(1H, dd, J = 10.5, 1.5 Hz, CHAHB), 4.01–3.84 (4H, m, 2 × CH2), 3.61 (2H, t, J = 6.0 Hz, CH2), 3.58–
3.48 (2H, m, CH2), 1.78 (2H, t, J = 6.0 Hz, CH2), 1.74–1.51 (8H, m, 4 × CH2), 0.88 (9H, s, 3 × CH3), 
0.03 (6H, s, 2 × CH3); 13C NMR (100 MHz, CDCl3) δ = 205.1 (CH), 137.3 (CH), 116.0 (CH2), 108.6 
(C), 64.6 (CH2), 58.7 (CH2), 49.5 (C), 45.3 (CH2), 36.7 (CH2), 31.5 (CH2), 28.1 (CH2), 26.5 (CH2), 
25.9 (CH3), 24.1 (CH2), 18.2 (C), −5.6 (CH3); HRMS m/z (ES) Found: MH+, 405.2222. 
C20H38O4Si35Cl requires MH+ 405.2222; Found: MH+, 407.2198. C20H38O4Si37Cl requires MH+ 








To a solution of chloromethyltrimethylsilane (3.4 mL, 25 mmol) in N,N-dimethylformamide (30 mL) 
was added sodium azide (4.8 g, 74 mmol) followed by potassium iodide (81 mg, 0.49 mmol). The 
mixture was stirred for 10 min at rt before being warmed to 60 °C. The mixture was stirred for 12 
h and cooled to rt. The crude product was collected using vacuum distillation (vapour temperature 
65 °C under house vacuum) and was diluted with Et2O (10 mL), washed with water (2 × 5 mL), 
dried over anhydrous MgSO4, and filtered. The solvent was removed through distillation to give 
azide 399 (2 g, 63%) as a colourless oil; FT-IR max (film)/cm-1 2958, 2893, 2088, 1685, 1293, 
1253, 840; 1H NMR (400 MHz, CDCl3) δ = 2.78 (2H, s, CH2), 0.14 (9H, s, 3 × CH3); 13C NMR 




To a suspension of phthalimide potassium salt (7.8 g, 42 mmol) and TBAI (154 mg, 0.417 mmol) 
in DMF (50 mL) was added chloromethyltrimethylsilane (5.3 mL, 38 mmol). The mixture was 
heated at 70 °C for 4 h and cooled to rt. The mixture was diluted with Et2O (200 mL) and water 
(50 mL). The organic layer was separated, washed with brine (50 mL), dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to give the crude product 400 (8.9 g, 
quantitative yield) as a yellow oil; Rf 0.25 [petrol–EtOAc (9:1)]; 1H NMR (400 MHz, CDCl3) δ = 
7.86–7.80 (4H, m, 2 × CH), 7.74–7.67 (2H, m, 2 × CH), 3.22 (2H, s, CH2), 0.14 (9H, s, 3 × CH3); 
13C NMR (100 MHz, CDCl3) δ = 168.5 (C=O), 133.6 (CH), 132.3 (C), 122.9 (CH), 29.2 (CH2), −1.8 







To a suspension of potassium cyanide (5.6 g, 85 mmol) in ethylene glycol (60 mL) was added 4-
bromo-1-butene (8.0 mL, 78 mmol). The mixture was heated at 100 °C for 2 h and cooled to rt. 
The crude product was collected using vacuum distillation (vapour temperature 80 °C under house 
vacuum) and was diluted with Et2O (20 mL), washed with water (2 × 10 mL), dried over anhydrous 
MgSO4, and filtered. The solvent was removed using distillation to give nitrile 404 as a colourless 
oil; Rf 0.20 [petrol–EtOAc (9:1)]; 1H NMR (400 MHz, CDCl3) δ = 5.96–5.73 (1H, m, CH), 5.26–5.15 
(2H, m, CH2), 2.52–2.35 (4H, m, 2 × CH2); 13C NMR (100 MHz, CDCl3) δ = 134.1 (CH), 119.2 (CN), 





To a solution of diisopropylamine (0.68 mL, 4.8 mmol) in THF (3 mL) was added n-BuLi (2.1 mL, 
4.8 mmol, 2.3 M in hexanes) at −78 °C. After 10 min, nitrile 404 (784 mg, 9.66 mmol) in THF (1 mL) 
was added dropwise. After 10 min, bromide 372 (500 mg, 2.41 mmol) in THF (1 mL) was added 
and the mixture was stirred for a further 30 min at −78 °C. The mixture was allowed to warm to rt 
over 1 h and was diluted with saturated aqueous NH4Cl (10 mL) and Et2O (60 mL). The organic 
layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a yellow oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (9:1) to give nitrile 405 (193 mg, 39%) as 
a colourless oil; Rf 0.17 [petrol–EtOAc (9:1)]; FT-IR max (film)/cm-1 3085, 2948, 2889, 2241, 1645, 
1454, 1408, 1207, 1189, 1043, 991, 927, 734; 1H NMR (400 MHz, CDCl3) δ = 5.90–5.78 (1H, m, 
CH), 5.73 (1H, dd, J = 17.0, 10.5 Hz, CH), 5.40 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.25–5.18 (3H, 
m, CHAHB & CH2), 4.01–3.87 (4H, m, 2 × CH2), 2.73–2.65 (1H, m, CH), 2.36 (2H, t, J = 7.0 Hz, 
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CH2), 2.02–1.93 (1H, m, CH), 1.89–1.81 (1H, m, CH), 1.78–1.71 (2H, m, CH2); 13C NMR (100 MHz, 
CDCl3) δ = 137.2 (CH), 133.1 (CH), 121.6 (CN), 118.9 (CH2), 116.2 (CH2), 108.3 (C), 64.7 (CH2), 
64.5 (CH2), 36.3 (CH2), 35.1 (CH2), 31.4 (CH), 25.7 (CH2); HRMS m/z (ES) Found: MH+, 208.1333. 





To a solution of diisopropylamine (0.22 mL, 1.6 mmol) in THF (1 mL) was added n-BuLi (0.66 mL, 
1.5 mmol, 2.3 M in hexanes) at −78 °C. After 10 min, nitrile 405 (158 mg, 0.762 mmol) in THF 
(0.5 mL) was added dropwise. After 20 min, 1-bromo-3-chloropropane (0.15 mL, 1.5 mmol) was 
added and the mixture was stirred for a further 30 min at −78 °C. The mixture was allowed to warm 
to rt over 1 h and was diluted with saturated aqueous NH4Cl (2 mL) and Et2O (10 mL). The organic 
layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a yellow oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol–EtOAc (9:1) to give nitrile 406 (169 mg, 82%) as 
a colourless oil; Rf 0.69 [petrol–EtOAc (7:3)]; FT-IR max (film)/cm-1 3078, 2960, 2888, 2233, 1643, 
1453, 1408, 1295, 1208, 1043, 993, 930, 655; 1H NMR (400 MHz, CDCl3) δ = 5.89–5.77 (1H, m, 
CH), 5.73 (1H, dd, J = 17.0, 10.5 Hz, CH), 5.40 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.29–5.19 (3H, 
m, CHAHB & CH2), 4.01–3.86 (4H, m, 2 × CH2), 3.58 (2H, t, J = 6.0 Hz, CH2), 2.41–2.31 (2H, m, 
CH2), 2.00–1.90 (2H, m, CH2), 1.90–1.83 (2H, m, CH2), 1.81–1.65 (4H, m, 2 × CH2); 13C NMR 
(100 MHz, CDCl3) δ = 137.1 (CH), 131.2 (CH), 122.9 (CN), 120.4 (CH2), 116.2 (CH2), 108.3 (C), 
64.7 (CH2), 44.6 (CH2), 40.3 (CH2), 39.7 (C), 33.4 (CH2), 32.6 (CH2), 29.5 (CH2), 27.5 (CH2); HRMS 
m/z (ES) Found: MH+, 284.1418. C15H23NO235Cl requires MH+ 284.1412; Found: MH+, 286.1409. 









To a solution of nitrile 406 (130 mg, 0.458 mmol) in CH2Cl2 (5 mL) was added DIBAL-H (0.92 mL, 
0.92 mmol, 1 M in hexanes) at −78 °C. The mixture was stirred for 1 h and aqueous oxalic acid 
(3 mL, 0.5 M) was added dropwise. After 20 min, the mixture was allowed to warm to rt before a 
further portion of aqueous oxalic acid (3 mL, 0.5 M) and Et2O (20 mL) was added. The organic 
layer was separated, dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a colourless oil. The crude product was purified by column 
chromatography on silica gel, eluting with petrol−EtOAc (19:1) to give aldehyde 401 (77 mg, 59%) 
as a colourless oil; Rf 0.47 [petrol–EtOAc (4:1)]; FT-IR max (film)/cm-1 3076, 2955, 2885, 2705, 
1725 (C=O), 1640, 1460, 1408, 1298, 1203, 1043, 995, 943, 885; 1H NMR (400 MHz, CDCl3) δ = 
9.46 (1H, s, CHO), 5.77–5.60 (2H, m, 2 × CH), 5.38 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.25–5.07 
(3H, m, CHAHB & CH2), 4.00–3.85 (4H, m, 2 × CH2), 3.52 (2H, t, J = 6.0 Hz, CH2), 2.28 (2H, d, J = 
6.0 Hz, CH2), 1.73–1.55 (8H, m, 4 × CH2); 13C NMR (100 MHz, CDCl3) δ = 205.6 (CH), 137.3 (CH), 
132.3 (CH), 118.8 (CH2), 116.0 (CH2), 108.6 (C), 64.6 (CH2), 51.1 (C), 45.1 (CH2), 36.4 (CH2), 31.7 
(CH2), 29.2 (CH2), 26.6 (CH2), 25.6 (CH2); HRMS m/z (ES) Found: MH+, 287.1418. C15H24O335Cl 
requires MH+ 287.1408; Found: MH+, 289.1396. C15H24O337Cl requires MH+ 289.1379; LRMS m/z 











To a solution of aldehyde 401 (133 mg, 0.464 mmol) in acetone (2.5 mL) was added sodium iodide 
(278 mg, 1.86 mmol). The mixture was heated at reflux for 16 h and cooled to rt. The mixture was 
diluted with Et2O (10 mL) and 5% wt aqueous sodium thiosulfate (3 mL). The organic layer was 
separated, washed with water (2 × 3 mL), and brine (3 mL), dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure to give aldehyde 408 (148 mg, 84%) as a yellow oil; Rf 
0.47 [petrol–EtOAc (4:1)]; FT-IR max (film)/cm-1 3076, 2952, 2887, 2701, 1722 (C=O), 1640, 1456, 
1405, 1188, 1045, 992, 921; 1H NMR (400 MHz, CDCl3) δ = 9.45 (1H, s, CHO), 5.79–5.60 (2H, m, 
2 × CH), 5.38 (1H, dd, J = 17.0, 1.5 Hz, CHAHB), 5.23–5.09 (3H, m, CHAHB & CH2), 3.99–3.86 (4H, 
m, 2 × CH2), 3.16 (2H, t, J = 6.5 Hz, CH2), 2.27 (2H, d, J = 7.5 Hz, CH2), 1.76–1.57 (8H, m, 4 × 
CH2); 13C NMR (100 MHz, CDCl3) δ = 205.6 (CH), 137.3 (CH), 132.3 (CH), 118.8 (CH2), 116.0 
(CH2), 108.6 (C), 64.6 (CH2), 51.1 (C), 36.4 (CH2), 32.9 (CH2), 31.7 (CH2), 27.4 (CH2), 25.6 (CH2), 
6.47 (CH2); HRMS m/z (ES) Found: MH+, 379.0760. C15H24O3I requires MH+ 379.0765; LRMS m/z 

















Table 1 Crystal data and structure refinement for oic278k_0m. 
Identification code oic278k_0m 
Empirical formula C18H19N3O3 
Formula weight 325.36 
Temperature 100 K 
Crystal system triclinic 
Space group P-1 
Unit cell dimensions a = 8.1741(7) Å                   α = 68.278(2)° 
b = 9.0755(8) Å                   β = 87.555(3)° 
c = 11.7728(10) Å               γ = 72.855(2)° 
Volume 773.11(12) Å3 
Z 2 
Density (calculated) 1.398 g/cm3 
Absorption coefficient 0.097 mm‑1 
F(000) 344 
Crystal size 0.32 × 0.28 × 0.21 mm3 
Radiation MoKα (λ = 0.71073) 
Theta range for data collection 3.734 to 55.246° 
Index ranges -10 ≤ h ≤ 10, -11 ≤ k ≤ 11, -15 ≤ l ≤ 15 
Reflections collected 19731 
Independent reflections 3593 [Rint = 0.0247, Rsigma = 0.0181] 
201 
 
Data / restraints / parameters 3593 / 0 / 218 
Goodness-of-fit on F2 1.037 
Final R indexes [I>=2σ (I)] R1 = 0.0354, wR2 = 0.0873 
Final R indexes (all data) R1 = 0.0432, wR2 = 0.0928 
Largest diff. peak and hole  0.31 and -0.23 e.Å-3 
 











CCDC Deposition Number 1907019 
Table 1 Crystal data and structure refinement for oic292v_0m. 
Identification code oic292v_0m 
Empirical formula C17H16N2O4 
Formula weight 312.32 
Temperature 99.97 K 
Crystal system monoclinic 
Space group P21/n 
202 
 
Unit cell dimensions a = 9.8029(10) Å                 α = 90° 
b = 10.9827(10) Å               β = 108.944(4)° 
c = 14.4853(13) Å               γ = 90° 
Volume 1475.1(2) Å3 
Z 4 
Density (calculated) 1.406  
Absorption coefficient 0.841 mm-1 
F(000) 656 
Crystal size 0.23 × 0.18 × 0.1 mm3 
Radiation CuKα (λ = 1.54178) 
Theta range for data collection 10.322 to 133.396° 
Index ranges -11 ≤ h ≤ 11, -13 ≤ k ≤ 13, -17 ≤ l ≤ 17 
Reflections collected 18953 
Independent reflections 2596 [Rint = 0.0606, Rsigma = 0.0343] 
Data / restraints / parameters 2596 / 0 / 210 
Goodness-of-fit on F2 1.242 
Final R indexes [I>=2σ (I)] R1 = 0.0412, wR2 = 0.1397 
Final R indexes (all data) R1 = 0.0466, wR2 = 0.1462 
Largest diff. peak and hole 0.31 and -0.25 e.Å-3 
 










Table 1 Crystal data and structure refinement for oic289k_0m_a. 
Identification code oic289k_0m_a 
Empirical formula C23H19N3O3 
Formula weight 385.41 
Temperature 100 K 
Crystal system monoclinic 
Space group Cc 
Unit cell dimensions a = 12.810(3) Å                 α = 90° 
b = 12.661(3) Å                 β = 95.874(8)° 
c = 12.025(3) Å                 γ = 90° 
Volume 1940.1(8) Å3 
Z 4 
Density (calculated) 1.319 g/cm3 
Absorption coefficient  0.089 mm-1 
F(000) 808.0 
Crystal size 0.379 × 0.267 × 0.211 mm3 
Radiation MoKα (λ = 0.71073) 
Theta range for data collection 4.536 to 55.28° 
Index ranges -16 ≤ h ≤ 16, -16 ≤ k ≤ 16, -15 ≤ l ≤ 15 
Reflections collected 31377 
Independent reflections 4501 [Rint = 0.0533, Rsigma = 0.0369] 
Data / restraints / parameters 4501 / 2 / 264 
Goodness-of-fit on F2 1.166 
Final R indexes [I>=2σ (I)] R1 = 0.0382, wR2 = 0.1021 
Final R indexes (all data) R1 = 0.0493, wR2 = 0.1210 
Largest diff. peak and hole 0.26 and -0.35 e.Å-3 

















CCDC Deposition Number 1939356 
Table 1 Crystal data and structure refinement for oic303k_0m. 
Identification code oic303k_0m 
Empirical formula C21H19N3O3 
Formula weight 361.39 
Temperature 100 K 
Crystal system monoclinic 
Space group Cc 
Unit cell dimensions a = 11.846(4) Å                 α = 90° 
b = 18.586(7) Å                 β = 124.369(9)° 
c = 9.443(3) Å                   γ = 90° 




Density (calculated) 1.399 g/cm3 
Absorption coefficient 0.095 mm-1 
F(000) 760.0 
Crystal size 0.36 × 0.28 × 0.26 mm3 
Radiation MoKα (λ = 0.71073) 
Theta range for data collection 4.382 to 55.102° 
Index ranges -15 ≤ h ≤ 15, -24 ≤ k ≤ 24, -12 ≤ l ≤ 12 
Reflections collected 19109 
Independent reflections 3965 [Rint = 0.0731, Rsigma = 0.0621] 
Data / restraints / parameters 3965 / 2 / 246 
Goodness-of-fit on F2 0.869 
Final R indexes [I>=2σ (I)] R1 = 0.0444, wR2 = 0.1130 
Final R indexes (all data) R1 = 0.0651, wR2 = 0.1306 
Largest diff. peak and hole  0.24 and -0.26 e.Å-3 
Flack parameter 0.0(8) 
 






Table 1 Crystal data and structure refinement for oic299k_0m. 
Identification code oic299k_0m 
Empirical formula C24H24Cl2N4O3 
Formula weight 487.37 
206 
 
Temperature 100 K 
Crystal system triclinic 
Space group P-1 
Unit cell dimensions a = 8.6240(10) Å                 α = 70.216(3)° 
b = 12.1397(14) Å               β = 77.391(3)° 
c = 12.1653(14) Å               γ = 74.423(3)° 
Volume 1143.0(2) Å3 
Z 2 
Density (calculated) 1.416 g/cm3 
Absorption coefficient 0.319 mm-1 
F(000) 508.0 
Crystal size 0.45 × 0.35 × 0.05 mm3 
Radiation MoKα (λ = 0.71073) 
Theta range for data collection 3.594 to 55.358° 
Index ranges -11 ≤ h ≤ 11, -15 ≤ k ≤ 15, -15 ≤ l ≤ 15 
Reflections collected 33392 
Independent reflections 5297 [Rint = 0.0648, Rsigma = 0.0437] 
Data / restraints / parameters 5297 / 252 / 263 
Goodness-of-fit on F2 1.042 
Final R indexes [I>=2σ (I)] R1 = 0.0550, wR2 = 0.1474 
Final R indexes (all data) R1 = 0.0697, wR2 = 0.1629 
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